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ii 
ABSTRACT 
Background 
In December 2010, a new genotype of respiratory syncytial virus (RSV) with a 72-
nucleotide duplication within the attachment (G) gene was identified in Ontario, 
Canada, and named ON1. Using the ON1 as a unique tag, this study aimed to 
understand; (1) how new RSV variants are introduced, spread and persist in 
communities, (2) the genomic signatures that define the emergent RSV variants and 
whether such substitutions may be associated with potential fitness advantages, and 
(3) the patterns of RSV spread across geographically defined regions (local and 
global). 
 
Methods 
Partial G gene (n=483) and whole genome (n=184) sequence datasets collected 
between 2010 and 2016 were analyzed using genetic diversity, phylogenetics and 
statistical methods to understand the molecular epidemiology of RSV in Kilifi 
County, Coastal Kenya. Further, Kenyan (partial G gene; n=2526) and global (full G 
gene, n=2238; whole genome, n=1194) sequence datasets collected between 1977 to 
2016  were analysed in a Bayesian framework for the inference of the 
phylogeographic history of local and global RSV spread, respectively. 
 
Results 
Following initial detection of the genotype ON1 in Kilifi in 2012, there was rapid 
replacement of the previously circulating RSV group A genotype GA2 by ON1 in 
subsequent epidemics. While this suggests elevated fitness of ON1 viruses, there was 
no clear evidence of altered pathogenicity of ON1 relative to GA2 in Kilifi. Signature 
   
 
 
 
iii 
amino acid substitutions were identified between surface proteins (G, F), polymerase 
(L) and matrix M2-1 proteins of Kilifi ON1 and GA2 viruses, suggesting co-evolution 
amongst antigenic and non-antigenic genes of RSV variants. Genetic and 
phylogenetic analyses reaffirmed previous conclusions that each RSV epidemic is 
characterized by the frequent introduction of multiple variants, few of which persist 
across epidemics. Finally, the phylogeographic analyses predicted the northern 
hemisphere to be the major source population of RSV into the tropics and the 
southern hemisphere and virus spread between locations in close proximity to be 
important for virus persistence within a country. 
 
Conclusions 
Tracking the ON1 tag offered important insights into RSV evolution and 
transmission. The use of whole genome sequencing and surveying all the variation 
throughout the genome will be crucial for greater understanding, and potentially 
improved control, of this important pathogen. However, there is a need for a more 
targeted approach to RSV surveillance and sequencing that will help build a better 
picture of RSV spread at different scales. 
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CHAPTER ONE 
Introduction 
1.1 RSV Disease Burden 
Human respiratory syncytial virus (RSV) is the most important cause of viral acute 
lower respiratory tract infections (ALRTI) in children worldwide and a health concern 
in terms of morbidity, mortality and costs (Simoes 1999; Cane 2001). The virus was 
first isolated from a captive chimpanzee in 1955 (Morris, Blount and Savage 1956) 
and thereafter identified to be a major human paediatric respiratory pathogen 
(Chanock and Finberg 1957; Chanock, Roizman and Myers 1957). Almost all 
individuals experience the first RSV infection by the age of two years, and about 1% 
of infants in their first year of life require hospitalization due to RSV-associated 
pneumonia or bronchiolitis (Henderson et al. 1979; Glezen et al. 1986; Nokes et al. 
2004).  Severe RSV infection early in life has been associated with later development 
of asthma and wheeze (Blanken et al. 2013). In addition, RSV is also an important 
cause of morbidity and mortality in the elderly and in adults with cardiopulmonary 
disease or with an impaired immune system (Falsey et al. 2005). 
 
A recent global study (2017) by Shi et al. reported that there were as many as 33·1 
million (uncertainty range [UR] 21·6–50·3) episodes of RSV-ALRI in 2015, and 
these resulted in about 3·2 million (2·7–3·8) hospital admissions and 59,600 (48,000–
74,500) in-hospital deaths in children younger than 5 years (Shi et al. 2017). In fact, 
they estimated that the overall RSV-ALRI mortality could be as high as 118,200 (UR 
94,600–149,400) if including deaths outside the hospital setting. Most of the RSV-
associated burden is in the developing countries (Weber, Mulholland and Greenwood 
1998; Williams et al. 2002; Nokes 2007; Nair et al. 2010; Shi et al. 2017). In Kenya, 
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about 85,000 RSV-associated infant severe lower respiratory tract infections (LRTI) 
cases have been estimated to occur per year (Nokes et al. 2008). Immunity to 
infection is not solid and repeat infection occurs throughout life (Connors et al. 1991; 
Hall et al. 1991; Falsey 2007; Agoti et al. 2012). Despite considerable effort to 
develop an RSV vaccine, none has been licensed so far (Neuzil 2016). Infants and 
young children at high risk for severe RSV disease can be substantially protected by 
the passive administration of a commercially available RSV-neutralizing monoclonal 
antibody (MAb), palivizumab (The IMpact-RSV Study Group 1998). An antiviral 
therapy, ribavirin, is available even though its efficacy is marginal and it is not 
recommended for routine use (Borkje 1982). The phenomenon of reinfection and 
difficulty in developing a vaccine may in part be due to the virus’ antigenic diversity 
(Melero and Moore 2013). However, there is a diverse set of vaccines that are in the 
development pipeline and targeting young children, older adults, and pregnant women 
(Neuzil 2016; PATH 2019). 
. 
1.2 RSV Genome and Diversity 
RSV is an RNA virus with an ~15.2 kb negative sense, single stranded genome made 
up of 10 genes encoding 11 proteins: the non-structural proteins (NS1, NS2) the 
nucleocapsid-associated proteins (N, P, L, M2-1, M2-2), matrix protein (M1) and 
surface glycoproteins (SH, G, F) (Cane 2001). A schematic representation of the RSV 
genome with the respective known function for each encoded protein is shown in, 
Figure 1.1 (Espinoza et al. 2014).  
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Figure 1.1: A schematic representation of the RSV genome indicating the known function for 
each encoded protein 
(Espinoza et al. 2014) 
 
 
A central characteristic of the majority of RNA virus populations is that they are 
highly dynamic, and this arises from short generation times (the average time taken 
for a viral genome or infected cell to produce another of its kind in a replication 
cycle), large population sizes, and high mutation frequencies (Rodrigo 1999; Belshaw 
et al. 2008; Peck and Lauring 2018). The accumulation of diversity often arises 
during genome replication whereby ~1 mutation per genome is generated as a result 
of an error-prone viral RNA-dependent RNA polymerase that lacks proofreading 
mechanisms (Holland et al. 1982; Steinhauer, Domingo and Holland 1992). During 
an infection, as a consequence of the high mutation rates, a heterogeneous population 
of closely related mutants is produced that is commonly referred to as a 
“quasispecies” (Domingo, Sheldon and Perales 2012). While it is thought that the 
   
 
 
 
18 
diversity in RSV is primarily driven by the error-prone polymerase, additional 
mechanisms of generation of diversity in other viruses include copy-choice 
recombination (the viral polymerase switches templates during replication) and 
reassortment (exchange of genetic segments during coinfection in segmented viruses). 
 
RSV strains are classified into two groups (A and B), Figure 1.2, based on antigenic 
and genetic variability in some of the structural proteins (Anderson et al. 1985; 
Mufson et al. 1985; Cristina et al. 1990). Phylogenetic studies of RSV molecular 
epidemiology have primarily focused on G-gene sequences. These studies have 
identified multiple distinct viruses within the two groups called genotypes (Peret et al. 
1998, 2000; Cane 2001). Peret et al in 1998 defined RSV genotypes based on 
sequence clusters in phylogenetic trees. Genotypes GA1 to GA5 were identified for 
RSV-A, resulting in amino acid level intergenotypic differences ranging between 10-
28%. For RSV-B, genotypes GB1 to GB4 were identified and the resultant 
intergenotypic differences ranged from 7-19% at the amino acid level (Peret et al. 
1998). The intergenotypic differences were calculated based on the G-protein’s 270nt 
second hypervariable region. The number of genotypes subsequently expanded with 
the rise, identification and classification of more circulating variants (Venter et al. 
2001; Venter, Collinson and Schoub 2002; Trento et al. 2003; Zlateva et al. 2004, 
2005; Eshaghi et al. 2012). These genotypes have informed current understanding of 
RSV molecular epidemiology, and it is thought that genotype genetic variability and 
replacements contribute to enabling the virus to cause yearly outbreaks (Peret et al. 
2000; Yamaguchi et al. 2011). 
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Figure 1.2: A schematic representation of the RSV classification into groups, genotypes and 
variants 
 
1.3 RSV Epidemiology 
RSV infections and disease in most places exhibit clear seasonality. Annual, biannual 
and biennial epidemics have been observed in different parts of the world (Weber, 
Mulholland and Greenwood 1998; Centers for Disease Control and Prevention (CDC) 
2004; Mlinaric-Galinovic et al. 2012; Agoti et al. 2014a). The two RSV groups often 
co-circulate in epidemics with RSV-A generally occurring more frequently (Michael 
Hendry et al. 1986; Hendry, Pierik and McIntosh 1989; Hall et al. 1990; Rajala et al. 
2003; Fodha et al. 2004). The pattern of alternation in dominance between RSV-A 
and B differs from place to place (Waris 1991; Cane 2001). In addition, epidemics are 
usually comprised of multiple genotypes even though the proportions of each 
genotype varies and genotype replacements are observed over time (Peret et al. 1998). 
The role and magnitude of genotype-specific herd immunity in driving the alternating 
patterns of change is not clear (Sande et al. 2013). Further, no conclusive association 
has been made between RSV groups or genotypes and disease severity based on the 
RSV-A	 RSV-B	
Genotypes		
Variants		
Groups	
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G-gene studies (Walsh et al. 1991; Panayiotou et al. 2014; Yoshihara et al. 2016; 
Otieno et al. 2017). While the existence of such an association would inform control 
strategies on prioritization of strains that need most urgent attention, little is known 
about the interaction between the non-structural proteins and disease severity or strain 
persistence in communities. 
 
An RSV genotype can be further divided into variants, Figure 1.2, which can either 
be (i) imported variants that show greater genetic divergence than expected from in 
situ diversification (Agoti et al. 2015b; Otieno et al. 2016), or (ii) local variants 
arising from recent introduction which subsequently diversify in situ (without time for 
purifying selection from, for example inter-epidemic bottlenecks) (Agoti et al. 2017). 
It has previously been shown that within RSV epidemics, there is co-circulation of 
viruses belonging to different RSV groups, genotypes and variants both imported and 
local, (Agoti et al. 2015b, 2017; Otieno et al. 2016). 
 
Generally, RSV outbreaks occur in the late fall and winter in the temperate regions 
and during the rainy seasons in the tropical regions (Moura et al. 2006; Goddard et al. 
2007; Meerhoff et al. 2009; Murray et al. 2012; Obando-Pacheco et al. 2018). 
However, associations between RSV and weather vary across years and geographic 
locations (Haynes et al. 2013). Most RSV seasons last between 5-6 months, with 
shorter seasons of 3-4months and longer seasons of up to 10 months reported for 
some countries (Obando-Pacheco et al. 2018). RSV seasonality is fairly consistent 
within most regions from year to year, with minor variations of 1-3 weeks in the start, 
end and/or peak of RSV activity. For countries with large territories and different 
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regional climatic regions such as Brazil, USA or Australia, intra-country differences 
in seasonality have been reported (Obando-Pacheco et al. 2018). 
 
1.3.1 RSV Epidemiology in Kenya 
Kilifi County, located in the South Eastern coastal Kenya, is characterized by a 
bimodal rainfall pattern with long rains during March-May and short rains in October-
November (http://en.climate-data.org/location/11152/ accessed on 30/03/2015); 
Figure 1.3A. Kisumu, located in the Western part of Kenya, equally has two rainy 
seasons from March through June and November through December albeit with 
higher annual and monthly average rainfall than Kilifi (http://en.climate-
data.org/location/715071/ accessed on 30/03/2015); Figure 1.3B. Annual RSV 
epidemics in Kilifi begin late October peaking from January to March, Figure 1.4. In 
western Kenya, however, RSV annual epidemics peak between April and July (Figure 
1.5), somewhat coincidental with the rainy season (Emukule et al. 2014). Therefore, 
RSV epidemics in these two regions of Kenya are seemingly and interestingly out of 
synchrony by about 3-4 months. 
 
 
Figure 1.3: Monthly avaerage rainfall and temperature in Kisumu and Kilifi, Kenya 
 
A: Kisumu B: Kilifi 
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Figure 1.4: Seasonality of RSV in Kilifi, Coastal Kenya, 2008– 2018 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Seasonality of RSV and other viruses in Western Kenya, 2009– 2012 
(Emukule et al. 2014) 
 
Understanding the mechanisms underlying the seasonal patterns of RSV remains a 
challenge and cannot be ascribed to climate alone (White et al. 2007). While prior 
infection can modulate disease severity, immunity to RSV infection is short-lived 
resulting in relatively common reinfections (Melero et al. 1997). At the population 
level, variation in herd immunity and socio-demographic factors between different 
communities are potential determinants of RSV infection transmission (Anderson et 
al. 1991; Peret et al. 2000; White et al. 2005; Zlateva et al. 2007; Lemey et al. 2014). 
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Factors such as HIV prevalence and malnutrition have also been found to potentially 
affect disease epidemiology in sub-Saharan Africa (Madhi et al. 2000; Preidis et al. 
2011). Therefore, an interplay of multiple factors determines the mechanics of virus 
transmission, i.e. introduction into a particular location, spread (or not) within and 
between locations, persistence or fade-out between epidemics; Figure 1.6. It follows 
that a study of local RSV transmission patterns in Kenya may not only elucidate the 
nature of RSV spread within and between the different parts of the country but also 
the potential factors influencing the countrywide disease transmission process (Out of 
Africa 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Virus strain introduction, spread, fadeout and persistence schema.  
A virus (star shape) may be introduced to a location (circle) and (i) not spread, or spread (ii) 
locally but not to other locations, (iii) between locations with various levels of local 
transmission, or (iv) countrywide (square) from a common source or in some order that may 
or may not be predictable, and (v) may (red virus) or may not (blue virus) persist between 
seasonal outbreaks. Here the term virus strain is interchangeable with variant, lineage, 
genotype, or group or species. 
(i)$
(ii)$
(iii)$ (iv)$
(v)$
   
 
 
 
24 
1.4 Immunity to RSV 
RSV repeatedly re-infects throughout life and re-infections can be severe (Nokes et 
al. 2008). Re-infection suggests an absence of sterilizing immunity to infection and 
disease and may in part relate to genetic diversity of the virus (Cane, Matthews and 
Pringle 1991; Sullender et al. 1991). Protective immunity in both infants and elderly 
adults correlates strongly with host factors such as the duration of circulating RSV 
neutralizing antibodies, the role of mucosal IgA and RSV-specific resident memory T 
cells (Johnson et al. 1987; Hendry et al. 1988; Habibi et al. 2015; Jozwik et al. 2015). 
 
The surface of an infectious RSV virion contains 3 virus encoded proteins; F, G and 
SH that are exposed to the host immune system. Studies with monoclonal antibodies 
have confirmed that two of these surface proteins, F and G, are the targets of antibody 
responses (Cote et al. 1981). Three distinct epitope regions have been identified on 
the G protein mainly through reactivity with murine monoclonal antibodies, i.e. 
conserved, group-specific and strain-specific epitopes (Martínez, Dopazo and Melero 
1997; Polack et al. 2005; Chirkova et al. 2013). Two forms of the G protein are 
synthesised in the course of infection; a membrane anchored form and a 6-9kD 
smaller soluble form (Hendricks et al. 1987). The soluble form is translated through 
an alternative in-frame start codon and is thought to act as an antigenic decoy by 
binding to host antibody and thus helping the virus to evade antibody mediated 
restriction both in vivo and in vitro (Roberts et al. 1994; Bukreyev et al. 
2008)(Bukreyev, Yang and Collins 2012). Neutralisation studies with monoclonal 
antibodies suggest that the F protein is the main target of cross-reactive neutralising 
antibodies (Olmsted et al. 1986). These studies show that only F specific monoclonal 
antibodies mediate complete neutralisation of RSV in vitro while antibodies to the G 
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protein mediate incomplete or strain specific neutralisation (Anderson, Bingham and 
Hierholzer 1988; Garcia-barreno et al. 1989). Multiple antigenic sites (I, II, IV and 0) 
in the F protein have been identified as  targets of neutralising antibodies (López et al. 
1990, 1998; McLellan et al. 2013). Other than the F and the G proteins, studies on the 
role of other RSV proteins in inducing resistance to RSV challenge  have shown that 
while the M, P and SH did not induce detectable resistance to RSV challenge of 
BALB/c mice, the M2 and N induced significant but not complete resistance. 
(Connors et al. 1991).  In addition to humoral responses, animal studies have reported 
the development of cytotoxic T-cell responses directed at the N, SH, F, M, M2 and 
NS2 proteins (Cherrie et al. 1992).  
 
Several RSV proteins also inhibit innate immune responses. The  1 and NS2 proteins  
prevent induction of and disruption of IFN a/b activity (Spann et al. 2004). Studies 
with bovine and human RSV strains with a deletion of the SH gene have 
demonstrated the roles of the SH protein in the inhibition of TNF-a signalling, 
increased IL-1β response, and induction of apoptosis (Fuentes et al. 2007; Taylor et 
al. 2014; Russell et al. 2015). Cytokines are an important element of the early 
immune response to RSV. RSV infection elicits production of an array of cytokines 
that mediate a number of functions that are not only necessary for virus clearance but 
that may also promote pathology. T cells produce pro-inflammatory mediators in 
response to RSV infection. Type 1 T helper (Th1) cells produce IL-2, IFN-g and 
lymphotoxin while Th2 cells produce IL-4, -5, -6 and -10. The type of T helper 
response elicited in response to infection is largely dependent on the cytokine milieu 
present at the time of priming (Openshaw 2002). An imbalance in Th1/Th2 responses 
to RSV has been cited as a contributor to severe illness (Folkerts et al. 1998). RSV 
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associated disease severity appears to be the product of a Th2 skewed response 
(Becker 2006) although this has not been consistently confirmed in the respiratory 
secretions of infants with acute RSV bronchiolitis (Garofalo et al. 2001). 
 
To a large extent, the dominant RSV strain in a particular epidemic is one that had 
been observed at low frequencies in previous seasons and has undergone some 
genetic changes since it was last seen (Cane and Pringle 1995; Yamaguchi et al. 
2011) However, studies in Kilifi and other places have shown that re-infection with 
the same RSV strain (same G-gene sequence) is possible and could cause mild to 
severe RSV disease in infants (Hall et al. 1991; Venter, Collinson and Schoub 2002; 
Scott et al. 2006). In addition, a study of RSV isolates from Cuba in 1994-1995 
showed that the isolates had only five G gene nucleotide differences with the RSV 
long strain isolated in 1956 in USA (Valdés et al. 1998). The lack of variation in the 
G (and potentially F) protein of re-infecting strains fails to accord with their role as 
targets of protective immunity and implies changes in other regions of the genome 
may also contribute to immune escape. Considered together, the results of these 
studies suggest that changes in parts of the genome that do not encode for surface 
exposed proteins may still exert potent effects on both virus fitness and potentially 
alter the effectiveness of protective host responses. Consequently, vaccine 
development programmes are likely to benefit from full-length genome studies, in 
which variations in the entire virus genome and not only in surface expressed proteins 
are analyzed. This will result in better understanding the targets of host immune 
responses and the virus-specific mechanisms that allow for evasion from these 
responses. 
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1.5 G-gene Duplication Variants 
RSV has a non-segmented genome and does not show the abrupt antigenic changes 
that occur, for example, in the influenza A viruses as a result of genome reassortment 
(Brown et al. 1998; Webby et al. 2000; Newman et al. 2008). Furthermore, 
recombination has not been observed or reported in natural infections with RSV to 
date and hence might not be a source of diversity for the virus population. As with 
any RNA virus, the low polymerase fidelity in virus replication leads to high mutation 
rates and existence of virus quasi-species (Holland et al. 1982). The distribution of 
fitness amongst the swarm of a virus population both spatially and temporally has 
implications for its transmission. Rapid accumulation of sequence changes in the RSV 
G protein with time suggests selective forces acting on the viral population (Cane and 
Pringle 1995). However, antigenic variation is not necessarily the result of immune 
selection (they may be random) as neutral variation may also result in amino acid 
replacements over time (Domingo et al. 1993). 
 
Two large duplication variants within the G-gene have been detected in RSV isolates, 
one in each group, Figure 1.7. The initial variant involved a 60-nucleotide duplication 
in RSV B that was first detected in Buenos Aires, Argentina, in 1999 and named the 
‘BA genotype’ (Trento et al. 2003). Retrospective analysis of RSV samples from 
Madrid, Spain, detected the BA genotype between 1998 to 1999 (Trento et al. 2010). 
The BA genotype has spread globally and become the predominant group B genotype, 
and also undergone genetic drift resulting in further subdivision into genotypes BA1-
BA10 (Trento et al. 2006; Dapat et al. 2010; van Niekerk and Venter 2011). The 
estimated nucleotide substitution rates for the BA viruses identified in Argentina were 
significantly higher than those previously reported for both RSV-A and B (Trento et 
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al. 2006). Notably, additional positively selected and glycosylation sites were 
identified within the duplicated segment in subsequent analysis (Zlateva et al. 2005). 
  
 
 
 
 
 
 
Figure 1.7: Amino acid alignments showing the duplication regions in the ON1 and BA 
genotypes. 
The areas enclosed by black rectangles show the duplication regions within the G protein for 
genotype (A) ON1 and (B) BA viruses. The amino acid positions for both (A) and (B) are 
relative to references JN257693 and JF704220, respectively. 
 
The more recent duplication variant involves a 72-nucleotide duplication within the 
G-gene of RSV-A. It was first identified in Ontario, Canada, in 2010 and named the 
‘ON1 genotype’ (Eshaghi et al. 2012). It has subsequently been detected globally in 
several countries (Lee et al. 2012; Prifert et al. 2013; Tsukagoshi et al. 2013; Valley-
Omar et al. 2013; Choudhary et al. 2013; Khor et al. 2013; Agoti et al. 2014b; 
Panayiotou et al. 2014; Pierangeli, Trotta and Scagnolari 2014; Ren et al. 2014; 
Auksornkitti et al. 2014; Avadhanula et al. 2015; Ahmed et al. 2016; Yoshihara et al. 
2016; Fall et al. 2016; Korsun et al. 2017; Park et al. 2017; Calderón et al. 2017; 
Comas-García et al. 2018; Gaymard et al. 2018). Through continuous hospital 
surveillance for RSV in paediatric pneumonia admissions, the first detection of the 
ON1 genotype in Kilifi was in February 2012, and by the end of 2012 the ON1 
variant was the dominant genotype of the RSV-A strains (Agoti et al. 2014b). 
However, it is neither known when this genotype was first introduced in Kenya nor all 
the variants circulating. 
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Most important for this thesis project, these duplications provide a vital tag as a 
mechanism for tracking a virus (in this case RSV) at a range of scales (local 
community, across the country, intra-continent and global) with the benefit of 
knowing how a new variant emerged, when it first entered a community, and 
assessing the pace and nature of spread and the accompanying genomic changes. 
From recent reports, it is becoming apparent that these G-gene duplication variants 
are not unique to RSV. Two duplications, 180nt and 111nt, have been detected in the 
G-gene of human metapneumovirus (hMPV) with increase in their frequencies in 
subsequent epidemics (Piñana et al. 2017; Saikusa et al. 2017a, 2017b). Therefore, 
further studies can be designed to not only determine the mechanisms leading to the 
generation of these duplications, but also the functional importance underlying the 
fitness and survival of these duplication variants. 
 
1.6 RSV Whole-genome Studies 
Previous and most of the current RSV epidemiological studies are based on partial G-
gene sequencing. This is because the G protein interacts with the host cell receptors 
(thus far undefined), is a target for neutralizing antibodies, and is highly variable 
(Johnson et al. 1987). G protein variability is greater than that of other RSV proteins, 
both between and within the RSV-A and B groups (Sullender 2000). However, the 
portion of the G-gene used in the studies mentioned above, the C-terminal 
hypervariable region, accounts for only ~2% (300 nt) of the RSV genome. 
 
There are few RSV studies at the whole genome level (Kumaria et al. 2011; Rebuffo-
Scheer et al. 2011; Tan et al. 2012, 2013; Agoti et al. 2015a, 2017; Bose et al. 2015; 
   
 
 
 
30 
Schobel et al. 2016). Because Sanger chain-termination sequencing is costly and 
labour-intensive, earlier RSV whole genome sequencing (WGS) studies were limited 
to reference and mutant strains as part of functional biology and vaccine studies 
(Connors et al. 1995; Tolley et al. 1996). However, with the development and 
increasing access to next generation sequencing (NGS) technologies (Metzker 2010), 
in addition to development of optimized protocols for whole genome sequencing 
(Agoti et al. 2015a; Goya et al. 2018), it has become more affordable and efficient to 
sequence full genomes (Morey et al. 2013). 
 
Very few studies have looked at diversity in genes other than the G (Johnson and 
Collins 1988, 1990; Moudy, Sullender and Wertz 2004; Agoti et al. 2015a). Since 
2011, there has been interest by different groups working with RSV to sequence full 
genomes. These whole genome studies have not only provided novel insights on the 
basic biology of the virus but also elucidated the patterns of diversity in the intergenic 
regions, gene-start and gene-end sequences, where differences within these areas have 
been ascribed some functional importance especially in transcription and selection 
advantage (Kuo, Fearns and Collins 1997; Sutherland, Collins and Peeples 2001; 
Harmon and Wertz 2002; Kumaria et al. 2011; Rebuffo-Scheer et al. 2011). 
 
The rate of nucleotide substitution for the G gene encoding the attachment protein has 
been estimated to be 1.83 × 10−3 (95% confidence interval [CI], 1.44 - 2.26 × 10−3) 
and 1.95 × 10−3 (95% CI, 1.15 - 2.34 × 10−3) nucleotide substitutions/site/year for 
group A and B, respectively, with some variation dependent on the timescale of 
observation (Zlateva et al. 2004, 2005). Similarly, although at a lower rate, there is 
also significant accumulation of substitutions across the rest of the genome (Agoti et 
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al. 2015a, 2017). At present, there is limited knowledge about the selective forces 
acting on genes other than the G gene as a result of paucity of WGS, particularly from 
the same location over a period spanning multiple seasons (Tan et al. 2012, 2013). 
Therefore, genetic signatures across the rest of the genome that might additionally 
inform on the adaptive mechanisms of RSV following introduction into communities 
have not been investigated before. 
 
NGS platforms are now increasingly in use in clinical microbiology laboratories 
(Deurenberg et al. 2017). However, there are currently relatively few RSV genomes 
(~ 1,000) to obtain a clear understanding of the virus. A whole genome sequence of a 
virus obtained from one isolate at a particular point in time provides a complete 
snapshot of that virus at that time. Sequencing multiple genomes sampled at different 
time points could further inform on the genetic diversity of the virus, its evolutionary 
history, genes and sites under immune selection, and the fine-grain resolution of 
transmission patterns into, within and between populations. Human influenza virus 
studies, for example, for which there are over 3,000 genomes have reported epistatic 
interactions between the gene coding for the virus surface haemagglutinin (HA) 
protein with genes encoding other (non-surface) viral proteins (Mitnaul et al. 2000). 
Studying RSV genetic variation at the genome level could have the potential of 
revealing additional genes, other than the G-gene, and individual codons that are most 
crucial for RSV survival.  
 
Tracking viral transmission over short periods and smaller geographical regions 
requires a greater evolutionary signal that is provided by whole genome sequences 
(Kamoun et al. 2015). Previous analyses have shown that the G-gene suffices to show 
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general patterns of diversity of RSV over multiple epidemics both locally and 
globally (Peret et al. 2000; Botosso et al. 2009; Katzov-Eckert et al. 2012). However, 
over shorter periods G-gene falls inadequate as the analyses include recently diverged 
isolates for which greater resolving power is required. Through our previous analyses, 
we observed multiple sequences sourced from the same epidemics that are 100% 
identical in the G-gene but possessing differences elsewhere in the genome (Agoti et 
al. 2015a). Such differences in the other open reading frames (ORFs) may be 
exploited to characterize transmission chains over short periods (single epidemics) or 
distances. In addition, as a result of the rapid spread of the virus, global variation 
equilibrium is quickly attained making tracking of transmission at the global level 
equally difficult over short periods using G-gene alone. 
 
1.7 Evolution of genotypes and variants 
RSV is continuously evolving as is exemplified by the rise of new variants and 
genotypes (Trento et al. 2010; Katzov-Eckert et al. 2012). The G-protein shows 
capacity to accommodate frequent multiple nucleotide and amino acid mutations and, 
twice in the recent past, large duplications. Factors such as short-term variant-specific 
herd immunity, selection, transmission bottlenecks and neutral epidemiological 
dynamics are likely to affect RSV genotype/variant prevalence (Sullender 2000; 
Botosso et al. 2009). With the complex RSV circulation patterns, little is known about 
when most of the genetic diversity observed is generated, for example between or 
within the annual epidemics. 
Although minor duplications or deletions of 1-2 codons in the G protein of RSV have 
been reported prior to emergence of the 60 and 72 nucleotide duplication genotypes, 
they were identified in few epidemics and were short-lived (García et al. 1994; 
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Melero et al. 1997; Moura et al. 2004; Blanc et al. 2005; Trento et al. 2006). The BA 
genotype has been, and still is, the dominant RSV B genotype for more than 15 years 
globally while ON1 is spreading globally fast (Trento et al. 2010; Duvvuri et al. 
2015). There are examples in several virus families (e.g. Orthomyxoviridae and 
Arenaviridae) of minor changes in viral genome sequences leading to large impacts 
on viral pathogenesis (Hatta et al. 2001; Conenello et al. 2007; Sullivan et al. 2011). 
Differential pathogenesis and disease severity arising from different RSV groups and 
genotypes is inconclusive (Walsh et al. 1997; Martinello et al. 2002; Stokes et al. 
2011; Tran et al. 2013; Panayiotou et al. 2014; Otieno et al. 2017). The determinants 
of differential transmission and pathogenesis associated with particular RSV strains 
have been investigated and some evidence identified, e.g. better binding avidity in BA 
versus non-BA viruses (White et al. 2005, 2007; Villenave et al. 2012; Stokes et al. 
2013; Hotard et al. 2015). However, it is important to note that the study by Hotard et 
al compared virus binding and replication of the BA genotype in cells expressing 
heparin sulphate compared to cells that don’t while RSV uses CX3CR1 as a receptor 
to infect human ciliated airway epithelial cells (Johnson et al. 2015). Nonetheless, it is 
somewhat likely that the circulation and dominance of the RSV variants with large 
duplications over multiple epidemics points to likely pathogenesis and/or transmission 
fitness advantage. It is also possible that pre-existing herd immunity to previous 
variants in circulation gave a fitness advantage to the duplication variants to which 
there was less cross-protective immunity (immune selection) as suggested by a high 
dN/dS ratio within the immunogenic regions of RSV G (Botosso et al. 2009). 
1.8 Viral phylodynamics; the basics 
The success or failure of a pathogen is entirely dependent on its ability to survive and 
reproduce in one host, and spread to a new host or environment (Bliven and Maurelli 
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2016). Host immune systems, predators, microbial competitors, parasites, and 
environmental resource limitations all exert selective pressures that shape the 
genomes of microbial populations (Toft and Andersson 2010). Grenfell et al. coined 
the term “phylodynamics” to refer to this melding of immunodynamics, epidemiology, 
and evolutionary biology (Grenfell et al. 2004), Figure 1.8. Pathogen evolution is 
often characterized by accumulation of genetic variation, and this genetic variation is 
modulated by host immunity, transmission bottlenecks, and epidemic dynamics. It is 
within this phylodynamic framework that the current study aimed to infer the local 
and global molecular epidemiological dynamics of RSV. 
 
 
 
 
 
 
 
 
Figure 1.8: A representation of the different components of viral phylodynamics 
(Pybus 2016) 
 
Phylodynamic data typically comprises gene or genome sequences sampled at 
different points in time and from different locations. The time points can be weekly or 
monthly within a single epidemic or over several epidemics (years). Locations can be 
subjects’ homes, local hospitals, cities, countries, or even continents. Because of the 
commensurate time-scale of evolutionary and spatial dispersal dynamics, genetic data 
when combined with other data streams may offer a valuable source of information to 
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reconstruct transmission for rapidly evolving pathogens such as the emergent RSV 
ON1 genotype (Holmes 2008; Pybus and Rambaut 2009). The increasingly complex 
quantitative phylodynamic approaches allow integration with these other data types, 
such as phenotypic trait data (e.g. immunological assays) in these analyses (Wallace 
et al. 2007; Wallace and Fitch 2008; Lemey et al. 2009). 
 
1.9 Phylogeography of respiratory viruses and determinants of spread 
The worldwide population is increasingly urbanized and mobile fuelled by 
technological advances and ease of movement. When this is considered with respect 
to infectious pathogens (including RSV), it presents a heightened risk of infectious 
disease spread of global magnitudes (Brockmann 2010). In fact, a recent study 
reported detection of multiple respiratory pathogens on frequently touched surfaces at 
airports (often inevitable for embarking passengers for security purposes), potentially 
creating pathogen “pick-up” hubs for onward transmission (Ikonen et al. 2018). To 
limit the enormous economic and social impacts from potential infectious disease 
global pandemics, for example by proposing appropriate containment and disease 
spread prevention strategies, a thorough understanding of the dynamics of spatial 
spread is critical. While RSV does not cause pandemic-sized outbreaks, it’s 
recurrence and persistence within communities poses a significant global health 
burden (Shi et al. 2017). 
 
A study of emerging infectious diseases (EIDs) between 1940 and 2004 by Jones et 
al. reported that the origins of the EIDs were significantly correlated with socio-
economic, environmental and ecological factors (Jones et al. 2008). This study, 
together with many others (Alonso et al. 2007; Lam et al. 2013; Obando-Pacheco et 
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al. 2018), make a case for more research in order to illuminate on where new EIDs 
are most likely to originate (emerging disease ‘hotspots’) as well as the source of 
current and recurrent human infections. Further, these studies may help global public 
health policy makers to allocate resources more appropriately to regions where EIDs 
are most likely to originate for control purposes. Obando-Pacheco et al. recently used 
national RSV surveillance reports and medical databases from 27 countries to 
describe the timings of RSV epidemics worldwide and concluded that the global 
annual RSV epidemics started in the South hemisphere moving to the North (Obando-
Pacheco et al. 2018). However, the authors admit that RSV surveillance data was 
scarce particularly from middle- and low-income countries that lack RSV surveillance 
networks, yet this is where most RSV burden rests, and therefore more information is 
critical to obtaining a better picture of global RSV epidemic patterns. 
 
Phylogeography or phylogeographic methods enable inference of the geographical 
history of genetic lineages, and therefore can shed light on the transmission dynamics 
of a given pathogen. Two stochastic models of phylogenetic diffusion have been 
proposed to perform spatiotemporal reconstructions in a Bayesian framework 
(Bloomquist, Lemey and Suchard 2010; Faria et al. 2011): A continuous time Markov 
chain (CTMC) process to model transitioning among discrete location states 
throughout evolutionary history (Lemey et al. 2009) and a Brownian random walk 
process to model diffusion in continuous space (Lemey et al. 2010). The discrete 
model has been extended beyond estimating the migration history of a virus of 
interest to testing and quantifying a range of potential predictors of spatial spread 
(Lemey et al. 2014). To the best of our knowledge, no study has reported a source-
sink type transmission model for RSV or rather an in-depth phylogeographic analysis 
of global and local (sub-country and country level) RSV spread, and the potential 
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predictors of such spread. Such a study would significantly build on the surveillance 
report-based studies such as that by Obando-Pacheco et al. as far more countries 
deposit RSV time-stamped sequence data without epidemiological details of RSV 
epidemics. 
 
1.10 Surveillance of respiratory viruses in Kenya  
Surveillance of different respiratory viruses is ongoing in several parts of Kenya 
(Adazu et al. 2005; Odhiambo et al. 2012; Scott et al. 2012). The major institutions in 
these surveillance activities are the Kenya Medical Research Institute (KEMRI), 
Ministry of Health, Kenya Ministry of State for Defence (KMoD), KEMRI-Wellcome 
Trust Research Programme (KWTRP), Centres for Disease Control and Prevention - 
Kenya (CDC-K), and US Army Medical Research Directorate – Kenya (USAMRU-
K). The Virus Epidemiology and Control (VEC) group has established collaborative 
links with CDC-K previously through a study on the RSV genetic diversity at the 
Dadaab refugee camp (Agoti et al. 2014a) and currently through a countrywide 
pathways of transmission study titled SPReD (Studies of the Pathways of 
transmission of Respiratory virus Disease) (http://virec-group.org/spred-kenya/). The 
collaboration enables use of CDC-K archived and RSV positive samples collected 
from different parts of the country for epidemiological and molecular evolutionary 
studies. 
 
1.11 Justification/contribution of the proposed study to Knowledge 
RSV is an important cause of childhood acute severe lower respiratory tract illnesses 
(ALRTI) and a major contributor to hospital admission of infants. The availability of 
a vaccine would significantly lower the disease burden that is most experienced in 
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developing countries, yet none exist at present. RSV circulating in a community 
appears to change season by season and it is thought that this ability of RSV to cause 
repeat infections and recurrent epidemics is driven by genetic and antigenic variation 
within the virus. An opportunity has arisen to best characterize the dynamics of RSV 
transmission and molecular evolution at various scales (local community, 
countrywide, continental and global) due to the coincidence of three factors, namely; 
the occurrence of a new RSV variant with a trackable mutation tag (the ON1 
genotype), the availability of respiratory virus samples across Kenya from a period 
dating back to the first introduction of the genotype, and advancement of sequencing 
technologies enabling complete virus sequence characterization. In addition, the data 
generated is potentially useful for formulating and predicting the impact of RSV 
disease intervention strategies. 
 
1.12 Hypothesis 
Using partial G gene and whole genome sequence data of the RSV ON1 genotype 
following first introduction to Kenya will elucidate the key characteristics associated 
with RSV introduction, spread and persistence within a population. 
 
1.13 Study objective 
The overall objective is to use the recently emerged genotype ON1 as a unique tag to 
characterize the diversity, evolution and phylogeography of RSV in Kenya and 
thereby develop improved understanding of the nature and factors important to virus 
spread and persistence. 
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1.13.1 Specific objectives 
1. Study the nature and pace of genomic variation of genotype ON1 variants in 
Kenya. 
The aim was to identify sequence signatures that characterize the ON1 
variants in comparison to prevailing group A genotypes, how such 
substitutions may relate to fitness advantage, and compare the rate of 
evolution for the ON1 genotype to those previously estimated for other group 
A and B genotypes in Kilifi and globally. 
 
2. Determine the spatiotemporal dynamics of the spread of the ON1 variants. 
The goal of this objective was to unravel local RSV epidemic seeding patterns, 
e.g. whether only a single variant or multiple variant introductions may be 
required to cause a local RSV epidemic, and also if the persistence of the virus 
in a community is fuelled by local diversification of introduced variants or 
frequent introductions from outside the community. 
 
3. Understand the connectivity of RSV epidemics at various levels. 
This objective aimed to discern RSV transmission patterns e.g. whether 
different locations experience independent virus introductions or spread from 
one location to another. Ultimately, this would highlight on the dispersal rate 
and presence of any identifiable pathways of spread of RSV both locally and 
globally. 
 
4. Identify factors influencing RSV transmission dynamics. 
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The target of this objective was to deduce the socio-ecological factors (e.g. 
geographic distance, travel, population size and density, etc), other than 
genetic factors, that could potentially influence RSV transmission patterns at 
different scales. 
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CHAPTER TWO 
2 Materials and Methods 
2.1 Introduction 
 
This chapter describes the study locations and populations from which samples were 
collected, and the laboratory and analysis methods used. However, for better 
readability, some methods are not described here but within the related chapters. 
 
2.2 Study locations 
For this thesis project, samples were collected through KWTRP and CDC-K from 
different sample collection sites across Kenya are shown in Figure 2.1. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: Respiratory viruses surveillance sites across Kenya from which RSV genotype 
ON1 samples were collected, 2011 - 2016 
The Sites are marked A to E, with the key shown top left. 
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2.2.1 Kilifi County 
Kilifi County is located at the Kenyan coast with a rural (predominant) and semi-
urban population of approximately 1.1 million (Kenya National Bureau of Statistics 
2013). The area experiences a tropical climate with two rainy seasons (long rains 
from May to July and short rains in October and November), with the main economic 
activities being subsistence farming (maize, cassava, cashew nuts, coconuts, goats and 
dairy cattle) and fishing. The County has a child rich population, where 0-14 year olds 
constitute 47% of the total population (Kenya National Bureau of Statistics (KNBS) 
and Society for International Development – East Africa (SID) 2013). 
 
The majority of the epidemiological samples described herein were collected within 
the Kilifi Health and Demographic Surveillance System (KHDSS) (Scott et al. 2012) 
with a minor proportion from outside the KHDSS but within the County. The KHDSS 
area was defined and mapped for demographic surveillance, clinical and 
epidemiological research by KWTRP in the year 2000. It covers an area of 891 Km2, 
50 km north and south, and 30 km west of the main referral hospital within the 
County, the Kilifi County Hospital (KCH). In addition to the KCH, there are 20 
public health facilities operated by Kenya's Ministry of Health offering outpatient 
services within the KHDSS. A population of around 296,000 residents (census 2016) 
are routinely monitored through household enumeration visits conducted every 4 
months. It has been previously estimated that 60% of the infant and young children 
admissions to KCH comes from the KHDSS area (Moïsi et al. 2011). 
 
The Virus Epidemiology and Control (VEC) group at KWTRP runs an ongoing 
hospital-based RSV surveillance since 2002 at KCH (Nokes et al. 2009). Surveillance 
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of respiratory viruses has also been conducted in households and additional Health 
Centres within Kilifi County (Nokes et al. 2008; Munywoki et al. 2011, 2014; Nyiro 
et al. 2018). The active surveillance is supported by the KHDSS that links medical 
data obtained from health facilities to socio-demographic and geo-positional data 
obtained through the triannual KHDSS enumerations and decennial national 
population and housing census (Scott et al. 2012). This active surveillance has 
enabled quantification of respiratory virus disease burden in Kilifi County, 
characterization of virus transmission within households and schools and also a 
description of the molecular evolution of these viruses within Kilifi County. 
 
2.2.2 Other regions of Kenya (CDC-K surveillance sites) 
The CDC-K conducts surveillance for influenza and influenza-like-illnesses (ILI) and 
Severe Acute Respiratory infections (SARI), e.g. RSV, adenovirus, human 
metapneumovirus, parainfluenza and enteroviruses through several clinical 
surveillance sites throughout Kenya (Bigogo et al. 2013; Emukule et al. 2014; Katz et 
al. 2014). These include sentinel regional hospitals, health facilities at demographic 
surveillance sites and refugee camps with varied demographic characteristics; urban, 
rural, high mobility, low socio-economic communities, etc (Adazu et al. 2005; Feikin 
et al. 2011; Odhiambo et al. 2012). The sentinel hospital surveillance sites were set up 
by KEMRI-CDC-Kenya and Ministry of Health as part of Global Influenza Program 
and have been in operation since 2006. However, the RSV studies by CDC-K 
primarily target disease burden with no analysis characterizing RSV molecular 
evolution and phylogeography in the various sampling sites. 
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2.3 Clinical specimens  
Clinical data related to the specimen to be processed was extracted from existing data 
capture systems in accordance with the respective study site. In both the CDC-K 
sentinel surveillance hospitals and KCH either or both nasopharyngeal (NP) and 
oropharyngeal (OP) swabs are collected. 
 
2.4 The study designs and population 
The samples analyzed as part of this PhD project were from the three studies 
described hereafter. 
2.4.1 RSV inpatient (IP) study (2011-2016) 
The RSV IP study is a long-term surveillance study of respiratory viruses within Kilifi 
County, starting 1st January 2002 to present (Nokes et al. 2009). While the initial 
objectives of the study were specific to RSV and intended to quantify the burden of 
disease requiring hospitalization, define the epidemiological patterns, determine 
social contact patterns, and support immunological and molecular epidemiological 
investigations in this developing country setting (Scott et al. 2004; Nokes et al. 2008, 
2009; Sande et al. 2013; Kiti et al. 2014; Nyiro et al. 2017), additional human 
respiratory viruses such as metapneumovirus (HMPV) (Owor et al. 2016), rhinovirus 
(HRV) (Onyango et al. 2012b), influenza (Onyango et al. 2012a), and coronavirus 
(HCoV) (Kiyuka et al. 2018) were subsequently included. Samples are collected from 
children (under 5 years of age) admitted to KCH presenting with syndromically 
defined severe or very severe pneumonia according to the World Health Organization 
(WHO) criteria (Nokes et al. 2009). 
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The samples analyzed in this thesis project from the RSV IP study were collected 
between September 2011 and August 2016, Figure 2.2. During this time period, a 
total of 3,157 samples were collected from eligible children at KCH, 3,146 (99.7%) 
were tested for RSV by IFAT and real-time PCR, and 801 (25.5%) RSV positives 
identified by either or both methods. Of these, 54.2% (423/740) were RSV-A, 39.6% 
(305/740) RSV-B, and 1.6% (12) RSV-A/B co-infections by real-time PCR. 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Temporal patterns of RSV strains from Kilifi Sept. 2011 – Aug. 2016.  
The combined monthly detection frequency of RSV-A (red) and RSV-B (blue) viruses from 
the KCH child in-patient surveillance study, September 2011 to August 2016. The black 
dashed line shows the number of samples tested while the solid black lines at the top show 
periods in which there were industrial action at KCH. 
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2.4.2 SPReD-Kenya Study (2011-2014) 
The SPReD-Kenya study (http://virec-group.org/spred-kenya/) is part of the larger 
SPReD study that aims to advance understanding of the nature of spread (i.e. 
characteristic routes of virus introduction, spread, persistence and fade-out) of 
respiratory viruses (including RSV, influenza, coronavirus and rhinovirus) at different 
scales of observation; from the individual, to the household and school, to the local 
community, to the country level, and across the continent. The information obtained 
from the study would also be used to innovate interventions. The work represents an 
integration of epidemiological, virus sequence, contact and mobility data. 
 
This is a collaborative project between KWTRP and KEMRI/CDC-Kenya and aimed 
to collect and analyze approximately 7,000 nasal specimens per calendar year (2014-
2016) from ten different sentinel surveillance sites across Kenya from patients of 
various ages with SARI or ILI. The ten sites were: Kenyatta National Hospital, Nyeri 
County and Referral Hospital, Siaya County and Referral Hospital, Lwak Mission 
Hospital, Kakuma Refugee Camp Clinics, Kakamega County and Referral Hospital, 
Mombasa County and Referral Hospital, Kibera (Tabitha outpatient) Clinic, Nakuru 
County and Referral Hospital, and Kilifi County Hospital, Figure 2.3. 
 
 
 
 
 
 
 
 
   
 
 
 
48 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Map showing the SPReD-Kenya surveillance sites. 
 
 
However, since it was of interest to determine when the ON1 viruses entered Kenya, 
and (i) the first detected case of ON1 in Kilifi was in February 2012 (Agoti et al. 
2014b) while (ii) the first reported case of ON1 was from Ontario Canada in October 
2010 (Eshaghi et al. 2012), the aim was to sample SARI and ILI specimens collected 
by CDC-K from January 2011 to December 2014 and targeted a minimum of one 
location each in Western, Central and Northern Kenya. The sites selected were Siaya 
(which included samples from Ting’wang’i and Lwak Mission Hospital), Kakuma 
Refugee Camp, Dadaab Refugee Camp, Kenyatta National Hospital and Kilifi, Figure 
2.1 and Table 2.1. 
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Table 2.1: Description of the selected ON1 study sites, patient inclusion criteria and 
sample types collected 
 
# 
 
Location 
 
Setting 
 
Inclusion criteria 
Sample type(s) 
1 Kenyatta National Hospital Hospital Based ILI1 andSARI2 in 
paediatric wards 
NP/OP swabs 
2 Siaya County Hospital Hospital Based SARI all patients* NP/OP swabs 
3 Dadaab Refugee Camp Hospital Based SARI all patients* NP/OP swabs 
4 Kakuma Refugee Camp Hospital Based SARI all patients* NP/OP swabs 
5 Kilifi County Hospital Hospital Based LRTI in under 13 years NP/OP swabs 
1 ILI is defined as an acute respiratory illness with a measured fever of ≥38°C AND a 
cough with an onset of symptoms within the last 7 days. 
 
2 SARI is defined as an acute respiratory illness requiring hospitalization with a history of 
fever or measured fever ≥38°C AND a cough with an onset of symptoms within the last 
14 days. 
 
*In both adult and paediatric wards 
 
NP - Nasopharyngeal; OP – Oropharyngeal; 
 
 
2.4.3 SPReD-KHDSS study (2016) 
The SPReD-KHDSS study (http://virec-group.org/local-spred/) is also part of the 
larger SPReD study, with a specific focus on the KHDSS and similarly aiming to map 
patterns of spread of a range of respiratory viruses using epidemiological and 
nucleotide sequence data. In this study, samples were collected between January and 
December 2016 from patients of all ages presenting at nine purposively selected 
health facilities within the KHDSS with one or more acute respiratory infection (ARI) 
symptoms of cough, sneezing, nasal congestion, difficulty breathing, or increased 
respiratory rate for age as defined by the WHO (Nyiro et al. 2018). However, new-
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borns aged less than 7 days and patients with ARI for more than 30 days were 
excluded. The nine public health facilities were (Figure 2.4); Matsangoni, Ngerenya, 
Mtondia, Sokoke, Mavueni, Jaribuni, Chasimba, Pingilikani and Junju, and their 
selection was based on representation across the geographical region, coverage of 
major road networks and variation in population density, (Nyiro et al. 2018). 
 
Patient recruitment and specimen collection has been described in detail in Nyiro et al 
(Nyiro et al. 2018). Briefly, the recruitment of patients into the study and collection of 
specimens was integrated within the routine patient care at the nine selected 
outpatient facilities led by a resident clinician or nurse. Each facility had one or two 
sampling days per week between Monday and Friday (9.00 am - 1.00 pm). Qualifying 
patients were consented, and nasopharyngeal swab samples collected. A target of 15 
samples per site per week was used on a ‘first-come first-served’ basis. 
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Figure 2.4: A map of the SPReD KHDSS study sites extracted from Nyiro et al. 2018 
The map defining the KHDSS is expanded from the map of Kenya and shows population 
density (person per Km2) and the nine health facilities (red circles) where the study was 
conducted in 2016. The green markers show the other public health facilities within the 
KHDSS area (Nyiro et al. 2018). 
 
 
2.5 Sample size determination 
For the period of 1st January to 31st December 2012, 834 nasopharyngeal swab 
specimens were collected from children eligible for the RSV IP study in Kilifi. Of the 
834 samples, 240 (28.8%) were RSV positive: 123 (51.3%) were group A infections, 
114 (47.5%) were group B infections, and 3 (1.3%) were A/B co-infections. Of the 
126 combined group A and group A/B viruses, 104 (82.5%) were successfully 
sequenced in the G gene ectodomain region, and of these, 77 (74.0%) were of the 
ON1 genotype. Based on these observations, the expectation was that the majority of 
the group A viruses from 2013 onwards to be of genotype ON1. In total, the aim was 
to obtain full-length genomes from ≈200 samples from Kilifi. 
 
As previously stated, a minimum of one location each in Western, Central and 
Northern Kenya was targeted for sampling. The Table 2.2 shows the number of RSV 
positive samples available from the selected five sites for the period 2011-2014. For 
KNH 2011-2012 whereby respiratory samples were not screened for RSV, and 
approximately 700 samples usually collected each year, it was estimated that 30% of 
these samples would be RSV positive, i.e. 0.3(700X2) = 420 samples. This made an 
estimated the total of the RSV positives from the CDC-K sites to be 1,271, Table 2.2. 
Because RSV groups A and B are known to alternate in dominance, albeit with group 
A occurring more frequently, and using data collected from Kilifi over 12 years 
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(Agoti et al. 2015b; Otieno et al. 2016), it was anticipated that ~60% of the CDC-K 
RSV positive isolates would be RSV-A, i.e. 0.6(1271) = 763 specimens. Further, it 
was predicted that very few (~30%) of the RSV-A specimen from 2011 would be 
ON1 considering the genotype’s initial detection in Kilifi in February 2012. Finally, it 
was expected that about two-thirds of the RSV-A positive specimens would have low 
Ct values (high viral load), e.g. Ct value of <30, which is suitable for WGS (Agoti et 
al. 2014a). Therefore, a total of ~400 isolates from western, central and northern parts 
of Kenya were anticipated to be taken through WGS. 
 
Table 2.2: RSV positive specimens from 5 sites in Kenya conducting respiratory 
virus surveillance, 2011 - 2015 
 2011 2012 2013 2014 TOTAL 
Kenyatta National Hospital TBS TBS 12 90 102 
Siaya County Hospital 125 101 80 52 358 
Kakuma Refugee Camp 112 60 43 21 236 
Kilifi County Hospitalβ N/A 126 66 119 311 
Dadaab Refugee Camp 99 1 21 34 155 
TOTAL 336 288 222 316 1162 
TBS: To be screened for RSV. Approximately 700 samples collected per year. 
βTotal number of RSV-A positive specimen from Kilifi. 
N/A: Not applicable as no ON1 viruses were detected in Kilifi prior to 2012. 
 
The data on the four CDC-K sites selected were clearly subject to variable collection 
effort over time and between sites. However, as a whole the sample set provided 
representation of RSV strains across the country in each of the years, and since the 
samples were already screened for RSV, they represented a cost-effective approach 
for this thesis investigation. Based on our previous studies, these numbers would be 
sufficient to identify seasonal patterns of RSV (Agoti et al. 2015a). 
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2.6 Study scientific and ethical approval 
Samples used in this study that had previously been collected and stored had received 
scientific and ethical approval from the UK (Coventry Research Ethics Committee), 
US and Kenyan (KEMRI Scientific and Ethics Review Unit [SERU]) ethics 
committees: CDC-K/Ministry of Health Influenza Sentinel Surveillance Program 
(SSC No. 2558 and 2692) and KWTRP (SSC No. 1055 and 1433) (Nokes et al. 2008, 
2009). The SPReD-Kenya study was approved by SERU (SERU No. 3044) while the 
SPReD KHDSS study was approved by both SERU (SERU No. 3103) and the 
University of Warwick Biomedical and Scientific Research Ethics Committee 
(BSREC# REGO-2015-6102) (Nyiro et al. 2018). An informed consent (written or 
verbal) depending on study site was obtained from the study patient or their guardian. 
 
However, to use the samples above in this study further scientific and ethical approval 
was sought. KWTRP is located within a Centre of the Kenya Medical Research 
Institute known as the Centre for Geographic Medicine Research – Coast (CGMR-C). 
Initial approval for this study was sought at Centre level through the Centre Scientific 
Committee (CSC) that reviews all proposals for studies conducted at the Centre 
involving human subjects. Subsequently, upon approval by CSC, national scientific 
and ethical approval was sought from SERU for the committee meeting on 
18/12/2015. An initial response letter from SERU was received on 12th January 2016, 
which suggested minor clarifications and changes. Following submission of the 
revised protocol, the study received scientific and ethical approval (SERU No. 3177) 
through a letter (Appendix 7.1) dated 4th February 2016. 
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2.7 Laboratory methods 
2.7.1 RSV diagnosis 
All respiratory specimens analyzed in this project from the RSV IP study were 
diagnosed for RSV by antigen detection using indirect immunofluorescent antibody 
assay test (IFAT) (Light diagnostics, Chemicon, UK) and by nucleic acid quantitative 
real-time polymerase chain reaction (PCR) using either an in-house multiplex reverse 
transcription (RT) PCR (Gunson, Collins and Carman 2005) or the Fast Track 
Diagnostics Respiratory Pathogens 33 test [FTD Resp-33; Fast-track Diagnostics, 
Sliema, Malta] (Hammitt et al. 2012). The real-time RT-PCR further types the RSV 
positives by group, i.e. RSV-A and RSV-B. For the SPReD-Kenya and SPReD-
KHDSS samples, only the real-time RT-PCR method was used for RSV detection 
(Nyiro et al. 2018). The 2011-2013 respiratory samples from CDC-K surveillance 
sites had previously been screened for RSV positivity using Taqman Array Cards but 
without RSV group information (Katz et al. 2012; Bigogo et al. 2013; Emukule et al. 
2014). 
2.7.2 RNA extraction 
For the RSV IP study samples, viral RNA was freshly extracted from 140µL of 
clinical specimens using QIAmp viral RNA mini kit (Qiagen Ltd, UK) in accordance 
with the manufacturer’s protocol. In the final elution step, 60µL of viral RNA was 
collected. As for the SPReD-Kenya and SPReD-KHDSS samples, RNA was extracted 
from the respiratory specimens by Qiacube HT using an RNeasy extraction kit 
(Qiagen, Germany). Positive (RSV A2 strain culture supernatant) and negative (either 
a previous confirmed negative sample or RNase free PCR purity water) controls were 
included in every extracted batch of samples to monitor potential cross-contamination 
during sample processing and false negatives in case of process failure. 
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2.7.3 G gene RT-PCR and Sequencing  
Viral RNA reverse transcription and G gene PCR amplification was performed as 
previously undertaken and described by the group (Scott et al. 2004; Agoti et al. 
2012, 2015b; Otieno et al. 2016). Briefly, extracted viral RNAs were reverse 
transcribed and amplified in a one-step reaction protocol (QIAGEN, Ltd) with the 
primers AG20 and F164 (Table 2.3) targeting the entire RSV G gene and part of the F 
gene. A microlitre of the resultant products was further amplified in a nested PCR 
with the primers BG10 and F1, Table 2.3. Success in amplification was confirmed on 
a 2% agarose gel (expected band size of ~ 830 bp) and sequencing done using the 
BigDye 3.1 Chemistry with the nested PCR primers and additional RSV-A group 
specific primers, 523F and 523R (Table 2.3). Sequenced contigs were assembled to 
obtain the consensus sequences using Sequencher v5.0.1 (Gene Codes Corporation, 
USA), Gap4 release 2.0.0b9 (Bonfield, Smith and Staden 1995) and/or Geneious 
v11.1.2 (Kearse et al. 2012). 
 
Table 2.3: Primers for RSV-A G gene amplification and sequencing 
Primer Group Gene Position* Function Sequence (5’-3’) 
AG20 A/B G 1-20  PCR GGGGCAAATGCAAACATGTCC 
F164 A/B F 164-187 PCR GTTATGACACTGGTATACCAACC 
BG10 A/B G 154-173 PCR & sequencing GCAATGATAATCTCAACCTC 
F1 A/B F 3-22 PCR & sequencing CAACTCCATTGTTATTTGCC 
523F A G 538-557 Sequencing ATATGCAGCAACAATCCAAC 
523R A G 557-538 Sequencing GTTGGATTGTTGCTGCATAT 
533F B G 532-551 Sequencing TGTAGTATATGTGGCAACAA 
533R B G 532-551 Sequencing TTGTTGCCACATATACTACA 
*The positions of the primers are given relative to the A2 strain (M11486). 
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2.7.4 Development of the RSV whole genome sequencing method 
 
2.7.4.1 The 6-amplicon WGS method 
 
We have previously undertaken whole genome sequencing of RSV within the VEC 
group in collaboration with and at the Sanger Institute (UK) through a novel 6-
amplicon polymerase chain reaction (PCR) amplification strategy, Figure 2.5A, 
followed by amplicon sequencing using Illumina MiSeq (Agoti et al. 2015a). The 
primers had lengths of between 20-28 bases and a calculated melting temperature 
(Tm) of 56.9-58.4°C, Appendix 7.2. However, sequencing difficulties were 
experienced in the 3’ and 5’ ends of the genomes. In addition, since ON1 was a novel 
genotype, the previously designed group A primers were mapped onto available 
genotype ON1 genomes and some primer mismatches both at the ends and internally 
within the genomes were observed. The WGS method was transferred to Kilifi and 
performed an update of the existing primers with the mismatches using the same 
bioinformatics approach previously described (Agoti et al. 2015a). 
 
2.7.4.1 The 14-amplicon WGS method 
With help from Matthew Cotten (previously at the Wellcome Sanger Institute), we 
developed a 14-amplicon WGS method (Figure 2.5B). All Human orthopneumovirus 
sequence entries with lengths in the range of 2000-16000 nt were retrieved from 
GenBank (On 5th Dec 2015). Patent entries and entries with multiple Ns were 
excluded. In addition, RSV genome sequences from Kilifi studies not yet in GenBank 
at the time (5th Dec 2015) were included to generate a final set of 717 entries with a 
total sequence length of 9568447 nt. All possible 23 nt sequences were generated and 
then trimmed to a final calculated Tm of 47.9-49.5 °C. Sequences with homology to 
rRNA sequences, with GC content outside of the range of 0.3 to 0.75 or with a single 
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nucleotide fractional content of >0.6 were removed. The primer set was made non-
redundant to yield a set of 98001 potential primer sequences (PoPros). The PoPros 
were mapped against all available RSV-A genomes, the number of perfect matches 
(frequency score) was retained as a score of sequence conservation. Finally, the RSV 
genome sequence was divided into 14 overlapping amplicons with 217 nt overlaps 
spanning the virus genome. The terminal region of each amplicon was defined as a 
primer bin. PoPros that mapped within each primer bin were identified and the two 
PoPros with the highest frequency score were selected. PoPros that mapped to the 
reverse bins were reverse complimented. In this manner, a final set of 58 primers was 
prepared. The primer sequences, lengths, calculated melting temperature), fractional 
GC content and mapping position on the RSV genome are presented in Appendix 7.3. 
 
2.7.4.1 Reverse transcription and PCR amplification 
 
Reverse transcription of RNA molecules and PCR amplification were performed 
initially with a 6-amplicon six-reaction strategy (Agoti et al. 2015a) and later using 
either a 6 or 14-amplicons strategy split into two reactions of three [1,3.5 and 2,4,6] 
and seven [1,3,5,7,9,11,13 and 2,4,6,8,10,12,14] amplicons, respectively. The 
reduction in the number of reactions was to cut down on the PCR amplification costs 
as amplification success was similar to the previous six reactions. Splitting the two 
reactions into odd and even numbered amplicons for both the 6 and 14-amplicon 
strategies was to increase chances of full genome amplification in case one reaction or 
some of the amplicons failed and/or to reduce genome fragment amplification bias. 
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Figure 2.5: The RSV-A whole genome amplification strategies 
The two panels show the (A) six and the (B) fourteen amplicons. For each panel the positions 
of primer targets for each amplicon are indicated by coloured circles (dark blue: perfect 
match, lighter blue: 1 mismatch, grey: 2 mismatches) while amplicon lengths are indicated by 
light green bars. 
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A reverse transcription primer mix was first prepared for each reaction. As the RSV 
genome molecule is negative stranded, the forward PCR primers were used for the 
reverse transcription. The respective forward primers for the different amplicons in a 
reaction were combined, e.g. forward primers for amplicons 1, 3, and 5 in reaction 
one and forward primers for amplicons 2, 4 and 6 in reaction two for the 6-amplicon 
two reaction strategy. A master mix was then prepared as shown in Table 2.4. 
Reagents 1-5 (enzyme mix) were premixed in a template free room and kept at -4ºC. 
Reagents 6-8, i.e. the template RNA, water and primers mix, were combined in the 
template addition hood, preheated at 65 ºC, and the containing tubes transferred to a 
frozen cooling block for one minute. The enzyme mix was then added to the primer-
template mix and incubated at 50 ºC for 1 hour, 70 ºC for 15 minutes and finally held 
at 4 ºC until used for whole genome PCR amplification. 
 
Table 2.4: Preparation of the WGS reverse transcription reaction mix 
 
Description  1 reaction (µl) Final concentration 
5X First-Strand Buffer 4 1x 
0.1 M DTT 1 0.005 M 
RNase Inhibitor (40 units/μL) 1 2 units/μL 
SuperScriptTM III RT (200 units/μL) 1 10 units/μL 
10 mM dNTP Mix 1 0.5 mM 
   
Forward Primer Mix 1.9 0.38 pmol/μL 
RNase free water 8.1  
Template RNA 2 µl  
Total reaction volume 20 µl  
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Whole genome PCR primer mixes were similarly prepared as for the reverse 
transcription for each reaction. However, in this case both the forward and reverse 
primers were used. A reaction mix was prepared as shown in Table 2.5. The reaction 
mixtures were incubated at 98°C for 30 sec, and then 40 cycles of 98°C for 10 sec, 
53°C for 30 sec, 72°C for 3.0 min, and final extension of 72°C for 10 min. Following 
PCR, an aliquot of the products for each reaction was run on a 0.6% agarose gel to 
check amplification success, and then pooled per sample in readiness for Illumina 
sequencing. 
 
Table 2.5: Preparation of the whole genome amplification PCR reaction mix 
 
 1 reaction (µl) Final concentration 
5 x Phusion HF buffer 5 1x 
Mix of dNTPs (10 mM each) 0.5 0.2 mM 
Phusion DNA Polymerase 0.25  
RNase-free water 12.35  
   
PCR primer mix, 1.9  
Template cDNA 5  
Total reaction volume 25  
 
 
2.8 Assembly of the short read NGS data 
There are many genome assembly tools available and they differ greatly in terms of 
their performance (speed, scalability, hardware requirements and acceptance of newer 
read technologies) and in their final output (composition of assembled sequence) 
(Nagarajan and Pop 2013). This process of genome assembly is further complicated 
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by the different read lengths, read counts, single or paired reads, and error profiles 
that are produced by different (or even similar) NGS technologies. Assembling these 
short sequence reads without a reference genome is even more challenging as it is 
quite difficult to tell what's real, what's missing, and what's an experimental artefact 
(Baker 2012). 
 
For this project, a set of four sequence assemblers in Table 2.6 (not in any particular 
order) were evaluated with a few of our NGS reads. The assembly scaffolding tools 
SGA, SOPRA and SSPACE were also evaluated and their selection was based on 
being the best scaffolders from an analysis by Hunt et al. (Hunt et al. 2014). It was 
quite helpful that there were partial G gene Sanger dideoxy sequences for the samples 
that had undergone WGS for comparison. 
 
Table 2.6: Genome assemblers tested on Kilifi RSV-A short read data 
 
Assembler Reason Reference 
SPAdes Had been used by our group from a previous 
analysis (Agoti et al. 2015a). 
(Bankevich et al. 2012) 
Viral-ngs pipeline A neat and easy to use pipeline for virus 
genomes assemblies, and previously used in 
the assembly of Ebola Virus genomes (Park 
et al. 2015). 
https://viral-
ngs.readthedocs.io/en/latest/ 
 
MaSuRCA Best assembler from GAGE-B [Genome 
Assembly Gold-standard Evaluation for 
Bacteria] (Magoc et al. 2013) 
(Zimin et al. 2013) 
Vicuna Targeted for diverse viral populations. (Yang et al. 2012) 
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For the same dataset, varied output was observed in some of the assemblies evaluated 
e.g. spurious insertions with MaSuRCA (Figure 2.6A), with Vicuna (Figure 2.6B) and 
with SPAdes (Figure 2.6C) or missing 72nt duplication for known ON1 viruses with 
viral-ngs (Figure 2.6D). For viral-ngs, it is thought that the duplicate reads removal 
step might have over-filtered reads resulting in ON1 virus assemblies without the 
duplication. As viral-ngs and SPAdes had the least number of spurious insertions and 
deletions, and highest agreement with the previously sequenced Sanger dideoxy G 
gene assemblies, the two were retained for assembling all the short reads in this 
project and picked the best assembly for each sample from either based on the 
assembler with the longest genome fraction, best agreement with sanger G gene 
sequences, and no spurious insertions or deletions. No additional benefit was realized 
with the scaffolding tools on the draft genome assemblies hence they were not used 
further. 
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Figure 2.6: Evaluation of genome assemblers on Kilifi RSV-A datasets 
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2.9 Estimating the number of local variant introductions 
To differentiate between local variants arising from a recent introduction and 
imported variants with greater genetic divergence than is expected from local 
diversification, we used a pragmatic criterion previously described by (Agoti et al. 
2015b). 
 
A variant is a virus (or a group of viruses) within a genotype that possesses ≥ "# 
nucleotide differences compared to other viruses, where: "# = %&'()* 
i.e. the product of the length of the genomic region analysed (La), estimated 
substitution rate for that region (Sr), and time elapsed (Te). 
 
We then calculated: "# %&⁄ . 100 
to get the % nucleotide difference which was then used in usearch (Edgar 2010) to 
find the number of clusters/variants within a sequence dataset. 
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CHAPTER THREE 
 
3 Molecular epidemiological, clinical and demographic characteristics of RSV-
A genotype ON1 in Kilifi: analysis of G gene sequences 
3.1 Background 
Of the 11 proteins encoded by the RSV genome, the attachment glycoprotein (G) is 
the most variable and shown to accumulate considerable amino acid changes over 
time (Cane and Pringle 1995). RSV is classified into two groups, RSV-A and RSV-B 
(Mufson et al. 1985), with each group divided into genotypes (Peret et al. 1998) and 
these further characterized into variants (Agoti et al. 2015b). Globally, viruses 
belonging to different RSV groups, genotypes and variants often co-circulate in 
epidemics (Agoti et al. 2015b; Otieno et al. 2016). The phenomenon of reinfection 
and the difficulty in developing a vaccine may in part be due to the antigenic diversity 
and variability in the virus, and specifically the G gene (Cane 2001). 
 
Two novel RSV genotypes with large duplications within the attachment G 
glycoprotein have been detected globally. In 1999, the BA genotype was detected in 
Buenos Aires, Argentina, based on a 60-nucleotide duplication within the C-terminal 
region of the G gene (Trento et al. 2003). The BA variant subsequently spread rapidly 
throughout the world becoming the predominant group B genotype and in some 
regions replacing all previous circulating RSV-B genotypes (Trento et al. 2010). 
More recently in December 2010, genotype ON1 with a 72-nucleotide duplication, 
also within the C-terminal region of the G gene, was detected in Ontario Canada 
(Eshaghi et al. 2012). Similarly, viruses belonging to this genotype have rapidly 
spread and diversified globally (Prifert et al. 2013; Tsukagoshi et al. 2013; Valley-
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Omar et al. 2013; Agoti et al. 2014b; Auksornkitti et al. 2014; Pierangeli, Trotta and 
Scagnolari 2014; Avadhanula et al. 2015; Duvvuri et al. 2015). Such emergent 
genotypes appear to have a fitness advantage over preceding genotypes of the same 
RSV group (Hotard et al. 2015). Whether the potential fitness increase is associated 
with increased severity and immune evasion (with potential vaccine modality 
implications) is of considerable public health interest. 
 
In February 2012, genotype ON1 was detected in Kilifi County, coastal Kenya, 
through routine partial G-gene sequencing. The temporal progression of RSV 
genotypes can be followed directly because of the distinctive tags (the duplications), 
providing a unique opportunity to understand more about the introduction, spread, 
severity and related selection processes (including immune evasion) for RSV, with 
the potential to lead into understanding the nature of emergence of novel virus 
variants. In this thesis chapter, an in-depth analysis of the epidemiological, clinical 
and sequence data of RSV-A viruses detected over five RSV seasons (2010/2011 to 
2014/2015) was undertaken, and this includes the period from the initial detection of 
this novel genotype within Kilifi. This work used partial G gene sequences only with 
later work (Chapter Four) analyzing the WGS. Cases were diagnosed through 
paediatric pneumonia surveillance (RSV IP study) at the Kilifi County Hospital 
(KCH). 
 
The work described in this chapter has been published and can be found from the 
following link; https://wwwnc.cdc.gov/eid/article/23/2/16-1149_article. 
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3.2 Aims of the Chapter 
Using the immediately available and routinely sequenced partial G gene sequences 
together with patient clinical data, the aim of the chapter was to determine (1.) how 
new RSV variants get into and spread within a community with regard to the pace of 
entry [gradual or rapid] and nature of introductions [single or multiple variants], and 
(2.) the demographic and clinical impacts of such new variants. 
 
3.3 Methods 
Study location and population 
The study was undertaken in Kilifi County, coastal Kenya, and is part of surveillance 
aimed at understanding the epidemiology and disease burden of RSV-associated 
pneumonia cases in this region (Nokes et al. 2009). Respiratory swab samples 
(combined nasopharyngeal and oropharyngeal) were collected between September 
2010 and August 2015 from children aged 1 day to less than 5 years admitted to Kilifi 
County Hospital (KCH) presenting with syndromically defined severe or very severe 
pneumonia (referred to here as lower respiratory tract infections, LRTI) (Nokes et al. 
2009). 
 
Study samples and laboratory procedures 
All specimens were screened for RSV by two methods (Nokes et al. 2004, 2009; 
Hammitt et al. 2011). Raw samples were tested for RSV antigen by 
Immunofluorescence Antibody Test (IFAT, Chemicon). Viral RNA was extracted 
from respiratory samples using QIAamp Viral RNA Mini Kit (QIAGEN) and tested 
for RSV (differentiating groups A and B) by multiplex real-time reverse transcriptase 
polymerase chain reaction (RT-PCR). All RSV positive samples tested positive by 
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either assay were taken forward for processing. Additionally, a small number of RSV 
negative samples were processed in parallel. 
 
The viral RNA was reverse transcribed into cDNA using the Omniscript RT Kit 
(QIAGEN). The cDNA was then amplified with primers targeting the G ectodomain 
region (Scott et al. 2004; Agoti et al. 2012), and sequencing of the amplicons 
performed using BigDye v3.1 Chemistry on an ABI 3130xl. Sequence reads were 
assembled into contigs using Sequencher® v5.0.1 (Gene Codes Corporation, USA). 
The sequences analyzed here have been deposited in GenBank under the accession 
numbers KX453303 - KX453534. Previously reported sequences from Kilifi added to 
this analysis had been deposited in GenBank with accession numbers KF587911–
KF588014 (Agoti et al. 2014b). 
 
Global comparison dataset 
To determine the relatedness of the Kilifi viruses to those circulating around the world 
and thereby understand their global context, all RSV-A G-gene sequences deposited 
in GenBank as of 19th January 2016 of length 241 to 687 nucleotides collected 
between 2010 and 2015 (inclusive) were downloaded. A total of 995 sequences from 
24 countries were used in this analysis. For the whole dataset and for some of the 
countries, sequences were further binned by calendar year for temporal analysis. 
Unique sequences, identified as sequences that differ by at least one nucleotide from 
any other sequence over the sequenced region, were sub-sampled by epidemic season 
(Kilifi only) or per calendar year. 
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Sequence alignments and diversity analysis 
All the sequences, from Kilifi and the global dataset, were collated and aligned using 
MAFFT alignment software v7.272 (Katoh and Standley 2013). Nucleotide and 
amino acid variability was calculated using MEGA v6.06 (Tamura et al. 2013). 
 
Phylogenetic analyses 
Maximum-Likelihood (ML) phylogenetic trees were inferred by MEGA 6.06 under 
the general time reversible (GTR) model with gamma (G) distributed among site rate 
heterogeneity model (Tamura et al. 2013). The GTR+G model was the best 
substitution model as determined by IQ-TREE v.1.4.2 (Chernomor, von Haeseler and 
Minh 2016). Bootstrapping with 1,000 iterations was implemented to evaluate branch 
support of the phylogenetic clusters. RSV-A genotypes were assigned as previously 
determined by Peret et al (Peret et al. 1998) and Eshaghi et al (Eshaghi et al. 2012). 
To position the genotype ON1 viruses in the global context, ON1 lineages were 
examined as recently assigned by Duvvuri et al (Duvvuri et al. 2015). 
 
RSV-A variants analysis 
The number of genotype GA2 and ON1 variants circulating in Kilifi and globally 
were calculated using a recently developed pragmatic criterion (Agoti et al. 2015b; 
Otieno et al. 2016), see the Methods chapter for specific details. Briefly, a variant is a 
virus or a group of viruses within a genotype that possesses ≥4 nucleotide differences 
(Nd) in the G ectodomain region compared to other viruses. This analysis was done 
using usearch v8.1.1861 (Edgar 2010). 
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Protein substitution and selection analysis 
The prediction of N-glycosylation sites was performed using the NetNGlyc 1.0 server 
(Gupta, Jung and Brunak 2004). Only the default Asn-X-Ser/Thr sequon (where X is 
not proline) was considered for prediction. Patterns of change in amino acids were 
also analyzed using python scripts. Finally, potential positively selected and co-
evolving sites were analyzed using the Datamonkey server 
(http://www.datamonkey.org/). For positive selection analysis, three methods were 
used; SLAC (Single Likelihood Ancestor Counting), FEL (Fixed Effects Likelihood) 
and MEME (Mixed Effects Model for Evolution). 
 
Statistical analyses 
Associations between demographic, clinical or outcome variables and RSV genotypes 
for all RSV positive severe and very severe pneumonia cases were explored using 
logistic regression and computing odds ratios using STATA v13 (StataCorp, Texas). 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
71 
3.4 Results 
3.4.1 RSV group and genotype temporal patterns 
Over the five RSV epidemics examined (2010/2011 to 2014/2015), 4,010 samples 
were collected from eligible children, 3,561 (88.8%) were tested for RSV and 881 
(24.7%) RSV positives identified, Table 3.1. Of these, 600 (68.1%) were RSV group 
A. Sequencing of the G-gene was successful for 442 (73.7%) samples. A further 41 
sequences were available from samples that were negative by both IFAT and PCR or 
from patients with mild pneumonia (data for these cases were, however, not included 
in the clinical severity analysis). Hence a total 483 sequences were taken forward for 
phylogenetic analysis. The sequences ranged 618-690 nt in length corresponding to 
nucleotides 295-912 of the reference strain A2 (M74568). 
 
Two RSV-A genotypes were identified to be circulating in Kilifi over the five 
epidemics: ON1 (n = 283, 58.6%) and GA2 (n = 200, 41.4%). The temporal 
prevalence of the total RSV, RSV-A and genotypes ON1 and GA2 is shown in Figure 
3.1 and Table 3.1. Rapid replacement of the previously circulating dominant GA2 by 
ON1 in Kilifi was observed, from a prevalence of 0% in the 2010/2011 epidemic to 
67.4% in 2011/2012 when ON1 was first detected in Kilifi, and to 96.1% in the recent 
2014/2015 epidemic. In addition, RSV-A predominated in three consecutive RSV 
epidemics from 2012/2013 to 2014/2015. Kilifi long-term RSV-A genotype patterns 
are shown in Appendix 7.4. 
   
 
 
 
72 
Table 3.1: Frequency of LRTI inpatient cases, samples tested, total RSV and RSV-A cases, and number sequenced over five successive 
epidemics (2010/2011 to 2014/2015) in Kilifi, Kenya 
Epidemic 
season* 
LRTI eligible 
cases 
Samples 
tested (%†) 
Number (%‡) 
of RSV 
positive 
samples 
Number (%§) 
of RSV-A 
samples 
Number of 
RSV-A 
sequences# 
Number (%¶) 
of ON1 
sequences 
Number 
(%¶) of GA2 
sequences 
2014/2015 876 866 (98.9) 203 (23.4) 133 (65.5) 128 123 (96.1) 5 (3.9) 
2013/2014 722 576 (79.8) 124 (21.5) 74 (59.7) 68 58 (85.3) 10 (14.7) 
2012/2013 659 563 (85.4) 142 (25.2) 107 (75.4) 87 71 (81.6) 16 (18.4) 
2011/2012 814 718 (88.2) 151 (21.0) 54 (35.8) 46 31 (67.4) 15 (32.6) 
2010/2011 939 838 (89.2) 261 (31.1) 232 (88.9) 154 0 (0) 154 (100) 
Total 4,010 3,561 (88.8) 881 (24.7) 600 (68.1) 483 283 (58.6) 200 (41.4) 
 
*Epidemic designated 1st September of one year to 31st August of the following year 
†As a proportion of the eligible LRTI inpatient cases 
‡As a proportion of the samples tested 
§As a proportion of the RSV positive samples 
#Includes 41 sequences from IFAT-ve/PCR-ve or mild pneumonia cases 
¶As a proportion of the RSV-A sequences 
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Figure 3.1: Circulating patterns of RSV in Kilifi, Kenya, September 2010 to August 2015.  
1A: Total RSV positive cases (grey continuous line) and typed RSV-A samples (dotted 
orange line) by month. 1B: The proportion of RSV-A genotypes ON1 (black) and GA2 
(green) per epidemic season. An RSV epidemic season is designated to start in September of 
one year until August of the following year. Unusually, for the last 3 seasons group A 
represents the vast majority of all RSV cases. 
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3.4.2 Demographic and clinical impact of ON1 in Kilifi 
To investigate the demographic and clinical impact of RSV-A genotype ON1 in 
Kilifi, a comparison was made of the proportions of GA2 and ON1 cases by gender, 
age, clinical features of cough, difficulty in breathing, chest wall indrawing, inability 
to drink, hypoxia, prostration/consciousness, pneumonia status (severe or very severe 
pneumonia), length of hospital stay, and death at the hospital (Table 3.2). The 
proportions of both genotypes were very similar for the demographic and clinical 
characteristics analyzed. Only the proportion of ON1 cases presenting with inability 
to feed was more than double that for GA2 cases (18.9% versus 8.8%), and this 
difference was found significant by logistic regression [OR 2.40 95% CI 1.31 – 4.36], 
Table 3.3, even after adjusting for age (categorical; <1 yr. and >=1 yr.) [OR 2.44 95% 
CI 1.31 – 4.57]. However, the proportion with very severe pneumonia was no higher 
in ON1 than in GA2 cases (OR 0.89, 95% CI 0.57 – 1.39). 
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Table 3.2: Demographic and clinical characteristics of RSV-A genotypes ON1 and 
GA2 in cases of severe or very severe pneumonia aged 1 day to less than 5 years 
admitted to Kilifi County Hospital September 2010 through August 2015. 
 
 
  ON1 GA2 Total 
    Number (%) Number (%) Number (%) 
Age 
  
< 1 year 223 (85.4) 158(87.3) 381 (86.2) 
> 1 year 38 (14.6) 23 (12.7) 61 (13.8) 
Gender 
  
Female 118 (45.2) 70 (38.6) 188(42.5) 
Male 143 (54.8) 111 (61.3) 254 (57.5) 
Cough 
  
No 5 (1.9) 4 (2.2) 9 (2.0) 
Yes 256 (98.1) 177 (97.8) 433 (98.0) 
Breathing difficulty  
  
No  15 (5.8) 3 (1.7) 18 (4.1) 
Yes 246 (94.3) 178 (98.3) 423 (95.9) 
Chest wall indrawing 
 
No 6 (2.3) 6 (3.3) 12 (2.7) 
Yes 255 (97.7) 175 (96.7) 430 (97.3) 
Inability to feed 
  
No 211 (81.2) 165 (91.2) 376 (85.3) 
Yes 49 (18.9) 16 (8.8) 65 (14.7) 
Oxygen saturation 
  
Above 90% 214 (82.0) 144 (79.6) 358 (81.0) 
Below 90% 47 (18.0) 37 (20.4) 84 (19.0) 
Prostration/Consciousne
ss 
 
No 240 (92.0) 172 (95) 412 (93.2) 
Yes 21 (8.0) 9 (5.0) 30 (6.8) 
Pneumonia status* 
  
Severe* 203 (77.8) 137 (75.7) 340 (76.9) 
Very severe† 58 (22.2) 44 (24.3) 102 (23.1) 
Hospital stay 
  
1-4 days 160 (62.0) 101 (55.8) 261 (59.4) 
>4 days 98 (38.0) 80 (44.2) 178 (40.5) 
Outcome 
  
Alive 250 (96.9) 177 (97.8) 427 (97.3) 
Dead 8 (3.1) 4 (2.2) 12 (2.7) 
*The denominator was 442 samples but for some of the features it ranged from 439 to 442 
†(Cough OR difficulty in breathing) AND chest wall indrawing 
‡(Cough OR difficulty in breathing) AND (hypoxic OR prostrate/unconscious) 
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Table 3.3: Clinical severity comparison between RSV-A genotype ON1 and GA2 
cases of severe or very sever pneumonia aged 1 day to less than 5 years admitted to 
Kilifi County Hospital September 2010 through August 2015 
 
*The denominator was 442 samples but for some of the features it ranged from 439 to 442 
 
3.4.3 Local Kilifi ON1 lineages as determined by the G-gene 
The ML tree in Figure 3.2 shows the clustering of unique genotype ON1 sequences in 
Kilifi. Two genotype ON1 lineages initially defined by Duvvuri et al were shown to 
be circulating in Kilifi, i.e. lineages ON1 [1.1] and ON1 [1.3] (Duvvuri et al. 2015). 
Of these two lineages, ON1 [1.3] was the most prevalent in 2011/2012 and 
2012/2013. However, a potential new lineage, denoted here as ON1 [1.4], clustered 
away from ON1 [1.3], and seemed to have recently arisen comprising of sequences 
from the 2013/2014 and 2014/2015 epidemics. The genetic divergence (p-distance) 
between ON1 [1.4] and the other ON1 lineages identified in Kilifi ranged between 
0.013 – 0.045, which was similar to the genetic distances between the previously 
defined ON1 lineages (Duvvuri et al. 2015). 
  
Unadjusted OR 
(95% Confidence 
Interval) p-value 
Age < 1 year 0.85 (0.49 – 1.49) 0.579 
Gender Male 0.76 (0.52 – 1.12) 0.172 
Clinical 
Presentation 
Cough  1.16 (0.31 – 4.37) 0.830 
Breathing difficulty 0.28 (0.08 – 0.97) 0.045 
Chest wall indrawing 1.46 (0.46 – 4.59) 0.520 
Inability to feed 2.40 (1.31 – 4.36) 0.004 
Oxygen saturation <90% 0.86 (0.53 – 1.38) 0.521 
Prostration/Consciousness 1.67 (0.75 – 3.74) 0.211 
Pneumonia 
status Very severe pneumonia 0.89 (0.57 – 1.39) 0.609 
Hospital stay >4 days 0.77 (0.53 – 1.14) 0.192 
Outcome Dead 1.416 (0.42 – 4.78) 0.575 
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Figure 3.2: An unrooted ML phylogenetic tree of unique genotype ON1 G-gene ectodomain 
sequences from Kilifi, Kenya, 2012 to 2015. 
The taxa are colour coded by the epidemic season of detection as shown by the key, and the 
names represent “KEN/Kilifi/serialno_date of collection”. Note that although the study 
detected RSV ON1 in the epidemic season 2011-12, the first ON1 cases were in 2012. 
Lineages ON1 [1.1] – ON1 [1.3] initially assigned by Duvvuri et al. are shown in bold in 
addition to the newly assigned lineage ON1 [1.4] identified in Kilifi. 
ON1 (1.3) 
ON1 (1.4) 
	2011/2012		2012/2013		2013/2014			2014/2015	
Ke	y	
 KEN/Kilifi/1255_08/12/2014
 KEN/Kilifi/1309_08/03/2015
 KEN/Kilifi/1250_06/12/2014
 KEN/Kilifi/1227_02/06/2014
 KEN/Kilifi/1225_20/05/2014
 KEN/Kilifi/1194_09/02/2014
 KEN/Kilifi/1191_30/01/2014
 KEN/Kilifi/1355_12/08/2015
 KEN/Kilifi/1190_30/01/2014
 KEN/Kilifi/1162_12/10/2013
 KEN/Kilifi/1301_08/02/2015
 KEN/Kilifi/1179_04/12/2013
 KEN/Kilifi/1180_04/12/2013
 KEN/Kilifi/1256_09/12/2014
 KEN/Kilifi/1304_21/02/2015
 KEN/Kilifi/1330_24/05/2015
 KEN/Kilifi/1338_01/06/2015
 KEN/Kilifi/1351_31/07/2015
 KEN/Kilifi/1352_02/08/2015
 KEN/Kilifi/1348_20/06/2015
 KEN/Kilifi/1341_10/06/2015
 KEN/Kilifi/1353_06/08/2015
 KEN/Kilifi/1326_20/04/2015
 KEN/Kilifi/1293_24/01/2015
 KEN/Kilifi/1185_10/01/2014
 KEN/Kilifi/1198_18/02/2014
 KEN/Kilifi/1265_16/12/2014
 KEN/Kilifi/1279_27/12/2014
 KEN/Kilifi/1290_08/01/2015
 KEN/Kilifi/1339_08/06/2015
 KEN/Kilifi/1181_09/12/2013
 KEN/Kilifi/1331_26/05/2015
 KEN/Kilifi/1333_29/05/2015
 KEN/Kilifi/1300_08/02/2015
 KEN/Kilifi/1349_05/07/2015
 KEN/Kilifi/1232_04/11/2014
 KEN/Kilifi/1296_29/01/2015
 KEN/Kilifi/1294_25/01/2015
 KEN/Kilifi/1231_03/11/2014
 KEN/Kilifi/1252_07/12/2014
 KEN/Kilifi/1307_26/02/2015
 KEN/Kilifi/1347_20/06/2015
 KEN/Kilifi/1241_17/11/2014
 KEN/Kilifi/1312_22/03/2015
 KEN/Kilifi/1329_13/05/2015
 KEN/Kilifi/1342_16/06/2015
 KEN/Kilifi/1202_24/03/2014
 KEN/Kilifi/1305_21/02/2015
 KEN/Kilifi/1299_04/02/2015
 KEN/Kilifi/1230_01/11/2014
 KEN/Kilifi/1233_06/11/2014
 KEN/Kilifi/1239_15/11/2014
 KEN/Kilifi/1229_29/09/2014
 KEN/Kilifi/1243_21/11/2014
 KEN/Kilifi/1245_25/11/2014
 KEN/Kilifi/1274_21/12/2014
 KEN/Kilifi/1277_24/12/2014
 KEN/Kilifi/1284_02/01/2015
 KEN/Kilifi/1318_08/04/2015
 KEN/Kilifi/1269_17/12/2014
 KEN/Kilifi/1319_11/04/2015
 KEN/Kilifi/1321_17/04/2015
 KEN/Kilifi/1336_30/05/2015
 KEN/Kilifi/1208_09/04/2014
 KEN/Kilifi/1164_19/10/2013
 KEN/Kilifi/1176_27/11/2013
 KEN/Kilifi/1186_15/01/2014
 KEN/Kilifi/1214_15/04/2014
 KEN/Kilifi/1051_24/04/2012
 KEN/Kilifi/1105_28/11/2012
 KEN/Kilifi/1082_10/11/2012
 KEN/Kilifi/1144_24/01/2013
 KEN/Kilifi/1337_31/05/2015
 KEN/Kilifi/1074_24/08/2012
 KEN/Kilifi/1156_02/04/2013
 KEN/Kilifi/1137_14/01/2013
 KEN/Kilifi/1095_24/11/2012
 KEN/Kilifi/1083_12/11/2012
 KEN/Kilifi/1152_04/03/2013
 KEN/Kilifi/1076_30/10/2012
 KEN/Kilifi/1132_11/01/2013
 KEN/Kilifi/1124_24/12/2012
 KEN/Kilifi/1042_04/04/2012
 KEN/Kilifi/1086_15/11/2012
 KEN/Kilifi/1093_23/11/2012
 KEN/Kilifi/1078_31/10/2012 ON1 (1.3)
 KEN/Kilifi/1066_28/06/2012
 KEN/Kilifi/1155_13/03/2013
 KEN/Kilifi/1061_13/06/2012
 KEN/Kilifi/1071_14/08/2012
 KEN/Kilifi/1056_30/05/2012
 KEN/Kilifi/1084_15/11/2012
 KEN/Kilifi/1075_27/10/2012
 KEN/Kilifi/1117_10/12/2012
 KEN/Kilifi/1091_22/11/2012
 KEN/Kilifi/1139_16/01/2013
 KEN/Kilifi/1147_04/02/2013
 KEN/Kilifi/1151_10/02/2013
 KEN/Kilifi/1281_30/12/2014
 KEN/Kilifi/1150_09/02/2013
 KEN/Kilifi/1025_13/02/2012
 KEN/Kilifi/1038_23/03/2012
 KEN/Kilifi/1120_19/12/2012
 KEN/Kilifi/1145_01/02/2013
 KEN/Kilifi/1153_12/03/2013
 KEN/Kilifi/1171_12/11/2013
 KC858255 1301-118RM   ON2
 KC858212 1251-195AN ON1 (1.2)
 JN257693 ON67-1210A ON1 (1.1)
 KEN/Kilifi/1344_18/06/2015
 KEN/Kilifi/1055_19/05/2012
 KEN/Kilifi/1070_23/07/2012
ON1 (1.1)94
80
88
93
72
79
85
0.002
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3.4.4 RSV-A introduction and persistence patterns 
A total of 66 RSV-A variants were detected over the whole surveillance period in 
Kilifi, Figure 3.3, where a variant is defined from Usearch using Nd ≥4 nucleotides 
difference. The variants comprised of between 1-82 sequences, with 39 of the 66 
variants (59.1%) being singletons. Most variants did not persist between epidemics 
(69.7%; 46/66). However, fourteen variants persisted for two consecutive seasons, 
one for four consecutive seasons and five for two non-consecutive seasons. Therefore, 
the number of variants when accumulated by epidemic increases to 86. The number of 
GA2 variants was observed to decline consistently over time, i.e. from seventeen 
variants in 2010/2011 (before ON1 arrived) to only four variants in 2014/2015. In 
contrast, the number of ON1 variants assigned remained at five variants between 
2011/2012 and 2012/2013 before increasing to eight variants in 2013/2014, then 
rising markedly to 25 variants in 2014/2015. 
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Figure 3.3: Temporal occurrence of RSV-A variants (rows) detected in Kilifi Kenya, 
2010/2011 to 2014/2015. 
A variant was defined as a group of viruses (where group includes a singleton) within a 
genotype that possesses ≥4 nucleotide differences in the G ectodomain region compared to 
other viruses (see Methods). Genotypes are shown in different colours: GA2 (dark blue) and 
ON1 (green). 
 
 
3.4.5 N-glycosylation patterns within the G-gene 
Seven codon sites were predicted to be N-glycosylated within the G protein for the 
Kilifi sequences: four sites for genotype ON1 viruses (codons 103, 135, 237 and 318) 
and six sites for genotype GA2 viruses (codons 103, 135, 237, 251, 273 and 294). 
However, none of the potential N-glycosylation sites occurred within the 72-
nucleotide duplication region (144 nucleotides; codons 260-307) of the ON1 viruses. 
Interestingly for GA2 viruses, sites 237 and 273 were mutually exclusive such that a 
virus belonging to this genotype had either one of these sites potentially N-
glycosylated but not both, Figure 3.4. 
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Figure 3.4: Differentiation of GA2 viruses in Kilifi based on N-glycosylation patterns. 
Amino acid alignment and ML tree highlighting the two codon sites (237 and 273) on the G protein that define two groups of GA2 viruses in Kilifi based on 
N-glycosylation patterns Samples are from Kilifi County Hospital admissions aged 1 day to under 5 years, 2012-2015. 
 
237                                               273 
 123414 15/04/2014
 123838 09/05/2014
 123159 01/04/2014
 120835 07/11/2013
 120846 08/11/2013
 KEN/1072 09/10/2012
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3.4.6 G-gene nucleotide and amino acid variability 
The nucleotide and amino acid variability over the four seasons is shown in Table 3.4. 
Amino acid substitutions over the sequenced portion of the G protein are shown in 
Figure 3.5A. Two codon positions possessed amino acid substitutions that 
distinguished between ON1 (232G, 253K) and GA2 (232E, 253T) viruses. In 
addition, the new ON1 [1.4] lineage viruses seem to have fixed a threonine (I/T136T) 
and acquired a unique substitution (P206Q) that distinguishes them from the other 
ON1 lineages. 
 
Table 3.4: G protein nucleotide and amino acid variability in RSV-A genotypes 
identified in Kilifi, Kenya, 2010/2011 to 2014/2015 
 
Epidemic 
season* 
All RSV-A ON1 GA2 
Nucleotide Amino acid Nucleotide Amino acid Nucleotide Amino acid 
2014/2015 0.88 1.40 0.68 1.10 2.02 4.12 
2013/2014 1.24 2.07 0.55 0.75 1.72 3.29 
2012/2013 1.21 2.14 0.46 0.58 1.69 3.13 
2011/2012 1.45 2.99 0.43 1.02 1.56 2.91 
2010/2011 0.66 0.99 - - 0.66 0.99 
Total* 2.04 3.41 0.85 1.23 1.01 1.71 
*Epidemic designated 1st September of one year to 31st August of the following year 
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Figure 3.5B and 3.5C illustrate amino acid substitutions within the duplication region 
of the Kilifi ON1 viruses. The first set of 72 nucleotides was designated as 
“duplication sequence I” and the second set as “duplication sequence II”. Within this 
region, it was observed that over the three seasonal epidemics of 2011/2012 to 
2013/2014 epidemics and in early (Sept-Nov) 2014/2015 epidemic, amino acid 
substitutions only occurred within the duplicated sequence I except for three 
substitutions in two viruses that occurred within the duplicated sequence II. From 
December 2014 of the 2014/2015 epidemic, however, numerous substitutions were 
detected in duplicated sequence II with two adjacent and corresponding positions 
between the duplicated sequences I and II acquiring similar amino acid substitutions, 
i.e. Y273H and Y297H; P274L/S and P298L/R. Furthermore, sites 273 and 297 were 
detected to be co-evolving from the Spidermonkey analysis. However, only one ON1 
codon site (251) was identified to be positively selected with p<0.05 by at least one 
method (SLAC, FEL and MEME). 
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Figure 3.5: Amino acid substitutions in RSV-A G-protein for sequences isolated in Kilifi Kenya from season 2011/2012 to 2014/2015. 
All unique protein sequences per epidemic were collated, aligned and the amino acid differences from the earliest sequence determined and marked with 
vertical coloured bars, with the substituted amino acid residue colour coded as shown by the key between panels A and B. Panel A shows the full aligned AA 
sequence inferred from the G gene sequences (ON1 and GA2) whereas Panel B (ON1 only) focuses on the region of the ON1 duplication. The positions 
shown at the bottom of panels A and B are relative to the first amino acid of the regions analyzed, i.e. from amino acid positions 94 and 260, respectively, of 
the reference strain A2 [Ref: M74568]. Indicated at the top of these panels are the functional domains of the G protein (A) and the 72-nucleotide duplication 
of genotype ON1 (B; duplicated sequence I in “orange” and duplicated sequence II in “purple”). Below this, the histogram indicates the total number of 
changes at each position. The green and pink rectangles in Panel B represent periods of minimal and numerous substitutions, respectively, within the 
duplicated sequence II. Panel C shows concurrent AA positions within the duplicated sequences I and II, and the respective amino acid substitutions 
(numbering similar to positions in Panel B). In bold are concurrent positions with similar amino acid substitutions. 
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3.4.7 The global dynamics of ON1 vs BA variants 
Using global datasets for genotypes ON1 and BA, we compared the temporal 
detection of RSV variants within each of these genotypes over the first five and ten 
years, respectively, from initial detection; Table 3.5. There was an explosion of new 
ON1 variants globally from eight variants in 2011, to 78 variants in 2012, and to 153 
variants in 2013. However, there was a decrease in the number of ON1 variants in 
2014 and 2015, which corresponded with a substantial decrease in both the number of 
ON1 sequences available in GenBank and the countries that have deposited sequences 
from these years. On the other hand, the number of BA variants followed a stepwise 
or punctuated pattern whereby the number of variants was stable between one to six 
variants from 1996-2001, then drastically increased to and stabilized between 20 to 30 
variants from 2002-2004, and again sharply rising to 82 variants in 2005. At the 
country level, Table 3.6, the rapid rise in the number of ON1 variants detected in 
Kilifi was similarly observed in Philippines and Germany while the number of BA 
variants detected in some of the countries sampled remained relatively stable over 
time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
87 
Table 3.5: Frequency of global genotypes BA and ON1 variants detected, by calendar 
year, 1998-2015 
 
BA* ON1 
Year Variants$ Sequences Countries Year Variants Sequences Countries 
1998 2 4 2 2010 1 5 2 
1999 3 11 4 2011 8 57 7 
2000 2 2 1 2012 78 368 19 
2001 6 23 4 2013 153 432 15 
2002 20 51 9 2014 59 256 8 
2003 30 60 10 2015 10 81 2 
2004 30 144 12     
2005 82 290 13     
2006 101 205 16     
*Data extracted from GenBank on 19th January 2016, length 241 to 687 bases. 
$Variant defined as Nd ≥4 
 
Table 3.6: Select country specific frequency of genotypes BA and ON1 variants, by 
calendar year, 1999-2015 
 
Genotype Country 
Year and variants* 
2010 2011 2012 2013 2014 2015   
ON1 
Philippines - - 7 29 - -   
Germany - - 5 26 - -   
Japan - - 5 9 7 1   
Spain - - 5 7 14 -   
BA 
 1999 2000 2001 2002 2003 2004 2005 2006 
Belgium 2 - 5 5 5 5 8 9 
Argentina 1 - - 6 8 5 -  
Japan - - 1 2 4 3 9 6 
*Data extracted from GenBank on 19th January 2016, length 241 to 687 bases. 
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3.5 Discussion and Conclusions 
In this chapter, we provide a detailed analysis on the spread and the associated 
demographic, clinical and evolutionary characteristics of the novel RSV-A genotype 
ON1 in Kilifi. ON1 was first detected in Kilifi in February 2012, and within that RSV 
epidemic (2011/2012) it displaced the previous dominant genotype GA2 by attaining 
a prevalence of 67%. Its dominance continued to rise to 96% within a span of only 
four epidemics. This rapid rate of replacement is unlike previous observations from 
the same location on the displacement of GA5 by GA2; it took GA2 about seven 
years to attain a similar prevalence of 95% (Otieno et al. 2016). ON1 seems to 
possess a greater fitness advantage over GA2 than GA2 over GA5. If such fitness is 
the result of immune evasion, there are potential implications for vaccines to deliver 
population level immunity via herd protection (Kinyanjui et al. 2015). 
 
The present study found evidence for increased severity of cases of RSV ON1 relative 
to GA2, showing a higher risk for inability to feed. However, overall cases of very 
severe pneumonia were equally prevalent in both genotypes. The data, therefore, does 
not provide a strong indication of more severe disease arising from the ON1 variant. 
Duvvuri et al. (Duvvuri et al. 2015) reported significant association of ON1 with 
females, which was not evident in the present study. Yoshihara et al (Yoshihara et al. 
2016) reported that ON1 ARI cases in Vietnam were significantly associated with 
clinically severe presentations of wheezing, tachypnoea and difficulty in breathing as 
compared to NA1 cases while Panayiotou et al (Panayiotou et al. 2014), on the 
contrary, reported that children infected with ON1 in Cyprus experienced 
significantly milder illness compared to infections with GA2. Some studies have 
reported no differences at all between genotypes in risk of clinical severity. The 
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discordant results may arise from methodological differences in analyses, clinical 
disease definitions and study designs, chance effects resulting from inadequate sample 
sizes, differences between viruses in different locations, or even host/environmental 
differences. Prospective studies specifically designed to evaluate virulence or clinical 
differences between genotypes may offer more reliable insight. 
 
We noted some change in the alternation of RSV subgroup dominance pattern in 
Kilifi since the introduction of ON1 into this community. While replacing GA2, the 
presence of ON1 appeared to also exclude group B strains. RSV-A predominated over 
RSV-B in three consecutive epidemics from 2012/2013 to 2014/2015. The epidemics 
thereafter of 2015/2016, 2016/2017 and 2017/2017 were predominated by RSV-B, 
RSV-B and RSV-A, respectively. Previously, using data collected between 2002 and 
2012 in Kilifi, RSV-A predominated in only up to two consecutive epidemics (Otieno 
et al. 2016). It is unclear whether the RSV-A predominance in the three consecutive 
epidemics was related to ON1, a general change in RSV epidemiological patterns or a 
chance occurrence. 
 
Globally, the reported prevalence of ON1 varies from one location to another. In 
Ontario, Canada, where ON1 was first detected in December 2010, the prevalence of 
ON1 has remained stable at 11-13% [2011-2012] (Duvvuri et al. 2015). Other 
countries that have similarly reported ON1 prevalence rates <20% include South 
Africa [2012] (Pretorius et al. 2013) and China [2011-2013] (Yu et al. 2015). Reports 
from Italy [2011-2013] (Pierangeli, Trotta and Scagnolari 2014), South Korea [2011-
2013] (Kim et al. 2014), USA [2011-2013] (Avadhanula et al. 2015), Malaysia 
[2011] (Khor et al. 2013), Japan [2012] (Tsukagoshi et al. 2013), Thailand [2010-
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2011] (Auksornkitti et al. 2014), Latvia [2009-2012] (Balmaks et al. 2014) and 
Cyprus [2010-2013] (Panayiotou et al. 2014) indicate a range of ON1 prevalence of 
between 20% to 70%. An article from Argentina reported the detection of ON1 as the 
only (100%) RSV-A genotype in Buenos Aires in 2014 (Viegas, Goya and 
Mistchenko 2016). Even though the prevalence rates reported in these publications 
may not have been long after ON1 introductions into those countries, the varied 
prevalence suggests that while ON1 is rapidly spreading globally there could be host 
or ecological differences that determine RSV spread.  
 
As shown here and in previous work from Kilifi (Agoti et al. 2015b; Otieno et al. 
2016), RSV epidemics are comprised of multiple variants to suggest separate 
introductions into the community (as opposed to arising from diversification during 
the epidemic). In addition, these variants often do not persist between epidemics. This 
suggests that each year (a) variants generate local herd immunity leading to their 
demise hence requiring reintroductions or (b) that there is competition for seeding 
new seasonal epidemics from many invading variants and the preceding year variants 
lose out (perhaps on a chance basis or as stated above because they have less fitness 
due to variant specific immunity). However, the notion of multiple introductions 
needs to be demonstrated by genetic diversity and phylogenetic analyses using full 
genome data that should have a better resolution at distinguishing between virus 
variants. 
 
RSV accumulates amino acid changes over time (Cane and Pringle 1995), and the 
same was similarly observed in the Kilifi ON1 viruses. It is of interest that in the first 
three RSV epidemic seasons of ON1 detection in Kilifi, amino acid substitutions were 
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restricted to the duplicated sequence I of the 72nt duplication save for three 
substitutions in two viruses that occurred within the duplicated sequence II. However, 
in the 2014/2015 epidemic an ‘explosion’ in amino acid substitutions was observed 
within the duplicated sequence II that coincided with a surge in the number of 
detected ON1 variants. In addition, there were similar amino acid substitutions in two 
adjacent and corresponding sites in the duplicated sequences I and II, with one set of 
these sites co-evolving. Considering that the 72nt duplication in ON1 viruses 
represents a longer attachment protein, this may offer more opportunities for variable 
changes, greater diversity and increased fitness over previous group A genotypes. 
 
Two codon sites, 232 and 253, within the G protein region analyzed were found to 
distinguish between genotype ON1 and GA2 viruses. The amino acid change Glu-
232-Val has been reported in RSV-A escape mutants that result in loss of reactivity to 
a specific monoclonal antibody (Cane and Pringle 1995). Further, a functional 
analysis of the 60-nucleotide duplication in BA strains has shown that the duplicated 
region in the G protein of these viruses augment their fitness (Hotard et al. 2015). A 
similar analysis has not been reported for ON1, but it is plausible that the 72-
nucleotide duplication may contribute considerably in the increased fitness observed 
in. However, G-protein N-glycosylation seems to play no role in the increased fitness 
of ON1 as similar potential N-glycosylation codon sites were detected in both ON1 
and GA2 and no additional N-glycosylation sites were detected within the ON1 
duplication region. 
 
The rapid diversification of ON1 observed in Kilifi seems to reflect rapid expansion at 
the global level. While sampling variability may play a role, and similar to varying 
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prevalence, there was variability in the diversification of ON1 viruses in different 
countries. The number of ON1 variants seemed stable in some countries (e.g. Japan) 
while expanding in others (e.g. Germany and Philippines). The temporal distribution 
of BA variants in different countries, however, was mostly stable. Comparisons in the 
temporal patterns of genotype BA and ON1 variants may highlight differences 
between the RSV group B and A viruses. Increased sampling and surveillance will 
help illuminate on whether such inter-genotypic and inter-group differences are due to 
ecological differences or variable sampling. 
 
In conclusion, it is evident that genotype ON1 is not only rapidly spreading globally 
but also increasing in frequency. The result is the near exclusion of the previous 
dominant group A GA2 genotype in some locations. The implications of this apparent 
increased fitness of RSV-ON1 are yet to be resolved. There is some evidence for 
increased severity of the virus, but this is by no means clear or consistent across 
studies. Continued surveillance for cases together with collection of detailed 
standardized clinical data is warranted. The possibility exists that ON1 and other 
similar new RSV variants (e.g. the BA genotype) become dominant by evading host 
immunity. It is reasonable to assume this could lead to evasion of future vaccine 
induced protection, lessening the herd immunity potential of vaccination, similar to 
influenza A vaccines. Analysis of genome-wide substitutions between viruses 
belonging to incoming and outgoing genotypes has the potential of highlighting 
substitutions with likely functional and fitness implications. 
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CHAPTER FOUR 
4 Whole genome evolutionary dynamics of RSV genotype ON1 
4.1 Background 
The single stranded negative-sense RSV genome is approximately 15.2Kb long and 
has 10 genes that encode 11 proteins (Collins and Melero 2011). However, the bulk of 
RSV molecular epidemiology studies to date have been (and still are) based on partial 
sequencing of the gene encoding the attachment G glycoprotein. This is because the G 
protein is the most variable RSV protein between and within viruses of the two co-
circulating RSV groups, A and B (Johnson et al. 1987), in addition to being a key 
target of protective immune responses (Melero et al. 1997). In this chapter, the utility 
of WGS in gaining a better understanding of the molecular epidemiology of RSV was 
explored. 
 
The G gene on its own has been shown to be insufficient in distinguishing between 
inpatient outbreak RSV strains isolated in a haematology-oncology and stem-cell 
transplant unit and outpatient epidemiologically-unrelated strains collected within the 
same time period (Zhu et al. 2017), and “who acquires infection from whom” in a 
household RSV transmission study (Munywoki et al. 2014). Further, an analysis by 
Agoti et al. 2015 showed that viruses that were 100% identical in this genome region 
had substitutions in other parts of the genome (Agoti et al. 2015a). In addition to 
providing data on the consensus genome sequences, NGS provides information on 
low frequency minority sequence variants, which could be useful in understanding the 
evolutionary and transmission dynamics of the target organism (Bull et al. 2012; 
Henn et al. 2012; Grad et al. 2014; Ha Do et al. 2015; Rodriguez-Roche et al. 2016; 
Cobbin et al. 2017; Githinji et al. 2018). Therefore, WGS has potential for a more 
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detailed understanding of RSV molecular epidemiology, evolution, phylogeography, 
diagnostics and vaccine development. 
 
The rapid replacement of the previously circulating RSV-A genotype GA2 by 
genotype ON1 since first detection in Kilifi in 2012 suggests some fitness advantage 
of ON1 over the GA2 viruses in Kilifi (Hotard et al. 2015; Otieno et al. 2017), and 
might be accompanied by other important genomic substitutions in ON1 viruses. 
Close observation of such a new virus genotype introduction over time provides an 
opportunity to better understand the transmission and evolutionary dynamics of the 
pathogen. This chapter presents WGS sequencing and analysis of 184 RSV-A 
genomes from Kilifi, the very first ON1 genomes from Africa, and advances the 
previous work on the patterns of introduction and persistence of the ON1 variant 
within this community that utilized partial G gene sequences (Agoti et al. 2014b; 
Otieno et al. 2017). The results of this analysis provide a higher resolution of the RSV 
genetic structure, spread and identification of variation that may be associated with 
molecular adaptation and apparent fitness advantages. 
 
The work described in this chapter has been published and can be found from the 
following link; https://academic.oup.com/ve/article/4/2/vey027/5106641. Analysis 
files and scripts can be found on GitHub: 
https://github.com/jrotieno/Kilifi_ON1_genomes 
4.2 Aims of the Chapter 
The  aims of this chapter were to utilize full length RSV-A genome sequences to 
identify genome-wide substitutions that differentiate between old and new RSV 
variants entering a community, characterize the genome regions where the 
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substitutions occur, and infer if such substitutions could impact on virus fitness, and 
to get a better understanding of the nature of emergence of the RSV-A ON1 genotype 
using WGS. 
4.3 Methods 
Study population 
Two sets of samples were used in the current analysis; (i) samples collected as part of 
the RSV IP study from children (under 5 years of age) admitted to KCH presenting 
with syndromically defined severe or very severe pneumonia between September 
2011 to August 2016 (Nokes et al. 2009; Otieno et al. 2017), and (ii) samples 
collected as part of the SPReD-KHDSS study from patients of all ages presenting at 
health facilities within the KHDSS with ARI between January to December 2016 
(Scott et al. 2012; Nyiro et al. 2018). 
 
RNA extraction and PCR amplification 
All KCH admissions specimens had previously been screened for RSV 
(immunofluorescent antibody test, IFAT), RSV group (multiplex real-time 
polymerase chain reaction) and RSV-A genotype status (G gene amplification 
followed by Sanger sequencing), and partial G-gene sequencing results reported 
(Otieno et al. 2017), while the KHDSS samples were screened afresh using the same 
multiplex real-time PCR methods referred to as above. To pick samples proceeding to 
WGS, we selected (i) all the RSV-A positives from the KHDSS, (ii) all the GA2 
positives from KCH, and (iii) a random subsample (50%) of the ON1 positives per 
epidemic from the KCH. Additionally, we targeted samples with real-time PCR cycle 
threshold (Ct) value < 30 based on the success rate from previous experience (Agoti 
et al. 2015a), with the exception of four test samples that were PCR negative or had 
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Ct>30. Viral RNA was extracted using QIAamp Viral RNA Mini Kit (QIAGEN, 
London, UK). Reverse transcription (RT) of RNA molecules and PCR amplification 
were performed with a six-amplicon, six-reaction strategy (Agoti et al. 2015a), or 
using a 6 or 14-amplicon strategy split into two reactions of three and seven 
amplicons, respectively for each (Chapter Two, Figure 2.4). Amplification success 
was confirmed by observing the expected PCR product size (1200-1500 bp) on 0.6% 
agarose gels. Amplicons from six or two reactions were pooled and purified for 
Illumina library preparation. 
 
Illumina library construction and sequencing 
The purified PCR products were quantified using Qubit fluorimeter 2.0 (Life 
Technologies) and normalized to 0.2 ng/μL. The normalized DNA was tagmented (a 
process of fragmentation and tagging) using the Nextera XT (Illumina, San Diego, 
USA) library prep kit as per the manufacturer’s instructions. Indices were ligated to 
the tagmented DNA using the Nextera XT index kit (Illumina). The barcoded libraries 
were then purified using 0.65X Ampure Xp beads. Library quality control was carried 
out using the Agilent high sensitivity DNA kit on the Agilent 2100 Bioanalyzer 
(Agilent, Waldbronn, Germany) to confirm the expected size distributions and library 
quality. Each library was quantified using the Qubit fluorimeter 2.0 (Life 
Technologies), after which the libraries were normalized and pooled at equimolar 
concentrations. The pooled libraries were sequenced on either (i) Illumina HiSeq 
system using 2 x 250 bp paired-end (PE) sequencing at the Wellcome Trust Sanger 
Institute (UK), or (ii) Illumina MiSeq using 2 x 250 bp PE sequencing at the KEMRI-
Wellcome Trust Research Programme (Kilifi, Kenya). 
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A preliminary quality check of the sequence reads was done using fastqc (Andrews 
2010) with the output per batch aggregated and visualized by multiqc (Ewels et al. 
2016). To determine the proportion of RSV and non-RSV reads in the samples used 
here, Kraken v0.10.6 (Wood and Salzberg 2014) was used with a pre-built Kraken 
database provided by the viral-ngs pipeline (Park et al. 2015, 2016) (downloaded in 
December, 2015; https://storage.googleapis.com/sabeti-public/meta_dbs/ 
kraken_ercc_db_20160718 .tar.gz). 
 
Depletion of human reads 
Prior to deposition of the raw short reads into NCBI short read archive (SRA), 
datasets were depleted of human reads. The raw reads were mapped onto the human 
reference genome hg19 using bowtie2 (Langmead et al. 2009) while samtools (Li et 
al. 2009) was used to filter, sort and recover the unmapped (non-human) reads. The 
final reads are available in the NCBI BioProject database under the study accession 
PRJNA438443. 
 
Genome assembly and coverage 
Consensus genome assemblies were generated either using viral-ngs versions 
1.18.0/1.19.0 (Park et al. 2015, 2016) and/or SPAdes version 3.10.1 (Bankevich et al. 
2012), selecting the most complete assembly from either assemblers (more details in 
the Methods Chapter [Chapter 2.8]). The available Sanger G-gene sequences (Agoti et 
al. 2014b; Otieno et al. 2017) for these samples were additionally used to confirm 
agreement with the WGS assemblies. The genomes generated in this study are 
available in GenBank under accession numbers MH181878 - MH182061. The 
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genomes were aligned using MAFFT alignment software v7.305 (Katoh and Standley 
2013) using the parameters ‘—localpair –maxiterate 1000’. 
 
To calculate and visualize depth of coverage, sample raw reads were mapped onto 
individual assemblies with BWA (Li and Durbin 2009), samtools (Li et al. 2009) 
were used to sort and index the aligned bam files, and finally bedtools (Quinlan and 
Hall 2010) were used to generate the coverage depth statistics. Plotting of the depth of 
coverage was done in R (Pereira et al. 2017) in the RStudio (RStudio Team 2016). 
 
Global comparison dataset 
All complete and partial genome sequences available in GenBank Nucleotide 
database (https://www.ncbi.nlm.nih.gov/genbank/) as on 19/09/2017 were used to 
prepare a global RSV-A genotype ON1 genomic and G-gene dataset. To prepare the 
global ON1 dataset, all RSV sequences from GenBank (search terms: respiratory 
syncytial virus) were downloaded, created a local blast database in Geneious (Eiter et 
al. 2003), and performed a local blast search using the 144 nucleotide sequence region 
of the ON1 genotype. To remove duplicates, the sequences were binned by country of 
sample collection, filtered of duplicates and then re-collated into a single dataset. For 
the global G-gene dataset of 1,167 sequences, the sequence length ranged from 238-
690bp. The final alignment of 344 ON1 genome sequences comprised the sequences 
reported in this study (n=154) and additional publicly available GenBank ON1 
sequences (n=190). In addition to the ON1 genomes, a total of 30 genotype GA2 
genome sequences from Kilifi were generated. The alignments were inspected in 
AliView (Larsson 2014) and edited manually removing unexpected spurious frame-
shift indels (largely homopolymeric and most likely sequencing errors). 
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Maximum likelihood phylogenetic analyses and root-to-tip regression 
Separate Maximum-Likelihood (ML) phylogenetic trees were generated using 
multiple sequence alignments of the three datasets, i.e. Kilifi WGS, and global G-
gene and WGS datasets. The ML trees were inferred using both PhyML and RaxML, 
with each optimizing various parts of the tree generation process (i.e. borrowing 
strengths of both approaches), using the script generated and deposited by Andrew 
Rambaut at (https://github.com/ebov/space-
time/tree/master/Data/phyml_raxml_ML.sh). The GTR+G model was used after 
determination as the best substitution model by IQ-TREE v.1.4.2 (Chernomor, von 
Haeseler and Minh 2016). 
 
To determine presence of temporal signal (‘clockiness’) in our datasets, TempEst v1.5 
(Rambaut et al. 2016) was used to explore the relationship between root-to-tip 
divergence and sample dates. The data were exported to R (Pereira et al. 2017) to 
perform a regression with the ‘lm’ function. 
 
Estimating the number of local variant introductions 
To differentiate between local variants arising from a recent introduction and 
imported variants with greater genetic differences than is expected from local 
diversification, a pragmatic criterion previously described by Agoti et al. in (Agoti et 
al. 2015b) was used. Briefly, a variant is a virus (or a group of viruses) within a 
genotype that possesses Nd≥10 nucleotide difference compared to other viruses. This 
Nd nucleotide difference is a product of the length of the genomic region analyzed, 
estimated substitution rate for that region, and time. This analysis was done using 
usearch v8.1.1861 (Edgar 2010). 
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Protein substitution and selection analysis 
Using the aligned Kilifi (ON1 and GA2) genome dataset, patterns of change in 
nucleotides (single nucleotide polymorphisms or SNPs) and amino acids were sought 
using Geneious v11.1.2 (Eiter et al. 2003) and BioEdit 7.2.5 (Hall 1999), respectively. 
Potential positively selected and co-evolving sites within the coding regions were 
identified using HyPhy (Pond, Frost and Muse 2005) and phyphy (J. Spielman 2018). 
SNPs were called from both the complete dataset and from an alignment of the 
consensus sequences from GA2 and ON1, whereby a consensus nucleotide was 
determined as the majority base at a given position. For the positive selection 
analysis, two strategies were used; gene-wide selection detection [BUSTED (Murrell 
et al. 2015)] and site-specific selection [SLAC, FEL (Kosakovsky Pond et al. 2005), 
FUBAR (Murrell et al. 2013) and MEME (Murrell et al. 2012)]. Codon positions 
with a p-value <0.1 for either the SLAC, FEL and MEME models or with a posterior 
of probability >0.9 for the FUBAR method were considered to be under positive 
selection. 
 
Bayesian phylogenetics 
To infer time-structured phylogenies, Bayesian phylogenetic analyses were performed 
using BEAST v.1.8.4 (Drummond et al. 2012). Because of sparse data at the 5’ and 3’ 
termini and in the non-coding regions of the genomic datasets, only the coding 
sequences (CDS) were used as input. The SRD06 substitution model (Shapiro, 
Rambaut and Drummond 2006) was used on the CDS and three coalescent tree priors 
were tested, i.e. a constant-size population, an exponential growth population, and a 
Bayesian Skyline (Drummond et al. 2005). For each of these tree priors, combinations 
with the strict clock model and an uncorrelated relaxed clock model with log-normal 
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distribution (UCLN) (Drummond et al. 2006) were tested with the molecular clock 
rate set to use a non-informative continuous time Markov chain rate reference prior 
(CTMC) (Ferreira and Suchard 2008). For each of the molecular clock and coalescent 
model combinations, the analyses were run for 150 million Markov Chain Monte 
Carlo (MCMC) steps and performed both path-sampling (PS) and stepping-stone (SS) 
to estimate marginal likelihood (Baele et al. 2012, 2013). The best fitting model was a 
relaxed clock with a Skyline coalescent model, Table 4.1. 
 
 
Table 4.1: Marginal likelihood estimation of the best clock and coalescent models 
Molecular Clock  
+  
Population Model 
Path-Sampling (PS) Stepping-Stone (SS) 
Strict + Skyline -40221.86 -40237 
Relaxed + Skyline -40203.78* -40212.06* 
Strict + Exponential -40285.47 -40293.39 
Strict + Constant -40284.81 -40293.96 
Relaxed + Constant -40263.39 -40275.27 
Relaxed + Exponential -40272.2 -40283.01 
*The highest marginal likelihood estimates for each analysis 
 
 
BEAST was then run with 300-400 million MCMC steps using the SRD06 
substitution model, Skyline tree prior, and relaxed clock model to estimate Bayesian 
phylogenies. For the time to the most recent common ancestor (TMRCA) estimates, 
the same substitution model and tree prior were used as above but with a strict clock 
model. For the global G-gene dataset, BEAST was run with 400 million MCMC steps 
using the HKY substitution model, Skyline tree prior, and a relaxed clock model. All 
the BEAST analyses were performed using the Broad-platform Evolutionary Analysis 
General Likelihood Evaluator (BEAGLE) library to enhance computation speed 
(Suchard and Rambaut 2009; Ayres et al. 2012). Tracer v1.6 was used to check for 
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convergence of MCMC chains and to summarize substitution rates. Maximum clade 
credibility (MCC) trees were identified using TreeAnnotator v1.8.4 after removal of 
10% burn-in and then visualized in FigTree v1.4.3.  
 
Principal component analysis 
To check on any clustering and stratification patterns, principal component analysis 
(PCA) was performed using the R package FactoMineR (Lê, Josse and Husson 2008). 
The input data were a matrix of pairwise distances from genome sequence alignment 
using the “N” model of DNA evolution, i.e. the proportion or the number of sites that 
differ between each pair of sequences. Each genome on the PCA plot was annotated 
by the continent of sample origin. 
 
4.4 Results 
4.4.1 Genome sequencing and assemblies 
Over the five RSV epidemics sampled (2011/2012 to 2015/2016), a total of 3,157 
samples were collected from eligible children at KCH, 3,146 (99.7%) were tested for 
RSV by IFAT or real-time PCR, and 801 (25.5%) RSV positives identified. Of these, 
434 (54.2%) were RSV-A, of which 412 (94.9%) were successfully sequenced from 
routine G-gene sequencing, with 354 (85.9%) of genotype ON1 and the remainder 58 
of genotype GA2. From the peripheral health centres within the KHDSS, a total of 32 
RSV-A positives were identified by real-time PCR. 
 
A total of 184 RSV-A genomes were generated in this study, comprising genotypes 
ON1 (n=154) and GA2 (n=30); Appendix 7.5. This dataset included 176 genomes 
from inpatients at KCH and 8 genomes from the KHDSS. The sequencing success for 
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KCH samples was 87% (154 full genomes /177 samples processed for sequencing) 
for ON1 viruses (the denominator a 50% sub-sample of all 354) and 52% (30 full 
genomes/58 samples processed for sequencing) for GA2 viruses, and for KHDSS 
samples was 25% (8 full genomes /32 samples processed for sequencing). The Ct 
values for KHDSS samples (as an indicator of viral load) had a median of 26.3 (IQR: 
22.9 - 28.0), which was slightly higher than for the KCH sample set with a median Ct 
of 24.4 (IQR: 22.2 - 26.9), Figure 4.1. The differential sequencing success rate 
between the KCH and KHDSS samples may have been due to the slightly lower viral 
loads in the KHDSS samples. Between 0.2 to 4.3 million short reads were available 
per sample of which RSV specific reads ranged between 0.001 to 3.9 million reads 
(each of 250 bases). The genome assemblies had a median length of 15,054 
nucleotides (range: 13,966-15,322) and mean depth of base coverage per genome 
ranging from 39 to 66,457 (calculated from e.g. [3.9m reads X 250 bases]/15,000). 
 
 
 
 
 
 
 
 
Figure 4.1: Histograms showing distribution of PCR Ct values (red line = median) for 
samples collected in Kilifi between 2011 and 2016 from the (A) KHDSS and at the (B) KCH. 
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Whereas the samples targeted for WGS were generally of high viral content (lower Ct 
value), it is apparent there was reduced genome yield (proportion of genome 
assembled) from samples with lower viral loads (i.e. higher Ct values); Fig 4.2A. 
However, the samples successfully sequenced and analyzed here generally had lower 
Ct values (higher viral loads) as shown in Fig 4.2B. The median fraction of the 
genome with unambiguous base calls was 98% with reference length from 
KC731482. Read coverage across the genomes was non-uniform, Fig 4.2C, 
suggesting varied PCR amplification efficiency among primer pair combinations 
combined with increased sequencing yield from the ends of the amplicons. 
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Figure 4.2: Kilifi RSV-A 2012-2016 sequenced genomes fraction,  Ct value and coverage 
(A) The proportion of RSV genome length sequence recovered (using KC731482 as the 
reference) for all the 184 genomes was plotted as a function of sample's diagnostic real-time 
PCR Ct value. (B) The distribution of the diagnostic real-time PCR Ct values for the 184 
sequenced samples reported here (KCH and KHDSS). (C) Shows the log (base 10) values of 
the sequencing depth (see Methods) at each position of the genome assemblies along the 
concatenated RSV ORFs (i.e. excluding the intergenic regions). 
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4.4.2 Bayesian reconstruction of ON1 epidemiological and evolutionary history 
The global ON1 whole-genome MCC phylogenetic tree, Figure 4.3A, shows 
evolutionary relationship among ON1 viruses from five sampled continents. The 
TMRCA of the ON1 strains from the most recent tip (7 April 2016) was estimated to 
be 11.07 years [95% HPD: 9.85-12.31], resulting in an estimated ON1 emergence 
date of between December 2003 and June 2006. This estimated date of emergence is 
earlier than a previous estimate (2008-2009) using the G-gene alone (Duvvuri et al. 
2015), but such a difference could be a reflection of the different datasets (by 
geography and sampling time frame). Comas-Garcia et al. have reported the earliest 
ON1 strain identified to date in November 2009 from central Mexico (Comas-García 
et al. 2018), and from our estimates this suggests a period of 3-6 years of circulation 
of this virus before first detection. The genome-wide substitution rate for the ON1 
viruses was estimated at 5.97 X 10-4 nucleotide substitutions per site per year [95% 
HPD: 5.42-6.58 X 10-4], similar to previous estimates for RSV group A full length 
sequences sampled over several epidemics (Tan et al. 2013; Agoti et al. 2015a) but 
slower than estimates from whole-genomes sequences of samples collected from a 
household study over a single RSV epidemic (2009-2010) within the same Kilifi 
location [2.307 × 10 − 3] (Agoti et al. 2017) and from using a global ON1 G-gene 
dataset [4.10 × 10-3] (Duvvuri et al. 2015). Across the genome, estimates of 
evolutionary rates for individual ON1 open reading frames (ORFs) varied, Figure 
4.3B, with the mean substitution rate highest in the G-gene, lowest in NS1, and 
moderate (with tight 95% HPD intervals) for the whole genome. 
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Figure 4.3: WGS MCC trees and PCA showing global and local clustering of ON1 viruses 
(A) Maximum clade credibility tree inferred from 344 global full genome sequences (see 
Methods) with the tips colour coded with the continent of sample collection. All the African 
samples (in blue, K1-3 and vertical bars) in this dataset were only available from Kilifi 
(Kenya). Node labels are posterior probabilities indicating support for the selected nodes. (B) 
shows the evolutionary rate estimates for the different genotype ON1 ORFs. (C) is an MCC 
tree inferred from 154 ON1 genomes from Kilifi annotated with identified lineages A and B, 
and the tips colour coded with the epidemic season. (D) is a PCA analysis (see Methods) of 
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the same dataset as (C) and similarly annotated with the epidemic season. Percentage of 
variance explained by each component is indicated on the axis.  
 
The Kilifi ON1 genomes were placed into three lineages (K1-3 and black vertical 
bars) on the global tree in Figure 4.3A. However, when the Kilifi ON1 WGS were 
analyzed separately, Figure 4.3C, two lineages were observed (labelled A and B) with 
a temporal grouping whereby A comprised sequences from the 2011-2013 RSV 
epidemic period while B comprised sequences predominantly from the epidemic 
period 2013-2016. These lineages and temporal patterns are further highlighted by the 
PCA analysis in Figure 4.3D. Based on the phylogenetic placement of the Kilifi ON1 
genomes on the global tree in Figure 4.3A, it was estimated that there could have been 
at least three separate introductions of ON1 viruses into Kilifi. One of these potential 
Kilifi ON1 introductions (K3) was characterized by only two cases, which is 
consistent with limited local transmission. In addition, the eight outpatient ON1 
viruses collected from the KHDSS were interspersed with viruses sampled from 
inpatient admissions at KCH suggesting that our sampling at the hospital might be 
representative of the larger KHDSS community. 
 
Using the global whole genome ON1 substitution rate estimate above, the Kilifi ON1 
genomes dataset (length 15,404 bp) and a pragmatic criterion previously described by 
Agoti et al. in (Agoti et al. 2015b) to differentiate between local and imported 
variants, it was estimated that there could have been up to 73 ON1 introductions into 
Kilifi implying that lineages K1 and K2 in Figure 4.3A are not just two initial 
introductions that have grown over time but comprise multiple introductions. Even 
when the higher substitution rate previously estimated from ON1 partial G-gene 
sequences by Duvvuri et al in (Duvvuri et al. 2015) was used, i.e. 4.10 × 10−3 
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substitutions/site/year which translates to a difference of at least 63 nucleotides 
between any two genomes to be classified as separate introductions, this resulted in an 
estimate of 6 separate introductions. This suggests that multiple seeding introductions 
of ON1 viruses may have been required to sustain their local transmission. 
 
4.4.3 Placement of Kilifi ON1 viruses in the global context using G gene 
As there are far more partial G gene sequences than full genomes, we explored the 
placement of Kilifi ON1 viruses in the global context using a set of 1,167 global G 
gene sequences. The global G gene MCC tree is shown in Figure 4.4A with the 
corresponding sampling locations in Figure 4.4B. Similar to Figure 4.3A, the Kilifi 
viruses in Fig 4.4A were placed in multiple (perhaps 4) lineages further supporting the 
idea of multiple introductions into Kilifi. On the contrary, viruses from each of the 
other two African countries represented (Nigeria and South Africa) were restricted to 
single major branches even though this could be as a result of the very few ON1 
sequences available from these countries (<10 from each). Furthermore, viruses 
closely related to the ON1 viruses with limited local transmission in Kilifi described 
above were frequently isolated in other locations. With the ON1 viruses assigned the 
corresponding continent of sample collection (Figure 4.4A), there was neither a single 
major branch on the tree comprised solely of viruses from a specific continent nor a 
continent whose viruses were only found within a single major branch, suggesting 
both intra and inter-continental circulation patterns. However, the majority of the 
Kilifi ON1 viruses in Figure 4.4A clustered with European viruses with a few others 
clustering with Asian viruses suggesting perhaps a predominantly European source of 
RSV introductions into Kilifi.  
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Figure 4.4: Relative sampling and placement of Kilifi ON1 viruses on a global MCC tree. 
(A) An MCC tree inferred from 1,167 partial ON1 G gene sequences with the tips 
colour coded with the source continent. (B) Sampling locations of the dataset in (A) 
with circles representative of relative proportion of contributing sequences by 
country. 
S1	Fig:	Sampling	locations	of	the	global	ON1	G-gene	dataset	with	circles	
representative	of	relative	proportion	of	contributing	sequences	by	country												
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4.4.4 Genomic diversity of Kilifi RSV-A viruses 
Pairwise intra-genotypic genetic diversity analysis of the GA2 and ON1 genomes 
from Kilifi, Figure 4.5A and 4.5B, show unimodal and bimodal distributions 
respectively consistent with two genetically distinct circulating strains of ON1 
viruses. Analyzing for substitutions across the genomes by entropy plots (Figure 
4.5C), a total of 746 single nucleotide polymorphisms (SNPs) were identified with 
frequencies of >1% in the set of 184 genomes. Of these SNPs, the majority (589, 
78.9%) were found within coding sequences/regions (CDS). The three CDSs with the 
most substitutions were the polymerase L (39.6%), the glycoprotein G (14.8%) and 
the fusion F protein (14.6%). However, when the SNP count is considered against 
CDS length then G, SH and M2-2 top the first three slots. Only 145/589 (24.6%) of 
these coding mutations resulted in non-synonymous changes, Appendix 7.6. The 
majority of the non-synonymous mutations occurred within the G, SH and M2-2. 
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Figure 4.5: Pairwise genomic distances and genome-wide amino acid variation 
The distribution of pairwise genetic distances between genotype GA2 and ON1 genome 
sequences are shown in (A) and (B), respectively. (C) is an entropy plot showing amino acid 
variation along the concatenated ORFs of Kilifi RSV-A genomes. 
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4.4.5 Phylogenetic divergence between ON1 and GA2 viruses 
The currently known or de facto distinguishing feature of the ON1 from GA2 strains 
is the 72-nucleotide duplication within the G gene. It has been shown from 
phylogenetic analysis of the G-gene that RSV-A genotypes form distinct clusters 
(Peret et al. 1998). However, it has not been investigated if the distinct clustering is 
replicated in the other genes especially for the closely related genotypes GA2 and 
ON1 viruses. An exploratory root-to-tip regression analysis of ORF specific ML trees, 
whose topologies were similar to the MCC BEAST trees described herein, confirmed 
that all but the NS1, NS2 and SH proteins had good temporal signals, Figure 4.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S3	Fig:	Root-to-tip	regression	analysis	of	Kilifi	RSV-A	ORFs	
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Figure 4.6: Root-to-tip regression analysis of Kilifi RSV-A genomes ORFs. 
GA2 and ON1 sequences are shown by red and cyan dots, respectively. 
 
 
To assess if the 72-nucleotide duplication is the only marker of the ON1 strains or a 
complementary mutation, the 11 RSV ORFs individually and a concatenated set of 10 
ORFs (excluding the G) were analyzed. Distinct and well supported ON1 and GA2 
clusters were observed in the concatenated set of 10 ORFs as well as in five 
individual coding regions (F, G, L, N and P), Appendix 7.7, confirming that genetic 
markers outside G also differentiate the ON1 and GA2 genotypes. The node posterior 
support, however, for divergence between GA2 and ON1 was quite low (50-70%) in 
the N and P proteins despite observation of distinct clusters. Nonetheless, determining 
the order in which the GA2-ON1 divergence in the five ORFs might have occurred 
was not feasible from this analysis as the divergence could have occurred anywhere 
on the branch between the GA2-ON1 split time and ON1 TMRCA in Figure 4.7A. 
This divergence chronology dilemma is highlighted by the overlapping MRCA 
estimates for the individual ORFs of between 2007-2011 [95% HPD: 2004.59- 
2012.06] in Figure 4.7B. 
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Figure 4.7: Estimated TMRCA for Kilifi RSV-A viruses and ORFs 
 (A) MCC tree inferred from 184 RSV-A complete genome sequences (concatenated coding 
regions only) from Kilifi with the tips colour coded by genotype, i.e. ON1 (cyan) and GA2 
(red). The two node bars indicate the 95% HPD interval for the TMRCA for the Kilifi GA2 
and ON1 viruses (grey), and Kilifi ON1 strains (blue). Node labels are posterior probabilities 
indicating support for the selected nodes. (B) shows the TMRCA (with 95% HPD interval) of 
the node separating Kilifi RSV-A genotype GA2 and ON1 viruses for a concatenated set of 
all ORFs (red) and five different ORFs (F: orange, G: green, l: cyan, N: blue, and P: purple). 
The stars (*) indicate node posterior support of less than 0.9 (i.e. low support) for the split 
between GA2 and ON1 in the nucleoprotein (N) and phosphoprotein (P) ORFs.  
 
4.4.6 Signature substitutions distinguishing ON1 from GA2 viruses 
Through a comparative genome-wide scan along the RSV-A coding genome, we 
analyzed for SNPs between the consensus Kilifi ON1 and GA2 viruses. A total of 66 
signature nucleotide substitutions (defined as SNPs differentiating ON1 from GA2 
viruses) were identified, highlighted in yellow in Appendix 7.6. While the majority of 
these signature substitutions were synonymous, 14 were non-synonymous 
substitutions (Table 4.2); nine in the G protein, two each in the F and L proteins, and 
one in the M2-1 protein. However, these signature substitutions had no effect on our 
RSV multiplex real-time PCR diagnostics as they occur outside the target primer 
binding sites in the N gene. Changes at the codon sites 142 and 237 of the G protein 
Fig	5:	Estimated	TMRCA	for	Kilifi	RSV-A	viruses	and	ORFs	
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have previously been shown to characterize antibody escape mutants, and were 
located within strain-specific epitopes (Martínez, Dopazo and Melero 1997). The two 
signature substitutions in the F protein (116 and 122) occur within site p27, which is 
the most variable antigenic site in the F protein (Hause et al. 2017). 
 
Table 4.2: Signature non-synonymous substitutions between genotype ON1 and GA2 
viruses 
 
ORF αORF Nt Pos. ORF AA Pos. Change AA Change SNP Type 
G 424 142 TT -> CA L -> Q Substitution 
G 622 208 C -> A L -> I Transversion 
G 695 232 G -> A G -> E Transition 
G 709 237 A -> G N -> D Transition 
G 758 253 A -> C K -> T Transversion 
G 817 273b T -> A Y -> N Transversion 
G 821 274 C -> T P -> L Transition 
G 851 284 
72 nt 
duplication 
24 AA 
insertion Deletion 
G 929 (GA2: 857) 310b C -> T P -> L Transition 
G 941 (GA2: 869) 314 T -> C L -> P Transition 
F 346 116 A -> G N -> D Transition 
F 364 122 G -> A A -> T Transition 
M2-1 349 117 A -> C N -> H Transversion 
L 1792 598 C -> T H -> Y Transition 
L 5175 1725 A -> T E -> D Transversion 
ORF=Open Reading Frame, Nt=Nucleotide, AA=Amino Acid, Pos.=Position 
αPositions are relative to ON1 strains, in which complementary positions in GA2 (without the 
duplication) within the G protein are shown in brackets. 
bPositively selected sites 
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4.4.7 Signature substitutions between ON1 lineages with successful and limited 
local transmission 
A similar genome-wide comparative scan between the consensus of genomes of 
viruses with successful (K1 and K2) and those with limited local transmission (K3) 
was performed for characteristic signature polymorphisms. A total of 33 SNPs were 
identified between these two groups of viruses, Appendix 7.8, of which nine resulted 
in non-synonymous changes; five in G, two in F and one each in M2-2 and L. In three 
of these nine non-synonymous SNPs, the K3 viruses shared substitutions with the 
GA2 viruses (G: codons P274L and P310L, and F: codon A122T). Whether these 
polymorphisms are neutral mutations or influence local transmission of the virus 
warrants further investigation. 
 
4.4.8 Signature substitutions distinguishing BA from non-BA viruses 
Similar to the previous two analyses above, we analyzed for SNPs between consensus 
global BA and non-BA viruses. A total of 39 signature non-synonymous substitutions 
were identified across nine RSV proteins, i.e. NS1, N, M, SH, G, F, M2-1, M2-2, and 
L, with most of the substitutions in the G (15 substitutions) and L (13 substitutions), 
Appendix 7.9.  
 
4.4.9 Nature of ON1 emergence: Multiple or single duplication event? 
Two papers studying the molecular evolution of RSV genotype ON1 have concluded 
that the emergence of ON1 happened multiple times or in a convergent manner 
(Schobel et al. 2016; Comas-García et al. 2018). These conclusions were based on the 
observation of clustering of some ON1 sequences amongst non-ON1 sequences. In 
addition, I have had discussions with colleagues working on RSV from Argentina 
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who had noticed some of their GA2 viruses phylogenetically placed with ON1 viruses 
and concluded that this might imply that these ON1 viruses had lost the 72nt 
duplication. None of these observations were made with the Kilifi dataset. However, 
based on these reports and discussions, an analysis of the global RSV sequence 
datasets was undertaken to investigate these conclusions. 
 
Similar to observations by Schobel et al. and Comas-Garcia et al., some of the ON1 
viruses in this analysis were phylogenetically placed within the non-ON1 cluster both 
for the WGS and G-gene global datasets, Figure 4.8. Surprisingly, there was a trend 
in the sources of these oddly placed ON1 viruses. For the WGS dataset, even though 
collected from Jordan and New Zealand between 2011 and 2012, they were 
sequenced at the J. Craig Venter Institute (JCVI) using Illumina sequencing 
technology, assembled using a referenced-based assembly (clc_ref_assemble_long v. 
3.22.5507), and did not form a single cluster within the GA2 viruses, Figure 4.8. With 
the global G-gene dataset, the G-gene regions extracted from WGS of ON1 viruses 
placed within the GA2 cluster described above still clustered with GA2 viruses and 
also did not form a single cluster, Figure 4.8. In addition to these, there were two 
ON1 sequences each from Argentina (Rojo et al. 2017) and Spain (unpublished) 
collected in 2014 and 2015 that were placed with GA2 viruses with the four 
sequences forming a single cluster. However, there were no Spanish or Argentinian 
sequences available post 2015 that would illuminate on whether this cluster has 
grown over time. 
 
We also looked at the non-ON1 viruses placed amongst ON1 viruses based on WGS 
assemblies. For the WGS dataset, they were collected in the US and came from JCVI, 
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Broad MIT (Illumina sequencing and assembled with Vicuna) and University of 
Washington (assembly method not stated). They did not form a single cluster but 
were interspersed within the ON1 viruses. For the G-gene dataset, the non-ON1 
viruses clustering with ON1 viruses included those extracted from the non-WGS 
sequences above and one sequence each from Brazil (2011, University of Sao Paulo) 
and Taiwan (2015), and these too did not form a single cluster. 
 
We hypothesized that since the RSV-B genotype BA 60nt duplication emerged first, 
we might observe the phenomenon of multiple independent emergence of the 60nt 
duplication and/or loss of the duplication in the RSV-B sequence dataset as well. For 
the WGS dataset, Figure 4.9, there were five BA viruses clustering with non-BA 
viruses from the JCVI collected in the US between 1996 and 1998. There were also 
two sequences from the JCVI (Jordan 2010 and USA 2013, not in a single cluster) 
and one sequence from Brazil (2010, Illumina, Spades, University of Sao Paulo) that 
were non-BA but clustered with the BA viruses. For the G-gene dataset, one of the 
BA viruses in non-BA cluster came from Brazil (collected in 2003, University of Sao 
Paulo) with the other five sequences from the JCVI and collected between 1996 and 
1998. For the non-BA strains clustering with BA viruses in this G dataset, they 
included G-gene sequences extracted from the three WGS described above and 
another two sequences from Kilifi Kenya (in a single cluster and previously suspected 
to have lost the 60nt duplication (Agoti et al. 2010)). 
 
Finally, as distinct clustering between ON1 and GA2 viruses had been observed in 
five individual coding regions (F, G, L, N and P) within the Kilifi RSV-A dataset we 
analyzed the global RSV-A WGS dataset. Similar observations were made with the 
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global dataset as with the Kilifi dataset, Appendix 7.10, with distinct clusters between 
ON1 and non-ON1 viruses in the five coding regions save for the sequences from the 
JCVI, Broad MIT and University of Washington as described above whose 
placements were out of order with their respective genotypes. 
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RSV-A WGS [728 sequences]       RSV-A G [1892 sequences, 696 bases] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8: Global RSV-A WGS and G-gene ML trees showing phylogenetic clustering between ON1 and other RSV-A genotypes 
genotype
GA2_AND_OTHERS
ON1
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RSV-B WGS [468 sequences]       RSV-B G [1528 sequences, 681 bases] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9: Global RSV-B WGS and G-gene ML trees showing phylogenetic clustering between BA and other RSV-B genotypes 
 
genotype
BA
NON_BA
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4.4.10 Patterns of selective pressure across the RSV-A genomes 
We conducted selection analysis on all 11 RSV ORFs for the dataset, Appendix 7.11. 
ORF-wide episodic diversifying selection was only detected in the NS1 and M 
proteins. A total of nine positively selected codon sites were identified within the G 
(73, 201, 250, 251, 273, 310), NS2 (15) and the L (2030, 2122) by at least one 
method, with site 310 in the G identified as positively selected by all the four 
methods. Notably, sites 273 and 310 (shown in bold in Table 4.2) within the G protein 
detected to be under positive selection were also identified as signature SNPs. 
However, the number of positively selected sites could have been underestimated in 
the analysis that was limited to Kilifi RSV-A genomes and care should be taken while 
interpreting these results as some of the positively selected sites were only detected by 
one method and at default (less stringent) cut-offs. 
 
 
4.5 Discussion and Conclusions 
In this chapter, we report an in-depth analysis of local and global RSV genotype ON1 
evolution and transmission using whole genome sequence data. We describe RSV-A 
genomic diversity and identify polymorphisms with the most potential in influencing 
RSV evolution and phenotype. Utilizing genomes from samples collected between 
2010–2016, including 184 complete genomes from Kilifi alone, we obtained a finer 
resolution on the pattern of RSV introductions, persistence and evolution in a defined 
location, and the changes within the genome that might be important for the persistent 
circulation of the virus. 
 
Genetic variation not only provides important insights into RSV relatedness by which 
to infer transmission events but also highlights potential functional changes in the 
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virus. From this analysis, it was shown that substitutions are widespread across the 
RSV genome (both for RSV-A and B) but occur at higher frequency within the 
structural proteins (G and F) and in the polymerase (L). The G protein has the most 
genetic flexibility of the RSV ORFs to accommodate frequent substitutions including 
large duplications, and previous studies have described epitope positions associated 
with escape using specific monoclonal antibodies or in natural isolates (García et al. 
1994; Cane and Pringle 1995; Cane 1997; Martínez, Dopazo and Melero 1997). The F 
protein site p27 with the two signature GA2-ON1 substitutions has been shown to (i) 
be involved in the host cell entry of RSV that involves micropinocytosis, followed by 
proteolytic activation of the F protein at the second furin-cleavage site and release of 
the p27 peptide (Krzyzaniak et al. 2013), and (ii) possess greater binding affinity for 
serum antibodies from young children (<2 years) than any of the other antigenic sites 
in the F protein and may be responsible for group specific immunity that distinguish 
between RSV-A and RSV-B viruses (Fuentes et al. 2016). The implications of 
observed substitutions in the L protein of the ON1 viruses remain unclear. However, 
considering both its role in genome replication and the emergence of the 72-
nucleotide duplication in the G ORF, it is hereby proposed that either (i) these 
polymorphisms might have resulted in a sloppy polymerase, that resulted in a slip that 
generated the 72-nucleotide duplication in the G ORF (Komissarova and Kashlev 
1997), or (ii) the 72-nucleotide duplication in the G may present a metabolic 
challenge for replicating a large genome and thereby facilitate adaptive 
polymorphisms within the polymerase (Canchaya et al. 2003). While a considerable 
number of SNPs were also found in ORFs other than the G, F and L proteins, only a 
very minor proportion of those changes resulted in amino acid substitutions implying 
very strong purifying selection. 
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Based on distinct phylogenetic clustering of ON1 and GA2 viruses in five ORFs 
within the Kilifi and global dataset, the emergence of ON1 is certainly characterized 
by additional substitutions across the genome in addition to the 72-nucleotide 
duplication within the G gene. And the same can be said of the emergence of the BA 
genotype. Assuming ON1 diverged from GA2 and through a single ancestral virus, it 
is unclear whether the multiple signature substitutions differentiating ON1 from GA2 
viruses all arose from that single split event or have been acquired progressively over 
time. In case of the latter, the chronology of changes across the different ORFs is 
unclear. Understanding how and which mutations define the emergence of a new RSV 
variant may be important in describing substitutions that are either crucial for the 
survival of the variant and/or of some complementary structural or functional 
integrity. It is also likely that some of these substitutions are nothing more than 
genetic hitchhikers. Notwithstanding this lack of clarity on ON1 emergence, it has 
been shown for influenza A viruses that linked selection amongst antigenic and non-
antigenic genes influences the evolutionary dynamics of novel antigenic variants 
(Raghwani, Thompson and Koelle 2017). Further, it has been demonstrated 
experimentally that adaptive evolution is a multi-step process that occurs in waves 
(Stern et al. 2017). The initial adaptive wave is thought to occur rapidly and is 
characterized by founder or gatekeeper mutations. Thereafter, additional waves of 
evolutionary fine-tuning occur (Grubaugh and Andersen 2017). Similar studies in 
RSV would be important to determine if such dynamics do characterize RSV's 
evolutionary history and may also inform the design of an RSV vaccine. 
 
From recent publications and personal discussions, it is not clear if the emergence of 
ON1 occurred once through a single ancestral ON1 virus or multiple times (Schobel 
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et al. 2016; Comas-García et al. 2018). From our analysis using global RSV-A and 
RSV-B datasets, we find oddly placed sequences (by genotype) but whose sources 
were often the same labs and/or part of large sequencing projects. It is also interesting 
that these ‘misplaced’ viruses do not have descendants (except in the one case where 
four sequences clustered together). There are three likely reasons for these 
observations; (i) recombination, (ii) cross-talk (contamination) between samples 
during pre-processing or sequencing, and (iii) miss-assemblies. Recombination in 
RSV is unprecedented in natural isolates and has only very rarely been detected under 
controlled laboratory conditions (Spann, Collins and Teng 2003). A recombination 
analysis by Tan et al  (Tan et al. 2012) showed that genomes in which recombination 
was detected, while sampled from natural infection, came from the same labs 
(Kumaria et al. 2011; Rebuffo-Scheer et al. 2011) and were likely to be either PCR or 
sequence assembly artefacts. Therefore, it is highly likely that the emergence of these 
duplication variants occurred only once in their evolutionary history. Further, since 
the discovery of RSV only the two large duplications, one of 60 nucleotides (BA) and 
the other of 72 nucleotides (ON1) have been detected. We think that if the 
phenomenon of multiple emergence of these duplications were likely and frequent in 
RSV, the same would have been evidenced in the emergence of the other RSV 
genotypes (e.g. some other group A genotypes such as GA2 also phylogenetically 
placed within GA5, etc) or even frequent detection of duplication variants. This 
analysis also highlights a potential problem from using sequences from large 
sequencing projects in analyses where the accuracy of the assemblies may be 
questionable. 
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ON1 is rapidly replacing GA2 in Kilifi, suggesting that this variant may have some 
fitness advantage in this location. We have however previously showed that genotype 
ON1 viruses did not result in higher risk of severe disease compared to GA2 viruses 
in Kilifi (Otieno et al. 2017). Globally, ON1 prevalence varies by location and there 
are conflicting reports with regards to differences in virulence between ON1 and GA2 
strains (Panayiotou et al. 2014; Yoshihara et al. 2016). Even with the discordant 
results, which may be due to differences in study populations and analysis methods, 
there might be phenotypic differences between viruses belonging to these two 
genotypes. Identification of such phenotypic differences and the potential drivers 
might augment our current understanding of the pathogenesis of this virus. Expanded 
RSV surveillance in additional locations will offer better insight into the nature of 
these replacement dynamics. 
 
Observations from this study using whole genomes reinforce previous findings based 
on partial G-gene sequences (Agoti et al. 2014b, 2015b; Otieno et al. 2016, 2017) that 
RSV epidemics are characterized by the introduction and circulation of multiple 
variants. In addition, persistence within the community seems to be sustained by only 
a proportion of these introductions. We have characterized genomic substitutions that 
distinguish between successful and dead-end ON1 introductions in Kilifi and find that 
the dead-end ON1 introductions share substitutions with the fast fading Kilifi GA2 
strains. Nonetheless, it is evident that besides viral genetic factors there could be other 
determinants of successful onward transmission of a virus lineage. ON1 strains that 
were non-persistent in Kilifi were abundant in other parts of the world albeit with 
varied frequencies relative to other genotypes. Such determinants could include the 
host factors (e.g. births, immunity, genetics, contact patterns and mobility) and 
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environmental factors (e.g. temperature, rainfall and humidity) which warrant further 
investigations. 
 
We live in times of rapid global movement of people, which may influence the spread 
of infectious diseases. The observation that most of the Kilifi sequences clustered 
with sequences from Europe and Asia suggests that RSV introductions into Kilifi 
originate predominantly from these two continents. It might not be surprising that 
Europe could be a source of RSV introduction into Kilifi, or a destination for viruses 
from Kilifi, considering that it accounts for the largest single group of tourists to 
Kenya (The Report: Kenya 2017 2017). In addition, the increasing Chinese economic 
interests in Africa (including Kenya) has resulted in an influx of Chinese into Africa 
for trade, work and tourism (The Economist 2013) and may account for the Asia-like 
ON1 strains. However, there are far too few partial ON1 sequences from Africa (only 
from Kenya, South Africa and Nigeria) and no ON1 genomes from outside Kilifi 
Kenya to help define intra-African transmission dynamics in detail. In fact, a recent 
study suggests that domestic tourism accounts for more than half of the growth in 
Kenya’s tourism (Sunday 2018). As such, availability of sequences from across the 
country would be critical in deciphering if and how such tourist activities influence 
virus transmission patterns in Kenya. Such studies could be helpful in the design of 
future RSV transmission intervention strategies. 
 
 
 
   
 
 129 
CHAPTER FIVE 
5 Local and global RSV transmission dynamics 
 
5.1 Introduction 
From the preceding two chapters, it is apparent that RSV genotype ON1 transmission 
is characterized by frequent introductions and circulation of multiple variants within a 
community (Otieno et al. 2016, 2017, 2018). In addition, it was observed that most of 
the Kilifi sequences clustered with sequences from Europe and Asia which may 
suggest frequent exchange of viruses between Kilifi and these two continents. 
However, the origin of the viruses seeding the recurring RSV epidemics at varied 
geographic scales (e.g. community [Kilifi], local [Kenya] or continental [Africa]) and 
the factors that determine spread remain unclear. There has only been a single 
phylogeographic analysis of RSV spread in 2012 using partial G gene sequences 
(Katzov-Eckert et al. 2012). With the availability of more sequences (including whole 
genomes) and robust Bayesian phylogeographic methods, there was sufficient 
motivation to conduct a detailed analysis of the local and global patterns of the spatial 
spread of RSV. 
 
In this chapter, RSV sequence data collected from across Kenya and other 50 global 
countries between 1977 and 2016 (inclusive) was used to estimate transition rates 
between discrete locations in a Bayesian statistical framework. To protect against 
sampling heterogeneity or bias in the sequence datasets, the transition rates were 
parameterized according to potential drivers of RSV spread (air travel or fluxes, 
depending on which fitted best) using a generalised linear model (GLM) within the 
same Bayesian framework (Lemey et al. 2009, 2014). This study highlights the 
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importance of integrating pathogen genetic and ecological information in improving 
understanding of the dynamics of infectious disease. 
Analysis files and scripts can be found on GitHub: 
https://github.com/jrotieno/rsv_phylogeography/ 
 
5.2 Aims of the Chapter 
We set out to determine the patterns of spread of RSV, locally within a country 
setting and between geographically defined regions (countries, continents and 
hemispheres). 
 
5.3 Methods 
Local (Kenyan) sample details and sequencing 
We received a total of 400 RSV positive samples from CDC-K collected in Siaya 
County, Kakuma Refugee Camp and Dadaab Refugee Camp between January 2011 
and June 2014 (see Chapter Two section 2.4.2 for an elaborate description of the 
study and sample details). While critical for this study due to the central location and 
its role as a major transport hub, samples from KNH (Nairobi) were not included in 
this analysis as they were received in Kilifi in November 2018 a time nearing thesis 
submission. However, these samples will be processed at a later date and sequences 
re-analyzed with the current dataset. 
 
Nucleic acid extraction, G-gene amplification, confirmation of amplification success, 
and sequencing were performed as described in the Methods chapter (sections 2.7.2 
and 2.7.3). However, to reduce costs and processing times, only the outer primers 
(AG20 and F164) were used for both G-gene amplification and sequencing reactions 
and thereby omitted the internal group specific nested PCR reactions. The sequencing 
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success of the two primers alone (see Results 5.4.1) was comparable to previous using 
four primers (see Chapter Three 3.4.1 and Chapter Four 4.4.1). 
 
Global sequence dataset compilation 
To prepare the global RSV datasets, all available RSV sequences from GenBank 
(https://www.ncbi.nlm.nih.gov/genbank/, search terms: respiratory syncytial virus) as 
on 22/05/2018 were retrieved and stored in Geneious (Eiter et al. 2003). All non-
human RSV, lab strains, synthetic/vaccine related sequences, and sequences with no 
collection date and location were removed. To separate RSV-A from RSV-B 
sequences, a local blast search was performed using the 144 and 120 nucleotide 
sequence regions of the ON1 and BA genotypes, respectively. This method was better 
at separating sequences belonging to the two RSV groups compared to using group 
information annotation on different fields of GenBank files for separation that were at 
times erroneous. The newly generated Kenyan sequences described above were then 
added to this dataset. 
 
To remove sequence duplicates, the sequences were binned by country of sampling, 
filtered of duplicates and then re-collated into a single dataset. Alignments were 
generated using MAFFT and edited manually in AliView and Geneious. For each 
RSV group, four sequence datasets with varying sequence lengths were prepared 
(Table 5.1 and Figure 5.1); (i) complete genomes [>14,000 bases], (ii) complete G 
gene [>900 bases], (iii) Partial G (1st hypervariable regions through to terminal stop 
codon; 650-700 bases), and (iv) Partial G (2nd hypervariable region only; 300-350 
bases).  
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Figure 5.1: Schematic of the functional domains of the G protein 
 
Table 5.1: Datasets available for local and global phylogeographic analysis 
 RSV-A RSV-B 
Full 
genomes 
Full G 
(>900nt) 
Partial G 
(>650-
700nt) 
Partial G 
(300-
350nt) 
Full 
genomes 
Full G 
(>900nt) 
Partial G 
(>650-
700nt) 
Partial 
G (300-
350nt) 
Local   1,346    1,180  
Global 728 1,402 1,892 3,632 466 836 1,528 3,626 
 
Centroid locations (geographical centre of the country in latitude-longitude co-
ordinates) were downloaded to generate an inter-location great-circle distance matrix 
(https://worldmap.harvard.edu/data/geonode:country_centroids_az8). We obtained air 
transportation and model-based fluxes from the global epidemic and mobility 
(GLEAM) team (Broeck et al. 2011). The GLEAM model integrates real 
demographic and mobility data in a fully stochastic metapopulation network model 
and allows for the detailed simulation of the spread of infectious agents around the 
globe. In these simulations, the world population is divided into geographic census 
areas (subpopulations) that are defined around transportation hubs and connected by 
mobility fluxes (Balcan et al. 2009). Further, within each subpopulation the disease 
spreads between individuals while individuals can also move from one subpopulation 
to another along the mobility network according to high quality transportation data 
and thus simulating the global spreading pattern of epidemic outbreaks (Pastor-
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Central 
conserved 
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Satorras et al. 2015). To model seasonal dynamics, the GLEAM framework was 
extended by using a compartmental model with the following parameters that best fit 
influenza seasonal dynamics (Poletto, private communication); (i) a temporary 
immunity to the virus with an average duration of between 2-10 years, (ii) a 
geographically dependent seasonal transmission in temperate areas, varying between 
a minimum basic reproductive number during summer (Rmin	 ! 	0.5-0.75) and a 
maximum basic reproductive number during winter (Rmax !  1.25-2.0), and (iii) a 
constant transmission with a basic reproductive number equal to Rmax in the tropics 
(Poletto, private communication). In the compartmental model, individuals are 
divided in susceptible, latent, symptomatic infectious (that may or may not be travel 
dependent on the severity of symptoms), asymptomatic infectious and recovered 
(immune to the virus), with the average duration of the exposed and infection period 
set to 1.1 and 2.5 days, respectively. These GLEAM simulations were used as the 
‘flux’ matrix predictors in the GLM-based phylogeographic analyses below. 
 
Temporal signal 
In order to visually examine the degree of temporal signal or accumulation of 
divergence in the datasets over the sampling time interval, the exploratory linear 
regression approach implemented in TempEst v1.5.1 (Rambaut et al. 2016) was 
employed. For each dataset, a maximum likelihood (ML) tree was generated using 
FastTree (Price, Dehal and Arkin 2010) under a generalized time-reversible (GTR) 
substitution model, and then plotted the root-to-tip divergences as a function of 
sampling time according to a rooting that maximizes the Pearson product moment 
correlation coefficient in TempEst. Outlier sequences that were either not divergent 
enough or too divergent, Figure 5.2, were removed from the datasets. The new 
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datasets were used to generate new ML trees that were heuristically time-transformed 
using TempEst and subsequently used as starting trees in phylogeographic analyses 
below to reduce burn-in of the Marko Chain Monte Carlo (MCMC) analyses. 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Examination of temporal signal in global sequence datasets in TempEst 
Root-to-tip divergence as a function of sampling time for ML tree clusters of global RSV-A 
full G gene sequence dataset highlighting (A) Too divergent and (B) Non-divergent 
sequences. 
 
Discrete phylogeographic analysis: Kenya 
The RSV-A and RSV-B partial G gene datasets used to perform this analysis included 
all the Kenyan sequences available in GenBank in addition to the new sequences 
generated in this study. Spatial diffusion dynamics among a set of six geographic 
locations in Kenya (i.e. Siaya, Kisumu, Kakuma, Nairobi, Dadaab and Kilifi; see 
Chapter Two Figure 2.3) was estimated using a Bayesian discrete phylogeographic 
approach (Lemey et al. 2009). Conditioning on the geographic locations of the tips of 
the G gene phylogenies, the transition history among the locations is modelled as a 
continuous time Markov chain (CTMC) process and thereby making inferences of the 
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unobserved locations at the ancestral nodes in each tree of the posterior distribution. 
A non-reversible CTMC model (Edwards et al. 2011) was used and incorporated 
Bayesian stochastic search variable selection (BSSVS) to identify a sparse set of 
transition rates that adequately summarize the epidemiological connectivity between 
the locations (Lemey et al. 2009). All the Markov chain Monte Carlo (MCMC) 
sampling analyses were performed using BEAST in conjunction with BEAGLE 
library to enhance computation speed (Ayres et al. 2012; Drummond et al. 2012). 
Two independent MCMC chains of 100 and 200 million steps were ran, and then the 
log and tree files combined. TreeAnnotator (Drummond et al. 2012) was used to 
summarize the location estimates on MCC trees after discarding 10% of the trees as 
chain burn-in. The MCC trees with annotations were then visualized using FigTree 
(http://tree.bio.ed.ac.uk/software/figtree/). 
 
Building up on previous work from Kilifi (Agoti et al. 2014b; Otieno et al. 2017), a 
separate analysis on the Kenyan RSV genotype ON1 viral evolution and dispersal was 
conducted using BEAST as described in Methods section in Chapter Four. 
 
Discrete phylogeographic analyses: Global 
We used a GLM extension of the discrete phylogeographic model in BEAST (Faria et 
al. 2013; Lemey et al. 2014), which not only aims to estimate the relative intensities 
of viral dispersal among pairs of locations but also determine the subset of 
explanatory variables that help to explain such intensities. The viral diffusion rates are 
modelled as a log linear function of the selected predictor variables. The support and 
effect size for each predictor is estimated using inclusion probabilities and GLM 
coefficients, respectively (Lemey et al. 2014). The predictors of spread for the GLM 
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analysis included the great-circle distance between location pairs, air traffic data and 
GLEAM seasonal flux simulations. All the predictors were log transformed prior to 
their inclusion in the GLM analyses. 
 
Prior to setting up the GLM analyses, to determine how best to include the predictors 
for the three traits, two test analyses were performed on the RSV-B G gene dataset; 
one with all the three predictors for countries and two predictors (air travel and 
fluxes) for the other two subdivisions, and one with two predictors (air travel and 
fluxes) for all the three subdivisions. Since distance was not preferred at the more fine 
(country) spatial subdivision level in addition to the difficulty in defining a distance 
between larger areas (where a centre becomes a very crude approximation), it was not 
included as a predictor in the continental and hemisphere traits. The XML files were 
edited to change the standard estimation procedure whereby instead of allowing all 
predictors to be included and excluded from the model, only one predictor was 
included. For this heterogeneous and fragmentary sampling, we were not concerned 
with how much better the predictors were than the 'equal-rates' null model but wanted 
to test which predictors suited best to protect against sampling bias. In addition, we 
did not want air travel and fluxes to both get into the model as fluxes are derived from 
air travel. Prior inclusion probabilities were specified that put 50% or 33% prior 
probability on no predictor being included, for the two and three predictor analyses 
respectively, and a normal prior with a mean of 0 and a standard deviation of 2 on the 
coefficients in log space. Bayes factor (BF) support for predictors was calculated 
based on the ratio of posterior to prior odds for predictor inclusion. 
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These analyses were initially performed with two of the four global datasets with the 
best molecular evolutionary signals, i.e. the complete G gene and whole genomes. For 
each dataset, in addition to the country of sampling, two more coarse spatial 
subdivisions were assigned, i.e. continent and hemisphere. There were six states for 
the continent trait (North America, South America, Africa, Asia, Europe, and 
Australia and Oceania) and three states for the hemisphere trait (temperate Northern, 
Tropics [including the subtropical regions] and temperate Southern; 
https://en.wikipedia.org/wiki/File:World_map_indicating_tropics_and_subtropics.png. 
We also estimated the number of location transitions (Markov jumps) and the time 
spent in each location state (Markov rewards) in order to have a complete summary of 
the spatial dispersal processes (Minin and Suchard 2008). 
 
5.4 Results 
5.4.1 G-gene sequencing and assembly 
Of the 400 CDC-K countrywide samples (2011-2014), 372 (93%) were successfully 
amplified out of which 327 (87.9%) were successfully sequenced. Since only the non-
group specific outer primers were used for both G-gene amplification and sequencing, 
both group A and B sequences from six of these samples were assembled and thereby 
assembling a total of 333 sequences, Table 5.2. These G gene sequences were 518-
824nt in length and covered a portion of the first hypervariable region through to the 
end of the G protein. 
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Table 5.2: Number of sequenced Kenyan non-Kilifi RSV-A and RSV-B samples 
(2011-2012) by group, year and location 
 
Site 
RSV-A RSV-B 
2011 2012 2013 2014 2011 2012 2013 2014 
Dadaab 1 0 0 1 [1]a 60 0 0 3 
Siaya 32 25 [4] 20 [8] 0 56 13 5 0 
Kakuma 31 8 9 [5] 1 52 6 8 2 
Total 
64 33 29 2 168 19 13 5 
128 205 
a Number of ON1 sequences 
 
The sampling over the years was quite sparse for Dadaab in this dataset, except for 
2011 where there were 60 group B sequences. However, with regard to sequence 
availability in GenBank, these are the first set of RSV sequences from Siaya and 
Kakuma. Therefore, they make an important contribution to available sequences than 
can be used to understand the local epidemiology and molecular evolution of the virus. 
In addition to Kilifi, a total of 18 ON1 viruses from the rest of Kenya were sequenced; 
12 from Siaya, 5 from Kakuma and 1 from Dadaab. 
 
5.4.2 Sampling bias in local and global datasets 
There was tremendous heterogeneity in sampling distribution between countries, 
Appendices 7.12 and 7.13, for both the G and the whole genome datasets. Even the 
local sampling of viruses in Kenya was heterogenous with majority of the sequences 
in the group A (77.7%) and B (73.1%) datasets collected from Kilifi, Table 5.3. 
Measuring the heterogeneity with Shannon entropy, however, yielded no obvious 
disparities (Appendices 7.12 and 7.13). There were no obvious disparities either in the 
Shannon entropy measure of heterogeneity with the larger geographic subdivisions of 
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continents and hemispheres, even though Australia and Oceania and the Southern 
hemisphere consistently had much lower numbers in the respective datasets. 
Nonetheless, analysis of the datasets was undertaken while expecting some challenges 
in getting an accurate and detailed information on the local and global RSV 
dissemination with the heterogenous sampling. 
 
Table 5.3: Number of RSV sequences available for phylogeographic analysis from 
across Kenya, 1999-2016 
 
Site RSV-A RSV-B 
Dadaab 173 [2008-2011,2014]a 169 [2007-2011] 
Kilifi 1046 [2000-2015] 863 [1999-2016] 
Nairobi 6 [2011] 8 [2011] 
Kisumu 3 [2011] - 
Kakuma 46 [2011-2014] 67 [2011-2014] 
Siaya 72 [2011-2013] 73 [2011-2013] 
Total 1,346 1,180 
aThe dates (years) of samples collection 
 
5.4.3 Estimating the date of introduction and evolutionary rate of Kenyan RSV 
genotype ON1 viruses 
The Kenyan ON1 sequence dataset used in this analysis comprised 378 sequences, of 
which 360 were from Kilifi, 12 from Siaya, 5 from Kakuma, and 1 Dadaab. While the 
first ON1 virus isolated in Kilifi was collected in February 2012 (Agoti et al. 2014b), 
from this dataset the earliest non-Kilifi ON1 viruses were collected in April 2012 
from Siaya, July 2013 in Kakuma and May 2014 in Dadaab (Figure 5.3). The most 
recent common ancestor (MRCA) for the ON1 viruses in Kenya was dated December 
2010 [95% Highest Posterior Density (HPD): December 2009 – October 2011], about 
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one year and two months before initial detection in Kilifi. These ON1 viruses had an 
estimated substitution rate of 4.21 × 10-3 [95% HPD: 3.13 × 10-3 – 5.51 × 10-3] 
substitutions per site per year which was quite similar to a previous estimate using a 
global ON1 G-gene dataset [4.10 × 10-3] (Duvvuri et al. 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: Time-calibrated MCC tree inferred for 378 G gene RSV genotype ON1 
sequences from Kenya 
The tips of the tree are coloured according to the location of sample collection as shown by 
the key at the top left. 
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5.4.4 Local dispersal of RSV in Kenya 
To capture the underlying RSV spatial diffusion dynamics across Kenya, the best 
supported rates of discrete location transitioning among all pairs of locations as 
inferred using BSSVS were summarized in Figure 5.4 and Appendix 7.14. For RSV-A 
and RSV-B, sequences were available from six and five locations, respectively. The 
best supported virus transition rates originated from Kilifi and destined for both 
geographically close locations such as Dadaab in Eastern Kenya and far flung areas 
such as Kakuma in the North West, an observation that most likely reflects the 
sampling bias in the datasets as shown in Table 5.3. However, locations that are in 
relatively close proximity from each other (e.g. Siaya and Kakuma or Kilifi and 
Dadaab) had well-supported diffusion pathways for both RSV groups. The location 
state estimates obtained by discrete phylogeographic reconstruction revealed a weakly 
spatially structured Kenyan RSV population (Figure 5.5).   
 
 
 
   
 
 142 
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 B: 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Bayes Factor (BF) support for RSV spatial diffusion in Kenya 
Panel (A) RSV-A and (B) RSV-B. Rates are shown for BF with posterior probability >0.9. 
The line color represents the relative strength by which the rates are supported: light blue and 
red reflect relatively weak and strong support, respectively. 
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Figure 5.5: Time-calibrated MCC trees inferred for Kenyan partial G gene sequences of 
RSV-A and RSV-B 
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Branches are coloured according to the most probable location state, indicated in the coloured 
key at the top left. 
 
5.4.5 Global dispersal of RSV 
In this analysis, two sequence datasets (full G gene and whole genome) per RSV 
group were used to infer the spatial dispersal of RSV between discrete 
locations/regions by summarizing the estimated virus jumps between countries, 
continents and hemispheres. In general, there were relatively higher jumps between 
countries using the WGS datasets than the G gene datasets, with the jumps mostly 
transcontinental but with fewer countries represented compared to the G gene (Figure 
5.6). With the G gene datasets, Figure 5.7, the best export destinations per country 
was often to a nearby country and within the same continent while most imports into 
countries mostly arose from the US, China, and India that have large land masses and 
huge populations. 
 
At the continental level, Figures 5.8 and 5.9, RSV-A G, RSV-A WGS and RSV-B G 
all supported Asia and North America as the most likely sources of RSV strains. 
These results mirrored those from the country trait above where the US (North 
America), India (Asia) and China (Asia) were the predominant exporters of viruses 
into other countries. In contrast, RSV-B WGS indicated that Europe was the 
predominant exporter of RSV-B viruses. 
 
Finally, at the hemisphere level, the highest jumps were between the Northern 
hemisphere and the Tropics with the two regions seemingly seeding each other 
(Figure 5.10). Virus importation into the Southern hemisphere arose from the 
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Northern hemisphere and the Tropics but with minimal exportations into these source 
populations. These observations were consistent across all the four datasets. 
 
   
 
 146 
Net Export Jumps
Ne
th
er
lan
ds
US
A
Ita
ly
UK S.
Ko
re
a
Pe
ru
Ge
rm
an
y
Br
az
il
Ar
ge
nt
ina
Be
lgi
um
M
ex
ico
Ke
ny
a
Jo
rd
an
-10
0
10
20
30
Country
Ju
m
ps
C
hi
na
S
.A
fri
ca
N
ew
 Z
ea
la
nd
V
ie
tn
am
 
Netherlands
Peru
USA Belgium
Jordan
New Zealand
Philippines
Taiwan 
Kenya
China
Brazil
India
Lowest (1.02)
Highest (7.40)
Markov Jumps
Global RSV-A Transmission
Data: GenBank WGS
Vietnam
Italy
Germany
Lebanon
Net Export JumpsJo
rd
an
US
A
Ne
th
er
lan
ds
Ho
ng
 K
on
g
Ta
iw
an
Be
lgi
um
 
Ge
rm
an
y
Pe
ru
Vi
et
na
m
Ph
ilip
pin
es
Ne
w 
Ze
ala
nd
-10
0
10
20
30
Country
Ju
m
ps
Le
ba
no
n
A
us
tra
lia
S
.K
or
ea
S
.A
fri
ca
Ita
ly
In
di
a
M
ex
ic
o
B
ra
zi
l
 K
en
ya
C
hi
na
 
USA Belgium
Netherlands
Brazil
Argentina
Italy
UK
New Zealand
Peru
S.Korea
Vietnam
Jordan
Kenya
Mexico
Germany
Lowest (1.01)
Highest (6.73)
Markov Jumps
Global RSV-B Transmission
Data: GenBank WGS
A: RSV-B: WGS 
 
 
 
 
 
 
 
 
 
 
B: RSV-A: WGS 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6: WGS based maps and bar graphs of the global RSV-A and RSV-B pairwise 
Markov jump history for the country trait in the posterior tree distribution. 
The thickness and colour of the connecting lines are based on the number of jumps.  
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Figure 5.7: G gene based maps and bar graphs of the global RSV-A and RSV-B pairwise 
Markov jump history for the country trait in the posterior tree distribution. 
The thickness and colour of the connecting lines are based on the number of jumps.  
   
 
 148 
AO
As
NA
Eu
SA
 Af
Lowest (1.06)
Highest (17.33)
Markov Jumps
Global RSV-B Transmission
Data: GenBank WGS
Eu As
NA
Af
AO
SA
Lowest (1.04)
Highest (10.80)
Markov Jumps
Global RSV-A Transmission
Data: GenBank WGS
RSV-B: WGS 
 
 
 
 
 
 
 
 
 
 
RSV-A: WGS 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8: WGS based maps and bar graphs of the global RSV-A and RSV-B pairwise 
Markov jump history for the continent trait in the posterior tree distribution. 
The thickness and colour of the connecting lines are based on the number of jumps. As: Asia, 
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Figure 5.9: G gene based maps and bar graphs of the global RSV-A and RSV-B pairwise 
Markov jump history for the continent trait in the posterior tree distribution. 
The thickness and colour of the connecting lines are based on the number of jumps. As: Asia, 
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Figure 5.10: Maps and bar graphs of the global RSV-A and RSV-B pairwise Markov jump 
history for the hemisphere trait in the posterior tree distribution. 
The thickness and colour of the connecting lines are based on the number of jumps. N: 
Northern hemisphere, T: Tropics, S: Southern hemisphere. 
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5.4.6 Predictors of global RSV dispersal 
The analyzed predictors of global RSV spread and the estimated inclusion 
probabilities and Bayes factors (BF) support for discrete diffusion rates are shown in 
Table 5.4. For RSV-B, the best predictor of RSV spread between countries was the 
seasonal fluxes while air traffic was the best predictor of spread between the larger 
spatial sub-divisions of continents and hemispheres. These observations were 
consistent for both the G gene and whole genome datasets. For RSV-A, the seasonal 
fluxes were the best predictors of RSV spread both between countries and continents. 
However, there was some inconsistency in the best predictor of RSV-A spread 
between the G gene and WGS datasets at the hemisphere level; for RSV-A G gene, 
air traffic was most preferred while for RSV-A WGS the seasonal fluxes were 
preferred. While the reason for this inconsistency between the RSV-A G gene and 
WGS datasets at this spatial subdivision was not immediately clear, the only 
noticeable difference was that there were more samples from the Tropics compared to 
those from the Northern hemisphere for the RSV-A WGS dataset unlike for the RSV-
A G, RSV-B G, and RSV-B WGS datasets where there were more samples from the 
Northern hemisphere than the Tropics. Nonetheless, often there wasn’t a great 
distinction between the predictors with air traffic and the fluxes receiving similar 
support and this may in part be due to the fluxes being derived from air-travel. 
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Table 5.4: Predictors of global RSV spread between countries, continents and 
hemispheres 
RSV-B 
  Country 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.2396 0.6399 0.4168 1.4508 
Distance 0 0 0.1160 0.2664 
Flux 0.7604 ‡ 6.4418 0.4673 1.7807 
  
  Continent 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.5844 1.4064 0.8141 4.3791 
Flux 0.4156 0.7111 0.1859 0.2284 
  
  Hemisphere 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.5971 1.4818 0.7175 2.5403 
Flux 0.4029 0.6749 0.2825 0.3937 
     
RSV-A 
  Country 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.3375 1.0341 0.1226 0.2838 
Distance 0 0 0.1016 0.2295 
Flux 0.6625 3.9862 0.7758 7.0257 
 
  Continent 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.2899 0.4082 0.4007 0.6685 
Flux 0.7101 2.4499 0.5993 1.4958 
   
  Hemisphere 
Predictor 
G WGS 
Inclusion Probability Bayes Factor Inclusion Probability Bayes Factor 
Air 0.5989 1.4931 0.4545 0.8332 
Flux 0.4011 0.6698 0.5455 1.2002 
 
‡ In bold, the best predictor of spread for each dataset and spatial sub-division 
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5.5 Discussion and Conclusions 
RSV is the most important cause of viral ALRI in children worldwide and a health 
concern in terms of morbidity, mortality and costs (Simoes 1999; Cane 2001; Shi et 
al. 2017). Persistence of the virus in communities, characterized by annual, biannual 
and biennial epidemics, is thought to be driven in part by frequent introductions of 
virus variants from other communities (Weber, Mulholland and Greenwood 1998; 
Centers for Disease Control and Prevention (CDC) 2004; Mlinaric-Galinovic et al. 
2012; Agoti et al. 2014a, 2015b; Otieno et al. 2016). In this study, we present novel 
work on understanding the local and global spread of RSV by reconstructing the 
phylogeographic history of the virus in a discrete (Lemey et al. 2009) space using 
Bayesian inference, and test and quantify a range of potential predictors of spatial 
spread (Lemey et al. 2014). 
 
We found that the local RSV dispersal in Kenya is predominantly characterized by 
virus transitions from Kilifi into other locations within the country, even though this 
observation is biased by heavy sampling of viruses from Kilifi. However, locations in 
close proximity to each other also had well-supported diffusion rates for both RSV 
groups implying regional circulation of viruses may be important for virus persistence 
within the country. The notion of sub-national transmission may be supported by the 
observation of weak spatial structuring of the virus populations. It is known from 
previous studies in Kilifi that virus persistence in this community is modulated by 
frequent introduction of virus variants from outside the community (Agoti et al. 
2015b; Otieno et al. 2016). The unanswered question that would greatly benefit 
understanding the epidemiology of RSV in the country is whether the introduction of 
a virus variant(s), e.g. ON1, is characterized by (i) entry into a single location (e.g. 
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Kilifi) which then spread across the country and subsequently maintained through 
sub-national transmission, or (ii) entry into multiple locations/regions independently 
with some exchange of variants between regions (Figure 1.5). 
 
In the global context, the northern hemisphere was predicted to be the major source 
population of RSV into the tropics and the southern hemisphere. This is at odds with 
the influenza virus where the tropics (mostly East and Southeast Asia, and India) has 
been shown to be the source population from incidence data and phylogeographic 
analyses (Russell et al. 2008; Lemey et al. 2014; Bedford et al. 2015). If one 
compares the air traffic and fluxes summarized by hemisphere, the main difference is 
the asymmetry in the fluxes, specifically between the tropics and the other two 
hemispheres. As the model underlying the fluxes allow continual transmission in the 
tropics similar to influenza, this region acts as a source population in the fluxes. So, 
perhaps, (i) a source population in the tropics is not really the case for RSV or (ii) 
sampling bias prevents us from identifying the source. There were more samples from 
the northern hemisphere compared to the tropics, which would make it difficult to 
identify the tropics as a source. In the case of the RSV-A WGS dataset where there 
were almost twice as many samples from the tropics than the northern hemisphere, 
the number of virus jumps from the tropics to the northern hemisphere only 
marginally surpassing those from the northern hemisphere to the tropics. If the tropics 
were the source, then the difference in jumps might have been substantial. However, 
sampling bias isn’t just about the difference in the number of samples as the 
distribution of the samples across time is equally critical and needs careful 
consideration in such analyses. 
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It has been reported that annual RSV outbreaks generally occur in the late fall and 
winter in the temperate regions and during the rainy seasons in the tropical regions 
(Moura et al. 2006; Goddard et al. 2007; Meerhoff et al. 2009; Murray et al. 2012; 
Obando-Pacheco et al. 2018). The study by Obando-pacheco et al. (Obando-Pacheco 
et al. 2018) reported that the RSV wave started between March and June in most 
countries in the Southern hemisphere and between September and December in the 
Northern hemisphere. There was a decrease in RSV activity from August to October 
in the Southern hemisphere and from February to May in the Northern hemisphere. 
However, they only partitioned the global countries into the Northern and Southern 
hemispheres unlike in this analysis where there was the tropical regions. Nonetheless, 
the period from mid-August to early October had the least RSV activity globally, a 
time that preceded the start of RSV activity in the Northern hemisphere. One can 
perhaps infer that annual RSV activity begins in the Northern hemisphere, and if this 
is the case then new variants initially circulate in the temperate north before onward 
transmission into the tropics and temperate south, a hypothesis that might agree with 
the observations from our phylogeographic analysis. 
 
Phylogeographic analyses not only allow the description of the spatiotemporal 
patterns of viral spread but may also aid the formulation of hypotheses about the 
underlying processes that shape the dynamics of spread. It was observed that for 
RSV-A there is support for the seasonal fluxes as the best predictor of RSV spread 
between countries, but as soon as larger groupings such as continents and 
hemispheres are considered then air travel is favoured. This seems reasonable as the 
fluxes will strongly prefer transmission between countries within the same continent 
and hemisphere as they would have similar seasonal transmissibility (as modelled for 
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the fluxes). However, it is interesting that seasonal fluxes would still be preferred for 
the virus spread between continents and hemispheres for RSV-B. Whether this 
reflects an inherent difference in the epidemiology of the RSV-A and RSV-B viruses 
or simply arises from sampling bias warrants further investigation. 
 
Sampling bias prevents us from making firm conclusions on the observations from 
this study. The sample patchiness in the datasets analyzed here arise from very 
heterogeneous RSV sequencing efforts across countries. These differences in the 
number of sequences do affect the migration rate estimates and hence the ancestral 
reconstructions. However, the current analysis takes an important first step towards 
the understanding of the dynamics and predictors of RSV spread at the local and 
global contexts. In the immediate future, the aim is to perform similar discrete spatial 
diffusion analyses using partial G gene sequence datasets (600-700nt) that capture 
more countries and samples, even though such a dataset runs the risk of reduced 
phylogenetic resolution due to shorter sequences. Due to the large numbers of these 
sequences and the computational time required for these analyses, the oversampled 
regions in these datasets will be down-sampled either (i) using known epidemiology 
(the prevalence in each location) or (ii) randomly for more similar or balanced 
numbers. Finally, there is a plan to quantify the virus spatial structure in the generated 
posterior set of trees by measuring the phylogenetic association in the location trait 
data (Wang et al. 2001; Parker, Rambaut and Pybus 2008; Lemey et al. 2009). 
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CHAPTER SIX 
6 Overall Discussion 
6.1 Introduction 
Emerging infectious diseases (EIDs) are a significant burden on global economies and 
public health (Fauci 2001; Morens, Folkers and Fauci 2004). In fact, EID events have 
risen significantly over time (Jones et al. 2008). While public health surveillance of 
both old and new pathogens continues to rise, it still is inadequate. This is exemplified 
by recent reports showing unnoticed detection of pathogens such as Ebola and zika 
viruses for several months within populations (Dudas et al. 2017; Faria et al. 2017; 
Grubaugh et al. 2017; Metsky et al. 2017). Increased globalization and travel between 
states, countries and across continents has heightened and extended the potential of 
rapid pathogen spread and geographic reach, respectively, a risk that seems to be 
perennially underestimated (Gostin 2017). While RSV does not leave behind a sudden 
acute “death trail” as other viruses such as Ebola and SARS, new variants continue to 
emerge and the cumulative annual deaths and disease burden is of great significance 
especially in low and middle-income countries (Trento et al. 2003; Eshaghi et al. 
2012; Shi et al. 2017). Therefore, increased surveillance and identification of new 
variants is important for the understanding the molecular epidemiology of RSV and 
design of future control strategies. 
 
Pathogen genetic data contains information about spatio-temporal spread that can be 
extracted using phylodynamic approaches (Lemey et al. 2014; Faria et al. 2017). In 
addition, pathogen genome analyses can also shed light on the origins, evolution and 
transmission dynamics of a pathogen during an epidemic or across multiple epidemics 
(Smith et al. 2009; Holmes et al. 2016). Study patients’ profiles can also be used to 
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investigate the clinical and demographic impact of emergent strains relative to 
previous or existing strains.  
 
In this study, using the emergent RSV-A genotype ON1 as a unique tag, an integrated 
approach was undertaken using partial and whole genome sequence data, patient 
clinical and demographic profiles, human mobility (air traffic) data, and stochastic 
models of RSV disease transmission to understand; (1.) how new RSV variants are 
introduced and spread into communities, (2.) how they persist locally within those 
communities, (3.) the genomic signatures that differentiate emergent from existing 
variants and whether such substitutions may impact on fitness, and (4.) the patterns 
and drivers of RSV spread across geographically defined regions (local and global). 
 
6.2 Key research findings 
The key research findings from this thesis project are presented hereafter under each 
of the three major analyses conducted. 
 
6.2.1 Molecular epidemiological, clinical and demographic characteristics of 
RSV-A genotype ON1 in Kilifi: analysis of G gene sequences 
 
In February 2012, the novel RSV group A genotype ON1 with the characteristic 72 
nucleotide duplication within the G-gene was detected in Kilifi County, coastal 
Kenya. To better understand the molecular epidemiological characteristics of new 
RSV variants into a community, a genetic and phylogenetic analysis of a set of group 
A G-gene sequences from Kilifi (n=483) collected through the continuous 
surveillance of RSV-associated pediatric pneumonia admissions at KCH (2010/2011 
to 2014/2015) was undertaken. The clinical and demographic information of the 
patients from whom these samples were collected were also statistically analyzed. 
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The following key findings were made:  
1. Very rapid replacement of previously circulating genotype GA2 by ON1, 
quite unlike previous RSV-A genotype replacements within the same 
community. This might suggest that ON1 viruses are relatively fitter than 
the previous RSV-A genotypes. However, it was noted that the prevalence 
of ON1 varied globally and in some places the ON1 are seemingly not 
about to displace the predominating RSV-A genotype several epidemics 
after initial entry into such communities. We conclude that, in addition to 
genetic constitution, host and ecological differences may also determine 
the fitness advantage or success of an RSV variant. 
2. Each RSV epidemic is characterized by the circulation of multiple 
variants, each differing sufficiently to suggest separate introductions into 
the community (as opposed to arising from diversification during the 
epidemic), very few of which persist across epidemics. While previous 
reports from this community had come up with the same conclusion 
analyzing RSV-A and B strains that had been circulating in Kilifi for a 
while and could be presumed to be the tendency of established variants 
(Agoti et al. 2015b; Otieno et al. 2016), this was a strong validation of 
these conclusions as the ON1 variant dynamics from initial introduction 
were analyzed. In all, it seems the concept of co-circulating lineages in 
communities exists at all levels of RSV classification (i.e. RSV group, 
genotype and genotype variants) albeit with varied rates of turnover year-
on-year. 
3. Accumulation of amino acid substitutions by the ON1 viruses, and more 
interestingly the acquisition of similar substitutions between adjacent and 
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corresponding positions within the duplicated region. This result probably 
gives the first indication of co-evolution between sites in RSV genotype 
ON1 viruses. While RSV uses CX3CR1 as a receptor to infect human 
ciliated airway epithelial cells, Hotard et al used cells expressing heparan 
sulphate to show that the duplication in the BA genotype resulted in better 
binding avidity (Hotard et al. 2015). Assuming the same effect in ON1 
viruses and in ciliated airway epithelial cells, the longer attachment protein 
appears to offer more opportunities for variable changes hence greater 
diversity and potentially increased fitness over previous group A 
genotypes. 
4. No clear evidence of altered pathogenicity of ON1 relative to GA2 in 
Kilifi, save for higher prevalence in inability to feed amongst ON1 
infected children, with overall cases of very severe pneumonia equally 
prevalent in both genotypes. However, reports from around the globe give 
conflicting results with regard to ON1 RSV disease severity relative to 
other genotypes and could arise from methodological differences in 
analyses, clinical disease definitions and study designs, chance effects 
resultant from inadequate sample sizes, differences between viruses in 
different locations, or even host/environmental differences. 
 
6.2.2 Whole genome evolutionary dynamics of RSV genotype ON1 
The G gene on its own has been shown, for example, to be occasionally insufficient in 
distinguishing between inpatient outbreak RSV strains isolated in a haematology-
oncology and stem-cell transplant unit and outpatient epidemiologically-unrelated 
strains collected within the same time period (Zhu et al. 2017), and “who acquires 
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infection from whom” (Munywoki et al. 2014). A total of 184 RSV-A whole genome 
sequences (WGS) from Kilifi (Kenya) collected between 2011 and 2016, the first 
ON1 genomes from Africa and the largest collection globally from a single location, 
were generated and analyzed. WGS has the potential to provide a more detailed 
understanding of RSV molecular epidemiology, evolution, phylogeography, 
diagnostics and vaccine development. 
 
What was novel and most interesting in this analysis was the identification of 
signature amino acid substitutions between Kilifi ON1 and GA2 viruses’ surface 
proteins (G, F), polymerase (L) and matrix M2-1 proteins, some of which were 
positively selected, and thereby provided an enhanced picture of RSV-A diversity. 
Furthermore, five of the eleven RSV open reading frames (ORF) (G, F, L, N and P) 
formed distinct phylogenetic clusters for the two genotypes. This might suggest that 
coding regions outside of the most frequently studied G ORF also play a role in the 
adaptation of RSV to host populations or rather there could be linked selection (co-
evolution) amongst antigenic and non-antigenic genes of novel RSV variants. 
However, without complementary and confirmatory functional analyses it is plausible 
that some of these signature substitutions could be neutral and provide no selective 
advantage. 
 
Phylogenetic analysis re-affirmed the conclusions obtained by partial G-gene 
sequencing that RSV-A circulation in this coastal Kenya location is characterized by 
multiple introductions of viral lineages from diverse origins but with varied success in 
local transmission. Nonetheless, there have been questions on the nature of the 
emergence of ON1, i.e. if this occurred through a single ancestral ON1 virus or 
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multiple times. While it was noted that oddly placed viruses of a given genotype 
amongst viruses of another genotype might give the impression of multiple 
emergence, these viruses often had no descendants and came from the same labs, and 
therefore might be nothing more than cross-contamination and/or mis-assemblies. 
 
This analysis reaffirms the epidemiological processes that define RSV spread, 
highlights the genetic substitutions that characterize emerging strains, and 
demonstrates the utility of large-scale WGS in molecular epidemiological studies. 
 
6.2.3 Local and global RSV transmission dynamics 
In addition to understanding (i) how frequent introduction of new RSV variants 
contributes to its persistence within communities, (ii) the associated clinical and 
demographic impacts of such new variants, and (iii) the genomic signatures that 
characterize the new variants and may impact on fitness, it is equally important to 
understand the dynamics of the virus spread within and between geographically 
defined regions. Future public health control strategies might benefit from such 
insights on the dynamics of virus spread as they have the potential of improving the 
predictive models of disease control. 
 
This phylogeographic analysis is a first for RSV in terms of aiming to unravel both 
the local and global patterns of RSV spread in discrete spaces. It was observed that 
virus spread between locations in close proximity might be important for virus 
persistence within the country. Favoured by more intensive sampling, the local RSV 
dispersal in Kenya was predominantly characterized by virus transitions from Kilifi 
into the other locations. Our hypothesis on the patterns of RSV spread in Kenya are 
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that a new virus variant(s) may be introduced into the country either at a single 
location then subsequently spread across the country or at multiple locations/regions 
independently with some exchange of variants between regions. With ongoing 
sequencing of more samples from across the country, it is expected that this might 
improve on the current observations and build a better picture of the local RSV 
spread. 
 
For a well-studied virus like influenza, it has been accepted that the global source 
population of influenza diversity is the tropics and specifically mainland China and 
Southeast Asia. It is not known if (i) there is a specific source population of new RSV 
variants and (ii) where that population might be located. From this analysis, it is 
predicted that the northern hemisphere might be the major source population of RSV 
into the tropics and the southern hemisphere. In fact this observation might agree with 
the findings from Obando-pacheco et al. (Obando-Pacheco et al. 2018) where they 
gathered that the annual RSV epidemics globally began in the Northern hemisphere 
regions followed by the regions in the Southern hemisphere. However, the scope of 
the current analysis could not allow us to make inferences on why the Northern 
hemisphere could be the likely source population and is an area of interest for future 
analysis. 
 
The phylogeographic analyses not only allowed us to describe the global 
spatiotemporal patterns of RSV spread but also formulate hypotheses about the 
underlying processes that shape the dynamics of spread. On one hand it was observed 
that seasonal fluxes and air travel were the best predictors of RSV-A spread at the fine 
(between countries) and coarse (between continents and hemispheres) geographic 
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scales, respectively. On the other hand, seasonal fluxes were the most preferred 
predictor of spread at all scales for RSV-B viruses. However, it is not apparent if this 
observation reflects on an inherent difference in the epidemiology of the RSV group 
A and B viruses or arises from sampling bias in our datasets. 
 
Sampling heterogeneity in the analyzed datasets presents a challenge that prevents us 
from making firm conclusions about our observations. However, the current analysis 
makes the important first step towards the understanding of the dynamics and 
predictors of RSV spread both at the local and the global contexts. It might also spur 
discussions and concerted efforts, as is the case with influenza, on intensive 
surveillance and sequencing of RSV strains across the world. 
 
6.3 Study limitations  
While all the study objectives were addressed, sampling bias presented a great 
challenge in the analysis of the local and global patterns and drivers of RSV spread. 
For the local analysis, samples from Nairobi which we hypothesize to be crucial to 
understanding local spread patterns (based on geographic and administrative 
positioning) arrived in late November when this thesis was nearing submission and 
therefore sample processing, sequencing and analysis was not feasible. At the global 
level, there’s an heterogenous effort in both surveillance and sequencing of RSV 
leaving such analyses fraught with inconclusive observations. 
 
6.4 Thesis summary  
Following initial detection of the genotype ON1 in Kilifi in 2012, there was rapid 
replacement of the previously circulating RSV group A genotype GA2 by ON1 in 
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subsequent epidemics. While this suggests elevated fitness of ON1 viruses, there was 
no clear evidence of altered pathogenicity of ON1 relative to GA2 in Kilifi. Signature 
amino acid substitutions were identified between surface proteins (G, F), polymerase 
(L) and matrix M2-1 proteins of Kilifi ON1 and GA2 viruses, suggesting co-evolution 
amongst antigenic and non-antigenic genes of RSV variants. Genetic and 
phylogenetic analyses reaffirmed previous conclusions that each RSV epidemic is 
characterized by the frequent introduction of multiple variants, few of which persist 
across epidemics. Finally, the phylogeographic analyses predicted the northern 
hemisphere to be the major source population of RSV into the tropics and the 
southern hemisphere and virus spread between locations in close proximity to be 
important for virus persistence within a country. Future work will explore (i) any 
functional consequences of the ON1-GA2 signature substitutions, and (ii) further 
RSV spread dynamics at the country and continental level with more sequence data 
currently being processed. 
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7 Appendices 
7.1 Study scientific and ethical approval 
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7.2 RSV-A WGS sequencing primers [6-amplicon method] 
 
Primer Amplicon Sequence Length 
Melting 
Temperature 
(Tm) 
GC 
fraction 
F_rsvas 1  ACGCGAAAAAATGCGTACAAC 21 57.13 0.43 
F_7543 1  TGAATGGCATTGTATTTGTGCATGT 25 58.35 0.36 
F_8823 1  TTAACTAATGCTTTGGCTAAGGCAG 25 57.68 0.4 
R_70 1  CACGTATGTTTCCATATTTGCCCC 24 58.38 0.46 
R_78 1  GGCACCCATATTGTAAGTGATGC 23 57.89 0.48 
F_211 2  ATGGCAAAAGACACATCAGATGAAG 25 57.92 0.4 
F_751 2  CAGATGAAGTGTCTCTCAATCCAAC 25 57.52 0.44 
R_1265 2  CAACTCCATTGTTATTTGCCCCA 23 57.54 0.43 
R_1769 2  TGCTAACTGCACTGCATGTTG 21 57.73 0.48 
F_2690 3  AGCATATGCAGCAACAATCCAAC 23 58.31 0.43 
F_3004 3  TTTGTACCCTGCAGCATATGCA 22 58.42 0.45 
R_1939 3  TCAATCAAGTCTTGAGAGGTCCAAT 25 57.68 0.4 
R_11745 3  GGTCCAATGGATTTCATTGAATGGT 25 57.84 0.4 
F_248 4  AATCAGCATGTGTTGCCATGAG 22 57.74 0.45 
F_1734 4  TTTTGAATGGCCACCCCATG 20 56.87 0.5 
R_87 4  AGATTGTACACCATGCAGTTCATC 24 57.21 0.42 
R_393 4  TGCTAGCAAATAATCTGCTTGAGC 24 57.85 0.42 
F_886 5  GGTAGAATGTTTGCAATGCAACC 23 57.28 0.43 
F_1850 5  AGTGCTCTATCATCACAGATCTCAG 25 57.55 0.44 
R_217 5  AATCTATGTTAACAACCCAAGGGCA 25 58.42 0.4 
R_2029 5  CCAAGGGCAAACTGTGAATTCTG 23 58.44 0.48 
F_373 6  AGTAGTAGACCATGTGAATTCCCTG 25 57.60 0.44 
F_1051 6  GAATTCCCTGCATCAATACCAGC 23 57.88 0.48 
R_362 6  CTGAAAACTTCATTACGTCCAGCTA 25 57.23 0.4 
R_46462 6  AATACAGTGTTAGTGTGTAGCCATG 25 56.95 0.4 
R_rsvae 6  ACGAGAAAAAAAGTGTCAAAAACTAATA 28 55.09 0.25 
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7.3 RSV-A WGS sequencing primers [14-amplicon method] 
Primer Sequence Length 
Melting 
Temperature 
(Tm) 
GC 
fraction Strand 
Position 
(in plus 
strand) 
A_F_1105 TTGACAATGATGAAGTAGC 19 48.52 0.37 Plus 104 
A_F_12259 TTCCATAACAAAACCTTTGA 20 48.63 0.3 Plus 4398 
A_F_1378 GGTGTAATAGATACACCTTG 20 48.44 0.4 Plus 6600 
A_F_1434 GATGGTACTGTGACAATG 18 48.24 0.44 Plus 6700 
A_F_1551 ATATAAGTAAACCAGTCAGAC 21 48.03 0.33 Plus 10963 
A_F_2104 GATGTAGAGCTTTGAGTTAA 20 48.28 0.35 Plus 2257 
A_F_2361 TATGACATACAAGAGTATGAC 21 47.91 0.33 Plus 8789 
A_F_2442 TGAAAGTTTTCTTCAATGC 19 47.78 0.32 Plus 13108 
A_F_4189 ATAATCTCCATCATGATTGC 20 48.70 0.35 Plus 4347 
A_F_5014 GATGTCAAAGTCTATGCTATA 21 48.25 0.33 Plus 8877 
A_F_657 TGGGGAGAGGGATATATAA 19 48.04 0.42 Plus 13068 
A_F_7149 TTAACTAATGCTTTGGCTAA 20 48.26 0.3 Plus 163 
A_F_774 CATGCTCAAGCAGATTAT 18 47.79 0.39 Plus 11001 
A_F_950 GAGAAGATGCAAACAACA 18 48.63 0.39 Plus 2331 
A_F_rvas-6 ACGCGAAAAAATGCG 15 49.00 0.47 Minus 15233 
A_R_1464 TTGCAGGACCTATTGTAA 18 48.13 0.39 Minus 14559 
A_R_2054 ATCATTTCGAGATCCACT 18 48.07 0.39 Minus 10123 
A_R_2299 CCCAATCCAATTTTGCTA 18 48.06 0.39 Minus 12408 
A_R_2348 ATTCTTCAGTGATGTTTTGA 20 48.52 0.3 Minus 5775 
A_R_2372 TCATAGTGAGATCTTTAACTG 21 48.09 0.33 Minus 3613 
A_R_238 GACATAGCATATAACATACCT 21 47.93 0.33 Minus 1310 
A_R_261 CTTGACGATGTGTTGTTA 18 48.14 0.39 Minus 1402 
A_R_346 CTAGGGAAACTAGTCCATAT 20 48.29 0.4 Minus 10180 
A_R_350 CCTATATAACTCTCTAGCACT 21 48.67 0.38 Minus 7878 
A_R_358 GCAACTCCATTGTTATTTG 19 48.42 0.37 Minus 5691 
A_R_5 GGTGTGGTTACATCATATG 19 48.69 0.42 Minus 3536 
A_R_663 AATCGATATCATCTTGAGC 19 47.86 0.37 Minus 14460 
A_R_74 ACATGCTGATTGTTTAGTTA 20 48.32 0.3 Minus 7912 
A_R_833 GCTATAGTGCTTGTTGTATA 20 48.15 0.35 Minus 12229 
B_F_143 ATGTGGCATGCTATTAATC 19 48.62 0.37 Plus 1236 
B_F_15612 AACATCCGAGTACCTATC 18 48.00 0.44 Plus 5551 
B_F_1577 GGTCATTGCTTGAATGG 17 48.72 0.47 Plus 7661 
B_F_17 TGCTTCCTTGGCATC 15 48.03 0.53 Plus 13951 
B_F_2225 GCCTACTTTAAGGAATGC 18 48.55 0.44 Plus 9956 
B_F_249 TACGTGAACAAACTTCAC 18 48.43 0.39 Plus 3220 
B_F_551 GAAATAAGTGGAGCTGC 17 48.14 0.47 Plus 7799 
B_F_63 ATGGCTCTTAGCAAAGT 17 48.05 0.41 Plus 1096 
B_F_638 AATGGTAGATGAAAGACAAG 20 48.44 0.35 Plus 9812 
B_F_651 CACTTACAATATGGGTGC 18 48.56 0.44 Plus 3302 
B_F_720 ACTGAGATGATGAGGAAAA 19 48.61 0.37 Plus 12012 
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B_F_84 GATCTTGGTCTTTATCCAATA 21 48.28 0.33 Plus 12142 
B_F_85 CACTTTATTGCATGCTTC 18 47.78 0.39 Plus 13939 
B_F_8930 AAATCCAGAACACACAAG 18 48.09 0.39 Plus 5398 
B_R_1024 GATGGAGGATGTTGCA 16 48.21 0.5 Minus 9121 
B_R_1299 TTGCCCTTTATTGATTCTAG 20 48.45 0.35 Minus 2382 
B_R_131 AACCAATGTATTAACCATGA 20 47.82 0.3 Minus 9139 
B_R_136 TTTGGACATGTTTGCATT 18 48.58 0.33 Minus 4645 
B_R_15653 GAATACAGTGTTAGTGTGTA 20 47.96 0.35 Minus 15062 
B_R_18507 ATTCCTCCTAGATCAAAATG 20 47.77 0.35 Plus 15281 
B_R_2394 GCTTTCTTTGGTTACTTCTA 20 48.74 0.35 Minus 2464 
B_R_2432 CTAATTCTTGTGTCAAACTAC 21 48.35 0.33 Minus 11262 
B_R_2565 TCTTTATACTAGCTGGGTAAT 21 48.60 0.33 Minus 11172 
B_R_260 CCACGATTTTTATTGGATG 19 47.89 0.37 Minus 6970 
B_R_359 TGGTAATGTTAAACTGTTCA 20 48.14 0.3 Minus 6809 
B_R_541 TGTGTTGGATGATAATCTATG 21 48.73 0.33 Minus 13420 
B_R_5492 AACTTGTATAAGCACGATG 19 48.72 0.37 Minus 4734 
B_R_778 ACAACCCAAGGGCA 14 48.23 0.57 Minus 13396 
B_R_rsvae-9 ACGAGAAAAAAAGTGTCAA 19 48.80 0.32 Minus 15233 
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7.4 Kilifi RSV-A Genotype patterns 2000-2016 
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7.5 Genome Details 
 
Sample 
Genome  
Accession Genotype 
PCR  
strategy 
 No. of 
Reads  
 RSV 
Reads  
 Genome 
length  
 Mean 
coverage  Assembler 
PCR 
Ct 
Collection 
date SRA Accession 
KEN/Kilifi/WGS/1022_28/12/2011 MH181878 GA2 6-amplicon 1,270,622 393,958 14,912 4,483.13 VIRALNGS NA 28/12/11 SAMN08724833 
KEN/Kilifi/WGS/1024_09/02/2012 MH181879 GA2 6-amplicon 1,407,764 270,288 14,697 2,961.69 VIRALNGS 22.94 09/02/12 SAMN08724834 
KEN/Kilifi/WGS/1025_13/02/2012 MH181908 ON1 14-amplicon 3,293,722 3,088,934 15,168 53,178.19 VIRALNGS 19.26 13/02/12 SAMN08724835 
KEN/Kilifi/WGS/1026_16/02/2012 MH181880 GA2 6-amplicon 1,454,390 332,690 14,697 3,457.63 VIRALNGS 21.38 16/02/12 SAMN08724836 
KEN/Kilifi/WGS/1028_02/03/2012 MH181881 GA2 6-amplicon 939,372 442,216 14,913 4,740.40 VIRALNGS 19.55 02/03/12 SAMN08724837 
KEN/Kilifi/WGS/1029_03/03/2012 MH181882 GA2 6-amplicon 1,125,168 465,202 14,903 5,023.98 VIRALNGS 21.31 03/03/12 SAMN08724838 
KEN/Kilifi/WGS/1031_05/03/2012 MH181883 GA2 6-amplicon 1,385,586 1,036,466 14,915 11,068.56 VIRALNGS 20.17 05/03/12 SAMN08724839 
KEN/Kilifi/WGS/1032_07/03/2012 MH181909 ON1 14-amplicon 2,602,100 2,252,496 15,070 38,777.92 VIRALNGS 21.64 07/03/12 SAMN08724840 
KEN/Kilifi/WGS/1033_09/03/2012 MH181910 ON1 14-amplicon 3,393,018 3,272,224 15,197 55,740.25 VIRALNGS 17.75 09/03/12 SAMN08724841 
KEN/Kilifi/WGS/1034_11/03/2012 MH181911 ON1 14-amplicon 2,218,728 1,065,438 14,959 18,236.55 VIRALNGS 24.22 11/03/12 SAMN08724842 
KEN/Kilifi/WGS/1035_16/03/2012 MH181912 ON1 14-amplicon 3,380,044 3,262,410 15,180 55,995.24 VIRALNGS 16.98 16/03/12 SAMN08724843 
KEN/Kilifi/WGS/1036_21/03/2012 MH181913 ON1 14-amplicon 3,858,536 3,746,792 15,205 64,113.11 VIRALNGS 17.98 21/03/12 SAMN08724844 
KEN/Kilifi/WGS/1037_23/03/2012 MH181884 GA2 6-amplicon 984,444 1,626 14,332 44.33 VIRALNGS 24.83 23/03/12 SAMN08724845 
KEN/Kilifi/WGS/1038_23/03/2012 MH181914 ON1 14-amplicon 3,886,448 3,641,296 15,152 62,377.42 VIRALNGS 20.41 23/03/12 SAMN08724846 
KEN/Kilifi/WGS/1039_25/03/2012 MH181885 GA2 6-amplicon 1,620,128 33,722 14,686 406.46 VIRALNGS 26.31 25/03/12 SAMN08724847 
KEN/Kilifi/WGS/1040_26/03/2012 MH181915 ON1 14-amplicon 4,350,992 3,963,646 15,061 66,457.67 VIRALNGS 20.16 26/03/12 SAMN08724848 
KEN/Kilifi/WGS/1041_29/03/2012 MH181916 ON1 14-amplicon 3,056,872 2,224,280 15,140 38,552.58 VIRALNGS 21.25 29/03/12 SAMN08724849 
KEN/Kilifi/WGS/1043_05/04/2012 MH181917 ON1 14-amplicon 2,191,722 1,876,406 15,232 32,307.51 SPADES 24.16 05/04/12 SAMN08724850 
KEN/Kilifi/WGS/1044_10/04/2012 MH181918 ON1 14-amplicon 2,916,484 2,762,130 15,164 47,482.85 VIRALNGS 20.87 10/04/12 SAMN08724851 
KEN/Kilifi/WGS/1045_10/04/2012 MH181886 GA2 6-amplicon 1,494,678 958,672 14,891 9,996.56 VIRALNGS 22.16 10/04/12 SAMN08724852 
KEN/Kilifi/WGS/1046_13/04/2012 MH181887 GA2 6-amplicon 1,251,788 880,908 14,549 9,824.38 VIRALNGS 21.33 13/04/12 SAMN08724853 
KEN/Kilifi/WGS/1047_15/04/2012 MH181888 GA2 6-amplicon 1,641,672 383,808 14,697 4,419.82 VIRALNGS 22.62 15/04/12 SAMN08724854 
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KEN/Kilifi/WGS/1048_16/04/2012 MH181889 GA2 6-amplicon 1,345,204 269,926 14,669 3,341.61 VIRALNGS 25.2 16/04/12 SAMN08724855 
KEN/Kilifi/WGS/1049_17/04/2012 MH181890 GA2 6-amplicon 1,287,742 912,588 14,876 9,912.84 VIRALNGS 20.66 17/04/12 SAMN08724856 
KEN/Kilifi/WGS/1050_17/04/2012 MH181891 GA2 6-amplicon 1,483,678 35,648 14,589 431.77 VIRALNGS 25.41 17/04/12 SAMN08724857 
KEN/Kilifi/WGS/1051_24/04/2012 MH181919 ON1 14-amplicon 3,036,992 2,853,918 15,198 49,164.32 VIRALNGS 18.44 24/04/12 SAMN08724858 
KEN/Kilifi/WGS/1052_25/04/2012 MH181892 GA2 6-amplicon 1,555,690 879,362 14,693 9,480.92 VIRALNGS 19.98 25/04/12 SAMN08724859 
KEN/Kilifi/WGS/1053_26/04/2012 MH181920 ON1 14-amplicon 2,552,538 2,084,818 15,116 35,963.84 VIRALNGS 21.81 26/04/12 SAMN08724860 
KEN/Kilifi/WGS/1054_16/05/2012 MH181921 ON1 14-amplicon 3,235,132 2,694,000 15,138 45,968.25 VIRALNGS 20.81 16/05/12 SAMN08724861 
KEN/Kilifi/WGS/1056_30/05/2012 MH181922 ON1 14-amplicon 2,935,820 1,780,478 15,049 30,814.75 VIRALNGS 22.72 30/05/12 SAMN08724862 
KEN/Kilifi/WGS/1058_08/06/2012 MH181923 ON1 14-amplicon 2,312,598 1,906,202 15,106 32,807.75 SPADES 21.04 08/06/12 SAMN08724863 
KEN/Kilifi/WGS/1059_08/06/2012 MH181924 ON1 14-amplicon 2,225,810 2,187,994 15,215 37,245.25 VIRALNGS 16.86 08/06/12 SAMN08724864 
KEN/Kilifi/WGS/1060_11/06/2012 MH181925 ON1 14-amplicon 2,470,026 2,348,036 15,188 40,483.39 VIRALNGS 18.23 11/06/12 SAMN08724865 
KEN/Kilifi/WGS/1061_13/06/2012 MH181926 ON1 14-amplicon 2,071,626 1,772,624 15,049 30,725.88 VIRALNGS 21.53 13/06/12 SAMN08724866 
KEN/Kilifi/WGS/1062_15/06/2012 MH181927 ON1 14-amplicon 1,688,810 1,123,748 15,059 19,373.45 VIRALNGS 23.13 15/06/12 SAMN08724867 
KEN/Kilifi/WGS/1063_18/06/2012 MH181928 ON1 14-amplicon 2,887,012 2,207,944 15,042 37,782.03 VIRALNGS 21.58 18/06/12 SAMN08724868 
KEN/Kilifi/WGS/1064_24/06/2012 MH181893 GA2 6-amplicon 1,151,112 400,912 14,572 4,631.14 VIRALNGS 23.79 24/06/12 SAMN08724869 
KEN/Kilifi/WGS/1066_28/06/2012 MH181929 ON1 14-amplicon 2,729,430 2,628,610 15,175 45,411.89 VIRALNGS 18.55 28/06/12 SAMN08724870 
KEN/Kilifi/WGS/1067_30/06/2012 MH181894 GA2 6-amplicon 1,691,236 114,412 14,698 1,384.07 VIRALNGS 29.82 30/06/12 SAMN08724871 
KEN/Kilifi/WGS/1068_10/07/2012 MH181930 ON1 14-amplicon 2,525,642 2,383,726 15,207 40,719.45 VIRALNGS 20.98 10/07/12 SAMN08724872 
KEN/Kilifi/WGS/1070_23/07/2012 MH181931 ON1 14-amplicon 2,159,538 1,535,640 15,049 26,480.83 VIRALNGS 25.32 23/07/12 SAMN08724873 
KEN/Kilifi/WGS/1071_14/08/2012 MH181932 ON1 14-amplicon 2,675,604 2,520,028 15,233 43,447.66 SPADES 21.45 14/08/12 SAMN08724874 
KEN/Kilifi/WGS/1075_27/10/2012 MH181933 ON1 14-amplicon 2,194,346 1,857,942 15,232 31,956.04 SPADES 24.8 27/10/12 SAMN08724875 
KEN/Kilifi/WGS/1076_30/10/2012 MH181934 ON1 14-amplicon 3,041,964 2,314,252 15,068 39,401.72 VIRALNGS 23.24 30/10/12 SAMN08724876 
KEN/Kilifi/WGS/1077_31/10/2012 MH181935 ON1 14-amplicon 2,438,426 2,175,418 15,232 37,609.41 SPADES 22.49 31/10/12 SAMN08724877 
KEN/Kilifi/WGS/1078_31/10/2012 MH181936 ON1 14-amplicon 2,476,744 2,311,046 15,230 39,698.20 SPADES 21.93 31/10/12 SAMN08724878 
KEN/Kilifi/WGS/1079_05/11/2012 MH181937 ON1 14-amplicon 2,114,774 1,819,602 15,232 31,236.65 SPADES 22.13 05/11/12 SAMN08724879 
KEN/Kilifi/WGS/1080_05/11/2012 MH181938 ON1 14-amplicon 1,786,686 1,465,770 15,074 25,257.87 VIRALNGS 25.1 05/11/12 SAMN08724880 
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KEN/Kilifi/WGS/1081_07/11/2012 MH181939 ON1 14-amplicon 2,096,870 1,926,670 15,151 33,319.15 VIRALNGS 21.73 07/11/12 SAMN08724881 
KEN/Kilifi/WGS/1082_10/11/2012 MH181940 ON1 14-amplicon 1,699,646 1,240,272 15,214 21,458.29 SPADES 24.24 10/11/12 SAMN08724882 
KEN/Kilifi/WGS/1083_12/11/2012 MH181941 ON1 14-amplicon 2,060,860 1,899,520 15,222 32,687.98 SPADES 19.74 12/11/12 SAMN08724883 
KEN/Kilifi/WGS/1084_15/11/2012 MH181942 ON1 14-amplicon 1,632,392 380,376 14,959 6,498.76 VIRALNGS 26.16 15/11/12 SAMN08724884 
KEN/Kilifi/WGS/1086_15/11/2012 MH181943 ON1 14-amplicon 2,275,828 2,057,472 15,226 35,609.99 SPADES 25.78 15/11/12 SAMN08724885 
KEN/Kilifi/WGS/1087_17/11/2012 MH181944 ON1 14-amplicon 2,287,906 2,032,176 15,049 34,971.14 VIRALNGS 21.43 17/11/12 SAMN08724886 
KEN/Kilifi/WGS/1088_19/11/2012 MH181945 ON1 14-amplicon 2,701,940 2,645,394 15,171 45,076.37 VIRALNGS 18.92 19/11/12 SAMN08724887 
KEN/Kilifi/WGS/1089_19/11/2012 MH181946 ON1 14-amplicon 2,355,836 1,933,388 15,110 33,278.48 VIRALNGS 23.96 19/11/12 SAMN08724888 
KEN/Kilifi/WGS/1090_19/11/2012 MH181947 ON1 14-amplicon 2,286,976 2,185,794 15,171 37,746.72 VIRALNGS 18.54 19/11/12 SAMN08724889 
KEN/Kilifi/WGS/1091_22/11/2012 MH181948 ON1 14-amplicon 2,359,658 2,288,890 15,198 39,369.58 VIRALNGS 16.91 22/11/12 SAMN08724890 
KEN/Kilifi/WGS/1092_23/11/2012 MH181949 ON1 14-amplicon 2,060,978 1,566,076 15,025 26,801.24 VIRALNGS 23.19 23/11/12 SAMN08724891 
KEN/Kilifi/WGS/1093_23/11/2012 MH181950 ON1 14-amplicon 1,182,120 416,874 15,150 7,324.31 SPADES 30.01 23/11/12 SAMN08724892 
KEN/Kilifi/WGS/1094_23/11/2012 MH181951 ON1 14-amplicon 2,346,184 2,265,498 15,227 39,009.62 SPADES 17.63 23/11/12 SAMN08724893 
KEN/Kilifi/WGS/1095_24/11/2012 MH181952 ON1 14-amplicon 2,169,590 2,002,620 15,104 34,587.63 VIRALNGS 24.14 24/11/12 SAMN08724894 
KEN/Kilifi/WGS/1096_24/11/2012 MH181953 ON1 14-amplicon 2,697,992 2,627,426 15,183 45,492.81 VIRALNGS 19.92 24/11/12 SAMN08724895 
KEN/Kilifi/WGS/1097_24/11/2012 MH181954 ON1 14-amplicon 2,698,368 2,339,798 15,231 40,334.68 SPADES 21.98 24/11/12 SAMN08724896 
KEN/Kilifi/WGS/1098_25/11/2012 MH181955 ON1 14-amplicon 2,671,940 2,502,752 15,232 43,168.08 SPADES 23.48 25/11/12 SAMN08724897 
KEN/Kilifi/WGS/1099_25/11/2012 MH181956 ON1 14-amplicon 2,654,944 2,542,430 15,183 43,877.84 VIRALNGS 20.64 25/11/12 SAMN08724898 
KEN/Kilifi/WGS/1100_25/11/2012 MH181957 ON1 14-amplicon 2,232,292 2,011,214 15,033 34,492.22 VIRALNGS 21.98 25/11/12 SAMN08724899 
KEN/Kilifi/WGS/1101_25/11/2012 MH181895 GA2 6-amplicon 1,476,584 531,814 14,883 6,072.07 VIRALNGS 24.75 25/11/12 SAMN08724900 
KEN/Kilifi/WGS/1102_27/11/2012 MH181958 ON1 14-amplicon 3,137,122 3,001,672 15,185 51,523.50 VIRALNGS 20.18 27/11/12 SAMN08724901 
KEN/Kilifi/WGS/1103_27/11/2012 MH181959 ON1 14-amplicon 2,561,480 2,387,270 15,145 41,078.44 VIRALNGS 20.05 27/11/12 SAMN08724902 
KEN/Kilifi/WGS/1104_27/11/2012 MH181960 ON1 14-amplicon 2,367,006 2,217,710 15,139 38,181.27 VIRALNGS 22.13 27/11/12 SAMN08724903 
KEN/Kilifi/WGS/1105_28/11/2012 MH181961 ON1 14-amplicon 2,553,394 2,370,212 15,192 40,462.29 SPADES 21.72 28/11/12 SAMN08724904 
KEN/Kilifi/WGS/1106_28/11/2012 MH181962 ON1 14-amplicon 2,958,126 2,940,148 15,176 50,168.19 VIRALNGS 18.98 28/11/12 SAMN08724905 
KEN/Kilifi/WGS/1107_28/11/2012 MH181963 ON1 14-amplicon 2,781,054 1,786,998 15,030 31,236.67 VIRALNGS 27.6 28/11/12 SAMN08724906 
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KEN/Kilifi/WGS/1108_28/11/2012 MH181896 GA2 6-amplicon 1,553,924 611,370 14,949 7,511.50 VIRALNGS 25.74 28/11/12 SAMN08724907 
KEN/Kilifi/WGS/1109_29/11/2012 MH181964 ON1 14-amplicon 3,244,876 3,065,026 15,232 52,644.38 SPADES 27.01 29/11/12 SAMN08724908 
KEN/Kilifi/WGS/1110_29/11/2012 MH181965 ON1 14-amplicon 2,750,196 2,413,804 15,147 41,452.34 VIRALNGS 22.03 29/11/12 SAMN08724909 
KEN/Kilifi/WGS/1112_29/11/2012 MH181966 ON1 14-amplicon 3,284,922 2,341,218 15,049 40,716.26 VIRALNGS 28.78 29/11/12 SAMN08724910 
KEN/Kilifi/WGS/1113_03/12/2012 MH181967 ON1 14-amplicon 3,211,012 3,101,106 15,228 53,002.60 SPADES 21.08 03/12/12 SAMN08724911 
KEN/Kilifi/WGS/1114_03/12/2012 MH181968 ON1 14-amplicon 2,226,714 1,582,202 15,050 28,471.78 VIRALNGS 27.02 03/12/12 SAMN08724912 
KEN/Kilifi/WGS/1115_04/12/2012 MH181969 ON1 14-amplicon 2,465,632 1,805,348 15,082 31,377.33 VIRALNGS 25 04/12/12 SAMN08724913 
KEN/Kilifi/WGS/1117_10/12/2012 MH181970 ON1 14-amplicon 2,254,784 1,873,994 15,232 32,492.81 SPADES 22.1 10/12/12 SAMN08724914 
KEN/Kilifi/WGS/1118_12/12/2012 MH181971 ON1 14-amplicon 2,783,040 2,095,178 15,049 36,339.50 VIRALNGS 22.79 12/12/12 SAMN08724915 
KEN/Kilifi/WGS/1119_15/12/2012 MH181972 ON1 14-amplicon 2,354,872 2,156,166 15,152 37,309.87 VIRALNGS 20.03 15/12/12 SAMN08724916 
KEN/Kilifi/WGS/1120_19/12/2012 MH181973 ON1 14-amplicon 2,108,962 1,920,920 15,099 32,979.37 VIRALNGS 19.74 19/12/12 SAMN08724917 
KEN/Kilifi/WGS/1121_21/12/2012 MH181974 ON1 14-amplicon 3,135,066 2,966,696 15,170 51,695.42 VIRALNGS 20.48 21/12/12 SAMN08724918 
KEN/Kilifi/WGS/1122_23/12/2012 MH181975 ON1 14-amplicon 2,404,842 2,248,908 15,145 38,581.46 VIRALNGS 18.57 23/12/12 SAMN08724919 
KEN/Kilifi/WGS/1124_24/12/2012 MH181976 ON1 14-amplicon 1,571,860 798,782 15,049 13,968.73 VIRALNGS 23.75 24/12/12 SAMN08724920 
KEN/Kilifi/WGS/1125_26/12/2012 MH181977 ON1 14-amplicon 2,626,156 2,516,622 15,227 43,345.79 SPADES 16.88 26/12/12 SAMN08724921 
KEN/Kilifi/WGS/1126_03/01/2013 MH181978 ON1 14-amplicon 1,969,924 1,436,248 14,959 24,636.93 VIRALNGS 23.18 03/01/13 SAMN08724922 
KEN/Kilifi/WGS/1128_07/01/2013 MH181979 ON1 14-amplicon 1,733,862 1,428,270 15,075 24,776.24 VIRALNGS 23.35 07/01/13 SAMN08724923 
KEN/Kilifi/WGS/1129_08/01/2013 MH181980 ON1 14-amplicon 2,637,728 2,557,822 15,169 43,864.26 VIRALNGS 20.43 08/01/13 SAMN08724924 
KEN/Kilifi/WGS/1131_10/01/2013 MH181981 ON1 14-amplicon 2,778,546 2,598,338 15,114 44,738.50 VIRALNGS 26.33 10/01/13 SAMN08724925 
KEN/Kilifi/WGS/1132_11/01/2013 MH181982 ON1 14-amplicon 2,898,380 2,801,846 15,322 48,134.24 SPADES 19.8 11/01/13 SAMN08724926 
KEN/Kilifi/WGS/1133_11/01/2013 MH181983 ON1 14-amplicon 3,266,658 3,046,788 15,150 52,451.71 VIRALNGS 22.94 11/01/13 SAMN08724927 
KEN/Kilifi/WGS/1134_12/01/2013 MH181984 ON1 14-amplicon 2,704,858 2,439,372 15,118 41,877.57 VIRALNGS 22.01 12/01/13 SAMN08724928 
KEN/Kilifi/WGS/1138_14/01/2013 MH181897 GA2 6-amplicon 1,980,492 1,268,738 14,985 15,156.29 VIRALNGS 20.06 14/01/13 SAMN08724929 
KEN/Kilifi/WGS/1140_17/01/2013 MH181985 ON1 14-amplicon 2,211,052 1,873,618 15,123 32,450.84 VIRALNGS 21.47 17/01/13 SAMN08724930 
KEN/Kilifi/WGS/1141_17/01/2013 MH181986 ON1 14-amplicon 2,438,632 2,291,448 15,160 39,710.23 VIRALNGS 22.23 17/01/13 SAMN08724931 
KEN/Kilifi/WGS/1142_21/01/2013 MH181987 ON1 14-amplicon 2,399,228 2,032,498 15,136 35,144.81 VIRALNGS 23.53 21/01/13 SAMN08724932 
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KEN/Kilifi/WGS/1144_24/01/2013 MH181988 ON1 6-amplicon 996,732 167,134 14,906 2,385.06 VIRALNGS 20.97 24/01/13 SAMN08724933 
KEN/Kilifi/WGS/1146_03/02/2013 MH181898 GA2 6-amplicon 1,460,748 247,094 14,693 2,739.55 VIRALNGS 19.26 03/02/13 SAMN08724934 
KEN/Kilifi/WGS/1148_07/02/2013 MH181899 GA2 6-amplicon 1,597,584 1,143,202 14,984 1,414.55 VIRALNGS 20.56 07/02/13 SAMN08724935 
KEN/Kilifi/WGS/1149_07/02/2013 MH181900 GA2 6-amplicon 1,333,010 777,046 14,978 8,232.99 VIRALNGS 20.88 07/02/13 SAMN08724936 
KEN/Kilifi/WGS/1151_10/02/2013 MH181989 ON1 6-amplicon 1,727,108 159,996 15,037 1,869.62 VIRALNGS 18.67 10/02/13 SAMN08724937 
KEN/Kilifi/WGS/1153_12/03/2013 MH181990 ON1 6-amplicon 1,520,970 887,602 15,001 10,661.08 VIRALNGS 18.79 12/03/13 SAMN08724938 
KEN/Kilifi/WGS/1155_13/03/2013 MH181901 GA2 6-amplicon 1,024,466 779,830 14,985 10,443.44 VIRALNGS 24.58 24/05/13 SAMN08724939 
KEN/Kilifi/WGS/1159_24/05/2013 MH181902 GA2 6-amplicon 1,795,530 959,456 14,981 11,739.93 VIRALNGS 22.76 24/05/13 SAMN08724940 
KEN/Kilifi/WGS/1160_31/05/2013 MH181903 GA2 6-amplicon 1,349,884 520,174 14,764 6,539.51 VIRALNGS 22.57 31/05/13 SAMN08724941 
KEN/Kilifi/WGS/1162_12/10/2013 MH181991 ON1 6-amplicon 1,003,770 784,072 15,047 10,930.69 VIRALNGS 21.5 12/10/13 SAMN08724942 
KEN/Kilifi/WGS/1163_15/10/2013 MH181992 ON1 6-amplicon 1,071,636 612,044 15,053 8,500.36 VIRALNGS 22.21 15/10/13 SAMN08724943 
KEN/Kilifi/WGS/1166_28/10/2013 MH181993 ON1 6-amplicon 845,020 193,328 15,021 2,668.08 VIRALNGS 26.99 28/10/13 SAMN08724944 
KEN/Kilifi/WGS/1167_04/11/2013 MH181994 ON1 6-amplicon 1,165,720 474,594 15,023 6,649.96 VIRALNGS 25.14 04/11/13 SAMN08724945 
KEN/Kilifi/WGS/1168_07/11/2013 MH181995 ON1 6-amplicon 1,209,356 203,814 14,979 2,880.96 VIRALNGS 23.27 07/11/13 SAMN08724946 
KEN/Kilifi/WGS/1169_07/11/2013 MH181904 GA2 6-amplicon 1,606,550 1,029,916 15,011 10,948.78 VIRALNGS 19.27 07/11/13 SAMN08724947 
KEN/Kilifi/WGS/1171_12/11/2013 MH181996 ON1 6-amplicon 947,458 479,690 14,828 6,448.30 VIRALNGS 19.7 12/11/13 SAMN08724948 
KEN/Kilifi/WGS/1173_19/11/2013 MH181997 ON1 6-amplicon 1,058,828 662,216 15,052 9,348.85 VIRALNGS 30.66 19/11/13 SAMN08724949 
KEN/Kilifi/WGS/1582_01/04/2014 MH181998 ON1 6-amplicon 1,568,332 687,440 15,026 8,437.15 VIRALNGS 24.16 13/04/14 SAMN08724950 
KEN/Kilifi/WGS/1583_13/04/2014 MH181999 ON1 6-amplicon 302,368 39,148 14,734 510.27 VIRALNGS 26.44 15/04/14 SAMN08724951 
KEN/Kilifi/WGS/1215_15/04/2014 MH181905 GA2 6-amplicon 1,729,644 998,364 15,044 11,774.25 VIRALNGS 21.29 15/04/14 SAMN08724952 
KEN/Kilifi/WGS/1584_23/04/2014 MH182000 ON1 6-amplicon 1,842,612 244,414 14,868 2,917.30 VIRALNGS 26.07 26/11/14 SAMN08724953 
KEN/Kilifi/WGS/1246_26/11/2014 MH182001 ON1 6-amplicon 1,174,582 955,666 15,187 12,678.17 VIRALNGS 21.34 26/11/14 SAMN08724954 
KEN/Kilifi/WGS/1247_04/12/2014 MH182002 ON1 6-amplicon 706,526 491,376 15,055 6,409.80 VIRALNGS 24.28 04/12/14 SAMN08724955 
KEN/Kilifi/WGS/1249_05/12/2014 MH182003 ON1 6-amplicon 2,218,820 1,646,984 15,057 19,674.11 VIRALNGS 24.08 05/12/14 SAMN08724956 
KEN/Kilifi/WGS/1250_06/12/2014 MH182004 ON1 6-amplicon 218,950 110,400 14,825 1,493.04 VIRALNGS 24.93 06/12/14 SAMN08724957 
KEN/Kilifi/WGS/1251_06/12/2014 MH182005 ON1 6-amplicon 1,174,208 89,898 14,802 1,320.67 VIRALNGS 26.32 06/12/14 SAMN08724958 
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KEN/Kilifi/WGS/1252_07/12/2014 MH182006 ON1 6-amplicon 1,114,664 424,006 15,043 5,840.78 VIRALNGS 24.72 07/12/14 SAMN08724959 
KEN/Kilifi/WGS/1253_08/12/2014 MH182007 ON1 6-amplicon 1,657,878 791,536 15,047 10,202.00 VIRALNGS 27.31 08/12/14 SAMN08724960 
KEN/Kilifi/WGS/1254_08/12/2014 MH182008 ON1 6-amplicon 2,111,452 1,448,258 15,052 19,567.76 VIRALNGS 24.71 08/12/14 SAMN08724961 
KEN/Kilifi/WGS/1256_09/12/2014 MH182009 ON1 6-amplicon 929,072 446,432 15,167 5,904.01 VIRALNGS 27.5 09/12/14 SAMN08724962 
KEN/Kilifi/WGS/1257_10/12/2014 MH182010 ON1 6-amplicon 905,314 679,084 15,023 9,435.24 VIRALNGS 24.48 10/12/14 SAMN08724963 
KEN/Kilifi/WGS/1258_11/12/2014 MH182011 ON1 6-amplicon 1,549,978 1,255,922 15,058 16,074.53 VIRALNGS 21.74 11/12/14 SAMN08724964 
KEN/Kilifi/WGS/1260_14/12/2014 MH182012 ON1 6-amplicon 1,050,160 881,444 15,060 11,114.68 VIRALNGS 23.38 14/12/14 SAMN08724965 
KEN/Kilifi/WGS/1261_14/12/2014 MH182013 ON1 6-amplicon 1,109,236 931,816 15,047 12,570.43 VIRALNGS 25.45 14/12/14 SAMN08724966 
KEN/Kilifi/WGS/1263_15/12/2014 MH182014 ON1 6-amplicon 1,227,836 608,602 15,180 8,407.71 VIRALNGS 26.53 15/12/14 SAMN08724967 
KEN/Kilifi/WGS/1264_15/12/2014 MH182015 ON1 6-amplicon 713,002 11,594 14,172 179.84 VIRALNGS 32.25 15/12/14 SAMN08724968 
KEN/Kilifi/WGS/1266_17/12/2014 MH182016 ON1 6-amplicon 1,620,164 1,332,364 15,059 16,697.38 VIRALNGS 23.34 17/12/14 SAMN08724969 
KEN/Kilifi/WGS/1268_17/12/2014 MH182017 ON1 6-amplicon 2,064,268 1,740,450 15,148 21,533.23 VIRALNGS 22.85 17/12/14 SAMN08724970 
KEN/Kilifi/WGS/1269_17/12/2014 MH182018 ON1 6-amplicon 1,193,216 830,040 15,187 11,270.51 VIRALNGS 25.02 17/12/14 SAMN08724971 
KEN/Kilifi/WGS/1271_18/12/2014 MH182019 ON1 6-amplicon 966,686 822,958 15,098 11,699.58 VIRALNGS 22.74 18/12/14 SAMN08724972 
KEN/Kilifi/WGS/1273_19/12/2014 MH182020 ON1 6-amplicon 1,279,716 942,368 15,053 12,026.06 VIRALNGS 24.03 19/12/14 SAMN08724973 
KEN/Kilifi/WGS/1274_21/12/2014 MH182021 ON1 6-amplicon 1,097,012 811,778 15,184 10,575.22 VIRALNGS 26.9 21/12/14 SAMN08724974 
KEN/Kilifi/WGS/1275_22/12/2014 MH182022 ON1 6-amplicon 1,650,292 1,292,028 15,047 17,744.98 VIRALNGS 25.17 22/12/14 SAMN08724975 
KEN/Kilifi/WGS/1278_25/12/2014 MH182023 ON1 6-amplicon 1,064,228 735,742 15,155 9,942.56 VIRALNGS 28.76 25/12/14 SAMN08724976 
KEN/Kilifi/WGS/1279_27/12/2014 MH182024 ON1 6-amplicon 757,922 130,334 14,824 1,797.32 VIRALNGS 27.91 27/12/14 SAMN08724977 
KEN/Kilifi/WGS/1281_30/12/2014 MH182025 ON1 6-amplicon 921,080 610,496 15,164 8,271.09 VIRALNGS 22.41 30/12/14 SAMN08724978 
KEN/Kilifi/WGS/1282_31/12/2014 MH182026 ON1 6-amplicon 1,648,622 676,458 15,020 8,667.22 VIRALNGS 29.32 31/12/14 SAMN08724979 
KEN/Kilifi/WGS/1283_31/12/2014 MH182027 ON1 6-amplicon 1,315,628 694,854 15,031 9,598.81 VIRALNGS 24.97 31/12/14 SAMN08724980 
KEN/Kilifi/WGS/1284_02/01/2015 MH182028 ON1 6-amplicon 1,059,850 813,254 15,184 10,727.02 VIRALNGS 24.28 02/01/15 SAMN08724981 
KEN/Kilifi/WGS/1286_04/01/2015 MH182029 ON1 6-amplicon 2,048,806 1,502,422 15,056 18,679.43 VIRALNGS 25.14 04/01/15 SAMN08724982 
KEN/Kilifi/WGS/1287_06/01/2015 MH182030 ON1 6-amplicon 1,320,088 1,006,680 15,204 13,479.43 VIRALNGS 22.91 06/01/15 SAMN08724983 
KEN/Kilifi/WGS/1288_07/01/2015 MH182031 ON1 6-amplicon 537,376 426,692 15,059 5,429.30 VIRALNGS 23.91 07/01/15 SAMN08724984 
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KEN/Kilifi/WGS/1289_08/01/2015 MH182032 ON1 6-amplicon 1,099,200 783,598 15,044 11,047.58 VIRALNGS 23.81 08/01/15 SAMN08724985 
KEN/Kilifi/WGS/1290_08/01/2015 MH182033 ON1 6-amplicon 930,504 107,914 14,796 1,529.49 VIRALNGS 34.87 08/01/15 SAMN08724986 
KEN/Kilifi/WGS/1292_09/01/2015 MH182034 ON1 6-amplicon 770,526 7,412 14,216 111.73 VIRALNGS 28.13 09/01/15 SAMN08724987 
KEN/Kilifi/WGS/1293_24/01/2015 MH182035 ON1 6-amplicon 1,040,044 848,258 15,056 10,945.92 VIRALNGS 24.24 24/01/15 SAMN08724988 
KEN/Kilifi/WGS/1295_27/01/2015 MH182036 ON1 6-amplicon 959,732 725,710 15,206 9,327.55 VIRALNGS 23.86 27/01/15 SAMN08724989 
KEN/Kilifi/WGS/1296_29/01/2015 MH182037 ON1 6-amplicon 1,024,190 681,324 15,052 9,406.83 VIRALNGS 25.01 29/01/15 SAMN08724990 
KEN/Kilifi/WGS/1298_31/01/2015 MH182038 ON1 6-amplicon 765,634 523,320 15,047 7,236.79 VIRALNGS 24.66 31/01/15 SAMN08724991 
KEN/Kilifi/WGS/1299_04/02/2015 MH182039 ON1 6-amplicon 1,390,092 34,784 14,741 497.77 VIRALNGS 31.57 04/02/15 SAMN08724992 
KEN/Kilifi/WGS/1301_08/02/2015 MH182040 ON1 6-amplicon 1,184,664 633,118 15,117 8,281.10 VIRALNGS 25.06 08/02/15 SAMN08724993 
KEN/Kilifi/WGS/1302_13/02/2015 MH182041 ON1 6-amplicon 1,134,242 469,232 14,848 6,827.43 VIRALNGS 25.69 13/02/15 SAMN08724994 
KEN/Kilifi/WGS/1305_21/02/2015 MH182042 ON1 6-amplicon 912,242 614,448 15,102 8,643.56 VIRALNGS 28.16 21/02/15 SAMN08724995 
KEN/Kilifi/WGS/1307_26/02/2015 MH182043 ON1 6-amplicon 1,032,236 867,040 15,033 11,866.93 VIRALNGS 24.37 26/02/15 SAMN08724996 
KEN/Kilifi/WGS/1308_05/03/2015 MH182044 ON1 6-amplicon 1,204,456 1,053,810 15,201 13,377.58 VIRALNGS 24.26 05/03/15 SAMN08724997 
KEN/Kilifi/WGS/1309_08/03/2015 MH182045 ON1 6-amplicon 1,110,724 915,046 15,053 12,126.92 VIRALNGS 24.14 08/03/15 SAMN08724998 
KEN/Kilifi/WGS/1311_21/03/2015 MH182046 ON1 6-amplicon 307,420 193,146 14,740 2,480.30 VIRALNGS 27.9 21/03/15 SAMN08724999 
KEN/Kilifi/WGS/1312_22/03/2015 MH182047 ON1 6-amplicon 1,722,762 1,296,644 15,050 15,953.55 VIRALNGS 24.91 22/03/15 SAMN08725000 
KEN/Kilifi/WGS/1313_27/03/2015 MH182048 ON1 6-amplicon 1,143,280 429,554 14,827 5,977.84 VIRALNGS 27.51 27/03/15 SAMN08725001 
KEN/Kilifi/WGS/1314_31/03/2015 MH181906 GA2 6-amplicon 1,625,342 1,010,186 15,022 11,311.20 VIRALNGS 20.75 31/03/15 SAMN08725002 
KEN/Kilifi/WGS/1315_01/04/2015 MH182049 ON1 6-amplicon 1,107,120 740,496 15,066 9,340.28 VIRALNGS 23.95 01/04/15 SAMN08725003 
KEN/Kilifi/WGS/1318_08/04/2015 MH182050 ON1 6-amplicon 900,852 759,034 15,202 9,913.31 VIRALNGS 23.52 08/04/15 SAMN08725004 
KEN/Kilifi/WGS/1320_12/04/2015 MH182051 ON1 6-amplicon 1,698,698 1,185,294 15,048 14,503.36 VIRALNGS 24.15 12/04/15 SAMN08725005 
KEN/Kilifi/WGS/1321_17/04/2015 MH182052 ON1 6-amplicon 1,074,506 944,630 15,019 12,360.20 VIRALNGS 25.73 17/04/15 SAMN08725006 
KEN/Kilifi/WGS/1322_17/04/2014 MH181907 GA2 6-amplicon 1,398,136 367,740 14,757 4,605.53 VIRALNGS 23.73 17/04/14 SAMN08725007 
KEN/Kilifi/WGS/1297_29/01/2015 MH182053 ON1 6-amplicon 1,598,292 1,046 13,966 39.95 VIRALNGS NA 29/01/15 SAMN08725008 
KEN/Kilifi/WGS/1585_17/02/2016 MH182054 ON1 6-amplicon 1,149,120 700,486 15,082 8,828.96 VIRALNGS 22.09 17/02/16 SAMN08725009 
KEN/Kilifi/WGS/1586_28/01/2016 MH182055 ON1 6-amplicon 1,156,030 266,436 14,704 3,938.20 VIRALNGS 22.58 28/01/16 SAMN08725010 
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KEN/Kilifi/WGS/1587_08/02/2016 MH182056 ON1 6-amplicon 939,876 48,486 14,882 712.62 VIRALNGS 25.82 08/02/16 SAMN08725011 
KEN/Kilifi/WGS/1588_29/03/2016 MH182057 ON1 6-amplicon 1,021,102 391,966 14,993 4,937.68 VIRALNGS 25.32 29/03/16 SAMN08725012 
KEN/Kilifi/WGS/1589_26/01/2016 MH182058 ON1 6-amplicon 1,281,062 99,496 14,660 1,353.70 VIRALNGS 25.92 26/01/16 SAMN08725013 
KEN/Kilifi/WGS/1590_01/02/2016 MH182059 ON1 6-amplicon 1,153,340 441,172 15,035 5,304.08 VIRALNGS 22.02 01/02/16 SAMN08725014 
KEN/Kilifi/WGS/1591_18/01/2016 MH182060 ON1 6-amplicon 1,124,140 191,242 15,026 2,565.53 VIRALNGS 22.5 18/01/16 SAMN08725015 
KEN/Kilifi/WGS/1592_07/04/2016 MH182061 ON1 6-amplicon 1,089,038 647,740 15,078 8,421.34 VIRALNGS 27.7 07/04/16 SAMN08725016 
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7.6 SNPs identified from dataset of all Kilifi genomes 
Highlighted in yellow are the signature substitutions that differentiate genotype ON1 
viruses from GA2 viruses 
 
Genome 
Position 
CDS Nt 
Pos. 
AA 
Pos. 
Codon 
Pos. 
Nt Change Variant 
Frequency 
Coverage Polymorphism AA Change 
2   
   
-AATTTGA 1.0% -> 1.3% 75 -> 96 Deletion 
 
9   
   
T -> C/- 7.3%/1.0% 96 Mixture 
 
10   
   
-AA 1.00% 97 -> 99 Deletion 
 
80 NS1 37 13 1 T -> C 1.50% 137 transition 
 
112 NS1 69 23 3 A -> G 2.60% 151 transition 
 
134 NS1 91 31 1 A -> G 2.70% 149 transition T -> A 
172 NS1 129 43 3 G -> A 6.30% 144 transition 
 
175 NS1 132 44 3 A -> T 3.50% 143 transversion 
 
187 NS1 144 48 3 A -> G 1.40% 142 transition 
 
196 NS1 153 51 3 G -> A 1.40% 139 transition 
 
244 NS1 201 67 3 T -> C 1.70% 172 transition 
 
359 NS1 316 106 1 G -> T 1.10% 178 transversion D -> Y 
460 NS1 417 139 3 A -> G 1.70% 177 transition 
 
498   
   
C -> A 2.20% 178 transversion 
 
507   
   
T -> C 2.80% 179 transition 
 
518   
   
+AAA 1.70% 181 Insertion 
 
531   
   
A -> G 3.40% 177 transition 
 
532   
   
G -> A 4.00% 177 transition 
 
534   
   
T -> C 5.10% 177 transition 
 
561   
   
A -> G 99.40% 177 transition 
 
567   
   
C -> T 1.70% 176 transition 
 
571   
   
C -> T 1.10% 177 transition 
 
605 NS2 33 11 3 A -> G 2.30% 176 transition 
 
629 NS2 57 19 3 A -> G 1.70% 176 transition 
 
638 NS2 66 22 3 A -> G 82.40% 176 transition 
 
641 NS2 69 23 3 T -> G 5.10% 176 transversion 
 
647 NS2 75 25 3 T -> C 2.30% 177 transition 
 
660 NS2 88 30 1 T -> C 88.80% 178 transition 
 
734 NS2 162 54 3 A -> G 1.10% 179 transition 
 
752 NS2 180 60 3 A -> G 2.20% 179 transition 
 
761 NS2 189 63 3 C -> T 1.10% 179 transition 
 
770 NS2 198 66 3 A -> G 1.10% 180 transition 
 
780 NS2 208 70 1 T -> C 1.10% 180 transition 
 
788 NS2 216 72 3 A -> G 1.10% 180 transition 
 
800 NS2 228 76 3 T -> C 1.10% 180 transition 
 
863 NS2 291 97 3 C -> T 3.30% 181 transition 
 
879 NS2 307 103 1 T -> C 6.60% 182 transition 
 
896 NS2 324 108 3 T -> C 1.10% 182 transition 
 
902 NS2 330 110 3 T -> C 1.10% 182 transition 
 
956   
   
A -> C/T 47.0%/36.5
% 
181 SNP 
 
978   
   
T -> C 5.60% 180 transition 
 
981   
   
C -> T 1.10% 180 transition 
 
983   
   
A -> G 81.10% 180 transition 
 
985   
   
T -> C 1.10% 180 transition 
 
986   
   
T -> C 1.70% 180 transition 
 
993   
   
T -> C 1.10% 180 transition 
 
1008   
   
G -> A 1.10% 182 transition 
 
1012   
   
A -> G 1.10% 182 transition 
 
1017   
   
G -> A 4.40% 182 transition 
 
1024   
   
A -> G 1.10% 181 transition 
 
1064   
   
A -> G 1.60% 183 transition 
 
1189 N 105 35 3 T -> A 36.50% 181 transversion 
 
1204 N 120 40 3 G -> T 6.60% 182 transversion 
 
1231 N 147 49 3 C -> T 36.50% 181 transition 
 
1235 N 151 51 1 T -> C 28.20% 181 transition 
 
1255 N 171 57 3 T -> C 2.80% 181 transition 
 
1267 N 183 61 3 C -> T 37.40% 182 transition 
 
1286 N 202 68 1 T -> C 4.40% 182 transition 
 
1300 N 216 72 3 T -> C 1.10% 182 transition 
 
1342 N 258 86 3 G -> A 1.10% 181 transition 
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1495 N 411 137 3 A -> G 1.10% 182 transition 
 
1501 N 417 139 3 A -> G 1.10% 182 transition 
 
1522 N 438 146 3 T -> C 1.10% 182 transition 
 
1543 N 459 153 3 T -> C 9.90% 182 transition 
 
1615 N 531 177 3 T -> A 88.50% 183 transversion 
 
1630 N 546 182 3 G -> A 1.10% 183 transition 
 
1642 N 558 186 3 T -> C 3.30% 183 transition 
 
1645 N 561 187 3 T -> C 2.20% 183 transition 
 
1675 N 591 197 3 T -> C 1.10% 183 transition 
 
1699 N 615 205 3 A -> C 1.60% 183 transversion 
 
1720 N 636 212 3 G -> A 1.10% 183 transition 
 
1765 N 681 227 3 T -> C 3.30% 183 transition 
 
1801 N 717 239 3 T -> C 2.20% 183 transition 
 
1807 N 723 241 3 G -> A 6.60% 183 transition 
 
1813 N 729 243 3 T -> C 1.10% 183 transition 
 
1820 N 736 246 1 T -> C 2.20% 183 transition 
 
1825 N 741 247 3 T -> C 1.10% 183 transition 
 
1827 N 743 248 2 T -> A 3.30% 183 transversion M -> K 
1859 N 775 259 1 C -> A 2.70% 184 transversion 
 
1861 N 777 259 3 G -> A 1.60% 184 transition 
 
1876 N 792 264 3 A -> G 1.60% 184 transition 
 
1885 N 801 267 3 T -> A 1.10% 184 transversion 
 
1885 N 801 267 3 T -> C 1.10% 184 transition 
 
1888 N 804 268 3 A -> G 4.90% 184 transition 
 
1921 N 837 279 3 A -> T 6.50% 184 transversion 
 
2032 N 948 316 3 A -> G 1.60% 184 transition 
 
2062 N 978 326 3 C -> T 1.10% 184 transition 
 
2080 N 996 332 3 C -> T 1.10% 184 transition 
 
2146 N 1062 354 3 T -> C 1.10% 184 transition 
 
2170 N 1086 362 3 G -> A 2.20% 184 transition 
 
2191 N 1107 369 3 C -> T 83.70% 184 transition 
 
2200 N 1116 372 3 A -> G 3.80% 184 transition 
 
2267   
   
(A)6 -> (A)7 4.90% 184 Insertion 
(tandem 
repeat) 
 
2267   
   
(A)6 -> (A)5 2.70% 183 Deletion 
(tandem 
repeat) 
 
2272   
   
A -> G 77.00% 183 transition 
 
2273   
   
G -> A 8.20% 183 transition 
 
2366 P 75 25 3 G -> A 1.10% 182 transition 
 
2478 P 187 63 1 A -> G 37.70% 183 transition I -> V 
2495 P 204 68 3 G -> A 5.40% 184 transition 
 
2513 P 222 74 3 G -> A 1.10% 184 transition 
 
2522 P 231 77 3 T -> C 98.90% 184 transition 
 
2525 P 234 78 3 T -> C 3.30% 184 transition 
 
2585 P 294 98 3 C -> T 98.40% 184 transition 
 
2588 P 297 99 3 A -> T 5.40% 184 transversion 
 
2600 P 309 103 3 A -> G 2.70% 184 transition 
 
2663 P 372 124 3 T -> C 1.10% 184 transition 
 
2678 P 387 129 3 T -> C 1.60% 184 transition 
 
2753 P 462 154 3 A -> G 1.10% 184 transition 
 
2756 P 465 155 3 G -> A 8.70% 184 transition 
 
2768 P 477 159 3 T -> C 83.70% 184 transition 
 
2780 P 489 163 3 G -> A 2.20% 184 transition 
 
2804 P 513 171 3 T -> C 3.80% 184 transition 
 
2837 P 546 182 3 G -> A 88.00% 184 transition 
 
2858 P 567 189 3 T -> C 2.20% 184 transition 
 
2873 P 582 194 3 T -> C 3.30% 184 transition 
 
2966 P 675 225 3 C -> T 2.20% 184 transition 
 
3011 P 720 240 3 T -> C 1.60% 184 transition 
 
3019   
   
T -> C 1.60% 184 transition 
 
3054   
   
T -> C 1.10% 184 transition 
 
3066   
   
A -> G 1.10% 184 transition 
 
3085   
   
T -> C 4.90% 184 transition 
 
3086   
   
C -> T 2.20% 184 transition 
 
3091   
   
C -> T 2.70% 184 transition 
 
3099   
   
T -> C 5.40% 184 transition 
 
3103   
   
C -> T 99.50% 184 transition 
 
3106   
   
C -> T 88.00% 184 transition 
 
3109   
   
C -> T 85.90% 184 transition 
 
3110   
   
T -> C 2.20% 184 transition 
 
3123   
   
A -> T 1.10% 184 transversion 
 
3135   
   
G -> T/A 1.6%/1.1% 184 SNP 
 
3136   
   
C -> T 2.20% 184 transition 
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3142   
   
T -> C 7.10% 184 transition 
 
3143   
   
A -> T 1.60% 184 transversion 
 
3159   
   
(A)6 -> (A)7 1.10% 184 Insertion 
(tandem 
repeat) 
 
3159   
   
(A)6 -> (A)5 1.10% 184 Deletion 
(tandem 
repeat) 
 
3171   
   
T -> C 99.50% 184 transition 
 
3181   
   
(A)7 -> (A)8 1.60% 184 Insertion 
(tandem 
repeat) 
 
3217 M 18 6 3 C -> T 85.20% 183 transition 
 
3229 M 30 10 3 G -> A 8.70% 183 transition 
 
3247 M 48 16 3 T -> A 1.60% 183 transversion 
 
3266 M 67 23 1 C -> T 4.40% 183 transition 
 
3277 M 78 26 3 C -> T 1.10% 183 transition 
 
3310 M 111 37 3 C -> T 2.20% 183 transition 
 
3322 M 123 41 3 A -> G 2.20% 183 transition 
 
3339 M 140 47 2 T -> A 37.70% 183 transversion L -> Q 
3394 M 195 65 3 C -> T 1.10% 183 transition 
 
3397 M 198 66 3 A -> G 88.50% 183 transition 
 
3403 M 204 68 3 T -> C 88.50% 183 transition 
 
3409 M 210 70 3 G -> A 99.50% 183 transition 
 
3418 M 219 73 3 G -> A 1.60% 183 transition M -> I 
3466 M 267 89 3 C -> T 1.10% 183 transition 
 
3475 M 276 92 3 C -> T 33.90% 183 transition 
 
3505 M 306 102 3 G -> A 2.20% 183 transition 
 
3538 M 339 113 3 G -> A 1.10% 182 transition 
 
3548 M 349 117 1 C -> T 1.60% 182 transition 
 
3565 M 366 122 3 A -> T 4.40% 182 transversion 
 
3643 M 444 148 3 A -> G 1.60% 182 transition 
 
3670 M 471 157 3 A -> G 4.90% 182 transition 
 
3674 M 475 159 1 A -> G 1.10% 182 transition I -> V 
3697 M 498 166 3 T -> C 1.10% 183 transition 
 
3703 M 504 168 3 T -> C 88.50% 183 transition 
 
3721 M 522 174 3 G -> A 9.30% 183 transition 
 
3745 M 546 182 3 C -> T 1.10% 183 transition 
 
3763 M 564 188 3 A -> C 97.30% 182 transversion 
 
3763 M 564 188 3 A -> T 2.20% 182 transversion 
 
3787 M 588 196 3 T -> C 1.60% 182 transition 
 
3800 M 601 201 1 C -> T 1.10% 182 transition 
 
3823 M 624 208 3 C -> T 4.90% 182 transition 
 
3844 M 645 215 3 C -> T 1.10% 183 transition 
 
3969 M 770 257 2 A -> G 38.30% 183 transition 
 
3972   
   
C -> T 4.40% 183 transition 
 
3976   
   
T -> C 1.60% 183 transition 
 
3977   
   
T -> C/- 2.2%/1.6% 183 Mixture 
 
3986   
   
T -> A 10.40% 183 transversion 
 
3994   
   
T -> C 82.00% 183 transition 
 
3998   
   
T -> C 2.20% 183 transition 
 
4002   
   
T -> C 82.00% 183 transition 
 
4009   
   
T -> C 4.90% 183 transition 
 
4010   
   
T -> A 1.10% 183 transversion 
 
4013   
   
T -> C 82.50% 183 transition 
 
4014   
   
A -> T 4.90% 183 transversion 
 
4017   
   
T -> C 82.00% 183 transition 
 
4021   
   
T -> C 2.20% 183 transition 
 
4030   
   
T -> C 82.00% 183 transition 
 
4031   
   
C -> T 1.10% 183 transition 
 
4039   
   
T -> C 81.90% 182 transition 
 
4049   
   
C -> T 6.00% 182 transition 
 
4053   
   
C -> T 7.10% 182 transition 
 
4054   
   
T -> C 81.90% 182 transition 
 
4057   
   
G -> T 1.10% 182 transversion 
 
4064   
   
T -> C 81.90% 182 transition 
 
4069   
   
C -> T 11.50% 182 transition 
 
4093   
   
A -> T 2.70% 182 transversion 
 
4107   
   
C -> T 2.20% 182 transition 
 
4112   
   
T -> A 1.60% 182 transversion 
 
4117   
   
C -> T 3.80% 182 transition 
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4118   
   
G -> A 99.50% 182 transition 
 
4119   
   
G -> A 4.40% 182 transition 
 
4123   
   
C -> A 5.50% 182 transversion 
 
4129   
   
T -> A 1.10% 182 transversion 
 
4131   
   
A -> G 1.10% 182 transition 
 
4143   
   
(A)6 -> (A)7 1.10% 184 Insertion 
(tandem 
repeat) 
 
4143   
   
(A)6 -> (A)5 2.20% 182 Deletion 
(tandem 
repeat) 
 
4148   
   
-AT 3.30% 182 Deletion 
 
4172   
   
G -> A 1.10% 181 transition 
 
4175   
   
G -> A 1.10% 181 transition 
 
4186   
   
T -> C 1.70% 181 transition 
 
4189   
   
T -> C 1.10% 181 transition 
 
4195   
   
C -> G/A 36.5%/1.1% 181 SNP 
 
4228   
   
T -> C 1.60% 182 transition 
 
4238   
   
C -> T 1.10% 182 transition 
 
4287 SH 48 16 3 T -> C 1.10% 182 transition 
 
4296 SH 57 19 3 A -> G 1.10% 181 transition 
 
4297 SH 58 20 1 T -> C 99.50% 182 transition 
 
4300 SH 61 21 1 A -> G 1.10% 181 transition I -> V 
4300 SH 61 21 1 A -> T 1.10% 181 transversion I -> L 
4303 SH 64 22 1 C -> T 35.70% 182 transition H -> Y 
4335 SH 96 32 3 A -> C 99.40% 181 transversion 
 
4365 SH 126 42 3 C -> T 1.10% 181 transition 
 
4374 SH 135 45 3 C -> T 1.10% 181 transition 
 
4385 SH 146 49 2 T -> C 1.10% 181 transition V -> A 
4386 SH 147 49 3 A -> G 1.10% 181 transition 
 
4391 SH 152 51 2 A -> T 2.80% 181 transversion H -> L 
4397 SH 158 53 2 A -> G 2.80% 181 transition K -> R 
4398 SH 159 53 3 A -> G 1.10% 181 transition 
 
4423 SH 184 62 1 G -> A 5.50% 181 transition V -> I 
4459   
   
A -> G 1.10% 182 transition 
 
4463   
   
T -> C 3.30% 182 transition 
 
4480   
   
G -> A 87.90% 182 transition 
 
4482   
   
G -> A 1.60% 182 transition 
 
4495   
   
C -> T 84.20% 183 transition 
 
4496   
   
T -> C 3.30% 183 transition 
 
4520   
   
T -> C 3.30% 183 transition 
 
4521   
   
T -> C 99.50% 183 transition 
 
4532   
   
C -> T 1.10% 183 transition 
 
4540   
   
T -> C 3.30% 182 transition 
 
4543   
   
A -> G 1.10% 182 transition 
 
4558   
   
A -> T 3.30% 182 transversion 
 
4561   
   
(A)5 -> (A)6 3.80% 184 Insertion 
(tandem 
repeat) 
 
4561   
   
(A)5 -> (A)6 57.40% 183 Insertion 
(tandem 
repeat) 
 
4570   
   
C -> T 1.10% 182 transition 
 
4575   
   
C -> T 4.40% 182 transition 
 
4579   
   
G -> A 1.10% 182 transition 
 
4585   
   
G -> A 38.50% 182 transition 
 
4592   
   
A -> G 2.20% 183 transition 
 
4598   
   
(A)5 -> (A)6 4.90% 183 Insertion 
(tandem 
repeat) 
 
4606   
   
C -> T 4.40% 183 transition 
 
4647 G 23 8 2 G -> A 1.60% 183 transition R -> H 
4651 G 27 9 3 C -> T 1.10% 183 transition 
 
4684 G 60 20 3 C -> T 2.20% 183 transition 
 
4691 G 67 23 1 CTA -> TTG 9.80% 183 Substitution 
 
4693 G 69 23 3 A -> G 71.60% 183 transition 
 
4708 G 84 28 3 G -> A 4.90% 183 transition 
 
4756 G 132 44 3 T -> C 1.10% 184 transition 
 
4763 G 139 47 1 G -> A 3.30% 184 transition A -> T 
4793 G 169 57 1 G -> A 32.20% 183 transition A -> T 
4842 G 218 73 2 C -> A 3.30% 183 transversion T -> N 
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4864 G 240 80 3 G -> A 1.60% 183 transition 
 
4867 G 243 81 3 C -> T 1.10% 183 transition 
 
4885 G 261 87 3 C -> T 26.10% 184 transition 
 
4900 G 276 92 3 C -> T 2.70% 184 transition 
 
4907 G 283 95 1 C -> T 1.60% 183 transition P -> S 
4909 G 285 95 3 C -> T 1.10% 183 transition 
 
4927 G 303 101 3 C -> A 1.10% 183 transversion F -> L 
4945 G 321 107 3 T -> C 5.50% 183 transition 
 
4968 G 344 115 2 T -> C 6.60% 183 transition L -> P 
4969 G 345 115 3 A -> T 1.10% 183 transversion 
 
4977 G 353 118 2 C -> T 4.90% 183 transition T -> I 
4993 G 369 123 3 G -> A 1.10% 183 transition 
 
5007 G 383 128 2 C -> T 2.20% 182 transition S -> F 
5021 G 397 133 1 A -> G 1.10% 182 transition I -> V 
5031 G 407 136 2 C -> T 30.80% 182 transition T -> I 
5046 G 422 141 2 T -> C 1.10% 182 transition I -> T 
5048 G 424 142 1 CA -> TT 87.90% 182 Substitution Q -> L 
5053 G 429 143 3 T -> C 6.60% 182 transition 
 
5076 G 452 151 2 G -> A 1.10% 183 transition R -> H 
5081 G 457 153 1 A -> G 1.60% 183 transition N -> D 
5083 G 459 153 3 T -> C 1.10% 183 transition 
 
5095 G 471 157 3 C -> T 37.70% 183 transition 
 
5096 G 472 158 1 A -> C 1.60% 183 transversion K -> Q 
5104 G 480 160 3 C -> T 1.10% 183 transition 
 
5158 G 534 178 3 T -> C 97.30% 182 transition 
 
5221 G 597 199 3 C -> T 2.20% 182 transition 
 
5226 G 602 201 2 G -> A 98.90% 182 transition R -> K 
5230 G 606 202 3 C -> T 31.90% 182 transition 
 
5241 G 617 206 2 C -> A 37.40% 182 transversion P -> Q 
5244 G 620 207 2 C -> T 3.30% 182 transition T -> I 
5246 G 622 208 1 A -> C 88.50% 182 transversion I -> L 
5275 G 651 217 3 T -> C 4.90% 182 transition 
 
5277 G 653 218 2 A -> G 2.20% 182 transition Q -> R 
5297 G 673 225 1 G -> A 1.10% 182 transition V -> I 
5302 G 678 226 3 C -> A 1.60% 183 transversion 
 
5305 G 681 227 3 C -> T 79.80% 183 transition 
 
5308 G 684 228 3 C -> T 1.60% 183 transition 
 
5309 G 685 229 1 A -> G 1.10% 183 transition K -> E 
5314 G 690 230 3 C -> T 83.60% 183 transition 
 
5319 G 695 232 2 A -> G 84.20% 183 transition E -> G 
5333 G 709 237 1 G -> A 88.50% 183 transition D -> N 
5335 G 711 237 3 C -> T 1.10% 183 transition 
 
5338 G 714 238 3 C -> T 1.60% 183 transition 
 
5340 G 716 239 2 CC -> TT 1.10% 183 Substitution T -> I 
5341 G 717 239 3 C -> T 73.20% 183 transition 
 
5346 G 722 241 2 C -> T 1.10% 183 transition T -> I 
5355 G 731 244 2 G -> A 3.80% 183 transition R -> K 
5361 G 737 246 2 C -> T 1.10% 183 transition T -> I 
5363 G 739 247 1 C -> T 4.40% 183 transition 
 
5372 G 748 250 1 T -> C 5.50% 183 transition S -> P 
5373 G 749 250 2 C -> T 1.10% 183 transition S -> F 
5377 G 753 251 3 C -> A 1.60% 183 transversion N -> K 
5382 G 758 253 2 C -> A 84.20% 183 transversion T -> K 
5390 G 766 256 1 C -> T 1.10% 183 transition P -> S 
5396 G 772 258 1 C -> T 4.40% 183 transition H -> Y 
5411 G 787 263 1 G -> A 1.60% 183 transition E -> K 
5424 G 800 267 2 C -> T 2.70% 183 transition S -> L 
5435 G 811 271 1 G -> A 1.10% 183 transition E -> K 
5441 G 817 273 1 A -> C 7.10% 183 transversion N -> H 
5441 G 817 273 1 A -> T 81.40% 183 transversion N -> Y 
5444 G 820 274 1 CT -> TC 7.10% 183 Substitution L -> S 
5445 G 821 274 2 T -> C 77.00% 183 transition L -> P 
5462 G 838 280 1 C -> T 17.50% 183 transition H -> Y 
5462 G 838 280 1 CAT -> TAC 81.40% 183 Substitution H -> Y 
5472 G 848 283 2 C -> T 1.10% 183 transition S -> F 
5475 G 851 284 2 
+GTCAAGAGGA
AACCC 
TCCACTCAACC
ACCCC 
CGAAGGCCATC
CAAGC 
CCATCACAAGT
CCATA 
CAACATCCG 2.20% 184 Insertion 
E -> 
GQEETLHSTT
PEG 
HPSPSQVHT
TSE 
5475 G 851 284 2 
+GTCAAGAGGA
AACCC 
TCCACTCAACC
ACCTCC 
GAAGGCTATCC
AAGCC 
CATCACAAGTC
CATAC 
AACATCCG 
76.60% 184 Insertion 
E -> 
GQEETLHSTT
SEG 
YPSPSQVHTT
SE 
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5475 G 851 284 2 
+GTCAAGAGGA
AACCC 
TCCACTCAACC
ACCTCC 
GAAGGCTATCT
AAGCC 
CATCACAAGTC
TATAC 
AACATCCG 
2.20% 184 Insertion 
E -> 
GQEETLHSTT
SEG 
YLSPSQVYTT
SE 
5475 G 851 284 2 
+TCCATCACAA
GTCCA 
TACAACATCCG 
1.10% 184 Insertion 
 
5481 G 857 286 2 C -> T 53.00% 183 transition P -> L 
5493 G 869 290 2 C -> T 82.50% 183 transition P -> L 
5493 G 869 290 2 CA -> TG 1.60% 183 Substitution P -> L 
5501 G 877 293 1 T -> A 1.10% 183 transversion S -> T 
5503 G 879 293 3 C -> A 6.00% 183 transversion 
 
5506 G 882 294 3 C -> T 1.10% 183 transition 
 
5509 G 885 295 3 A -> G 30.60% 183 transition 
 
5510 G 886 296 1 A -> C 3.80% 183 transversion T -> P 
5515 G 891 297 3 A -> C 3.30% 183 transversion K -> N 
5533 G 909 303 3 C -> T 4.40% 183 transition 
 
5543 G 919 307 1 C -> T 1.10% 183 transition 
 
5549 G 925 309 1 G -> A 1.10% 183 transition A -> T 
5551 G 927 309 3 C -> T 4.40% 183 transition 
 
5568 G 944 315 2 G -> A 1.10% 183 transition R -> K 
5572 G 948 316 3 C -> T 1.10% 183 transition 
 
5577 G 953 318 2 T -> C 3.80% 183 transition I -> T 
5583 G 959 320 2 C -> T 1.10% 183 transition S -> F 
5615 F 18 6 3 C -> T 7.20% 181 transition 
 
5633 F 36 12 3 C -> A 4.40% 181 transversion 
 
5633 F 36 12 3 C -> T 5.00% 181 transition 
 
5649 F 52 18 1 G -> A 1.10% 181 transition V -> I 
5663 F 66 22 3 C -> T 2.80% 181 transition 
 
5678 F 81 27 3 C -> T 1.70% 181 transition 
 
5720 F 123 41 3 C -> T 32.60% 181 transition 
 
5729 F 132 44 3 T -> C 1.60% 182 transition 
 
5783 F 186 62 3 T -> C 1.10% 180 transition 
 
5786 F 189 63 3 T -> C 4.40% 180 transition 
 
5816 F 219 73 3 C -> T 5.00% 181 transition 
 
5817 F 220 74 1 G -> A 5.50% 181 transition A -> T 
5819 F 222 74 3 T -> C 1.70% 181 transition 
 
5849 F 252 84 3 T -> C 1.70% 181 transition 
 
5857 F 260 87 2 A -> G 1.70% 181 transition K -> R 
5902 F 305 102 2 C -> T 1.70% 181 transition A -> V 
5906 F 309 103 3 C -> T 2.20% 181 transition 
 
5916 F 319 107 1 G -> A 1.10% 181 transition A -> T 
5928 F 331 111 1 C -> T 37.00% 181 transition 
 
5943 F 346 116 1 G -> A 88.50% 182 transition D -> N 
5961 F 364 122 1 A -> G 81.30% 182 transition T -> A 
5963 F 366 122 3 C -> T 1.60% 182 transition 
 
5983 F 386 129 2 T -> C 2.70% 182 transition L -> S 
5987 F 390 130 3 C -> T 88.50% 182 transition 
 
6041 F 444 148 3 C -> T 1.10% 182 transition 
 
6044 F 447 149 3 C -> T 5.50% 182 transition 
 
6050 F 453 151 3 C -> A 3.30% 181 transversion 
 
6059 F 462 154 3 A -> G 2.20% 182 transition 
 
6069 F 472 158 1 C -> T 1.10% 182 transition 
 
6074 F 477 159 3 C -> T 1.60% 182 transition 
 
6104 F 507 169 3 T -> C 1.10% 180 transition 
 
6111 F 514 172 1 C -> T 7.80% 180 transition 
 
6113 F 516 172 3 A -> G 2.20% 181 transition 
 
6116 F 519 173 3 C -> T 3.30% 181 transition 
 
6143 F 546 182 3 T -> C 5.00% 181 transition 
 
6170 F 573 191 3 A -> G 84.00% 181 transition 
 
6185 F 588 196 3 A -> G 1.70% 181 transition 
 
6213 F 616 206 1 A -> G 1.10% 181 transition I -> V 
6266 F 669 223 3 C -> T 1.10% 181 transition 
 
6275 F 678 226 3 G -> A 1.10% 181 transition 
 
6278 F 681 227 3 C -> T 1.10% 181 transition 
 
6287 F 690 230 3 A -> G 1.10% 182 transition 
 
6362 F 765 255 3 T -> C 1.10% 181 transition 
 
6374 F 777 259 3 A -> G 4.40% 181 transition 
 
6431 F 834 278 3 T -> C 1.10% 182 transition 
 
6476 F 879 293 3 A -> G 2.20% 182 transition 
 
6510 F 913 305 1 T -> C 99.50% 183 transition 
 
6530 F 933 311 3 T -> C 1.10% 182 transition 
 
6557 F 960 320 3 T -> C 5.00% 181 transition 
 
6578 F 981 327 3 G -> A 2.20% 182 transition 
 
6593 F 996 332 3 C -> T 1.10% 182 transition 
 
6641 F 1044 348 3 A -> T 6.60% 182 transversion 
 
6677 F 1080 360 3 T -> C 1.60% 182 transition 
 
6689 F 1092 364 3 G -> A 2.20% 182 transition 
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6692 F 1095 365 3 A -> G 83.50% 182 transition 
 
6731 F 1134 378 3 G -> A 2.20% 182 transition 
 
6743 F 1146 382 3 T -> C 88.50% 182 transition 
 
6764 F 1167 389 3 C -> T 1.10% 184 transition 
 
6770 F 1173 391 3 T -> C 2.70% 184 transition 
 
6782 F 1185 395 3 T -> C 2.70% 184 transition 
 
6812 F 1215 405 3 C -> A 1.10% 183 transversion 
 
6812 F 1215 405 3 C -> T 2.20% 183 transition 
 
6825 F 1228 410 1 C -> T 2.20% 184 transition 
 
6830 F 1233 411 3 G -> A 99.50% 184 transition 
 
6845 F 1248 416 3 C -> T 3.80% 184 transition 
 
6851 F 1254 418 3 C -> A 1.10% 183 transversion 
 
6863 F 1266 422 3 T -> C 4.40% 183 transition 
 
6875 F 1278 426 3 T -> C 3.30% 183 transition 
 
6941 F 1344 448 3 T -> C 8.80% 182 transition 
 
6968 F 1371 457 3 T -> C 3.90% 181 transition 
 
6977 F 1380 460 3 T -> C 4.40% 181 transition 
 
7031 F 1434 478 3 T -> C 1.70% 181 transition 
 
7046 F 1449 483 3 C -> T 1.10% 180 transition 
 
7104 F 1507 503 1 C -> A 2.20% 181 transversion L -> I 
7109 F 1512 504 3 A -> G 32.00% 181 transition 
 
7181 F 1584 528 3 T -> C 2.80% 181 transition 
 
7184 F 1587 529 3 T -> C 89.00% 181 transition 
 
7199 F 1602 534 3 T -> A 5.50% 181 transversion 
 
7199 F 1602 534 3 T -> C 2.20% 181 transition 
 
7226 F 1629 543 3 T -> A 89.00% 181 transversion 
 
7229 F 1632 544 3 A -> T 89.00% 181 transversion 
 
7253 F 1656 552 3 C -> T 1.10% 181 transition 
 
7262 F 1665 555 3 A -> G 1.10% 181 transition 
 
7268 F 1671 557 3 C -> T 1.10% 181 transition 
 
7277 F 1680 560 3 T -> C 3.30% 181 transition 
 
7295 F 1698 566 3 T -> C 1.10% 181 transition 
 
7301 F 1704 568 3 T -> C 4.40% 181 transition 
 
7313 F 1716 572 3 T -> C 5.00% 181 transition 
 
7337   
   
T -> C 7.70% 181 transition 
 
7340   
   
T -> C 2.20% 181 transition 
 
7359   
   
C -> T 1.10% 181 transition 
 
7360   
   
A -> G 87.30% 181 transition 
 
7365   
   
T -> A 4.40% 181 transversion 
 
7367   
   
A -> G 98.90% 181 transition 
 
7374   
   
G -> A 32.60% 181 transition 
 
7392   
   
G -> A 84.50% 181 transition 
 
7393   
   
G -> A 2.20% 181 transition 
 
7400   
   
C -> T 3.90% 181 transition 
 
7405   
   
A -> G 4.40% 181 transition 
 
7421   
   
A -> T 1.10% 181 transversion 
 
7423   
   
C -> T 1.10% 181 transition 
 
7437   
   
C -> T 1.10% 182 transition 
 
7438   
   
C -> T 3.80% 182 transition 
 
7453   
   
A -> T 89.00% 181 transversion 
 
7457   
   
A -> G 1.10% 181 transition 
 
7461   
   
A -> G 82.20% 180 transition 
 
7470   
   
T -> A 3.90% 180 transversion 
 
7484   
   
-AA 87.40% 183 Deletion 
 
7489   
   
C -> A 95.00% 180 transversion 
 
7491   
   
A -> G 1.70% 180 transition 
 
7500   
   
C -> T 6.70% 179 transition 
 
7569 M2-1 27 9 3 C -> T 2.20% 179 transition 
 
7611 M2-1 69 23 3 T -> C 3.30% 180 transition 
 
7650 M2-1 108 36 3 T -> A 2.70% 183 transversion 
 
7686 M2-1 144 48 3 G -> A 1.60% 182 transition 
 
7701 M2-1 159 53 3 C -> T 3.80% 182 transition 
 
7716 M2-1 174 58 3 A -> T 32.60% 181 transversion 
 
7771 M2-1 229 77 1 G -> A 1.10% 182 transition V -> I 
7782 M2-1 240 80 3 A -> T 1.10% 182 transversion 
 
7788 M2-1 246 82 3 T -> C 1.10% 182 transition 
 
7791 M2-1 249 83 3 T -> C 1.10% 182 transition 
 
7802 M2-1 260 87 2 T -> C 1.10% 182 transition I -> T 
7842 M2-1 300 100 3 C -> T 3.30% 182 transition 
 
7851 M2-1 309 103 3 C -> T 80.20% 182 transition 
 
7866 M2-1 324 108 3 C -> T 1.10% 182 transition 
 
7891 M2-1 349 117 1 C -> A 88.50% 183 transversion H -> N 
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7899 M2-1 357 119 3 A -> G 99.50% 183 transition 
 
7901 M2-1 359 120 2 C -> T 1.10% 183 transition P -> L 
7902 M2-1 360 120 3 A -> C 1.60% 183 transversion 
 
7902 M2-1 360 120 3 A -> G 1.10% 183 transition 
 
7904 M2-1 362 121 2 G -> A 99.50% 183 transition S -> N 
7917 M2-1 375 125 3 A -> G 1.10% 184 transition 
 
7929 M2-1 387 129 3 T -> C 1.60% 184 transition 
 
7971 M2-1 429 143 3 A -> G 1.10% 184 transition 
 
7986 M2-1 444 148 3 G -> A 3.80% 184 transition 
 
8034 M2-1 492 164 3 A -> G 1.60% 184 transition 
 
8052 M2-1 510 170 3 C -> T 4.90% 184 transition 
 
8091 M2-1 549 183 3 T -> C 2.20% 184 transition 
 
8100 M2-1 558 186 3 C -> T 1.60% 184 transition 
 
8101 M2-1 559 187 1 C -> T 3.80% 184 transition H -> Y 
8105 M2-1 563 188 2 C -> T 1.10% 184 transition A -> V 
8105 M2-2 4 2 1 CCA -> TCT 1.10% 184 Substitution P -> S 
8107 M2-1 565 189 1 A -> T 1.10% 184 transversion 
 
8128 M2-2 27 9 3 C -> T 3.80% 184 transition 
 
8149 M2-2 48 16 3 T -> C 1.10% 182 transition 
 
8156 M2-2 55 19 1 C -> A 1.10% 182 transversion L -> I 
8166 M2-2 65 22 2 G -> A 2.20% 182 transition S -> N 
8167 M2-2 66 22 3 T -> C 1.10% 182 transition 
 
8185 M2-2 84 28 3 G -> A 2.70% 182 transition M -> I 
8215 M2-2 114 38 3 T -> C 1.10% 182 transition 
 
8232 M2-2 131 44 2 A -> G 2.20% 182 transition N -> S 
8246 M2-2 145 49 1 C -> T 2.20% 182 transition P -> S 
8251 M2-2 150 50 3 T -> A 1.10% 183 transversion D -> E 
8263 M2-2 162 54 3 T -> C 3.30% 183 transition 
 
8280 M2-2 179 60 2 C -> T 2.20% 183 transition S -> F 
8287 M2-2 186 62 3 C -> T 1.10% 182 transition 
 
8294 M2-2 193 65 1 G -> A 1.60% 182 transition D -> N 
8302 M2-2 201 67 3 T -> C 1.60% 182 transition 
 
8342 M2-2 241 81 1 T -> C 3.30% 182 transition Y -> H 
8359 M2-2 258 86 3 A -> G 37.90% 182 transition 
 
8378   
   
C -> T 2.20% 182 transition 
 
8402   
   
T -> C 1.60% 182 transition 
 
8421   
   
T -> A 99.50% 182 transversion 
 
8459 L 25 9 1 T -> A 4.90% 182 transversion S -> T 
8521 L 87 29 3 T -> C 98.40% 182 transition 
 
8524 L 90 30 3 C -> T 84.60% 182 transition 
 
8536 L 102 34 3 C -> T 4.90% 183 transition 
 
8546 L 112 38 1 G -> A 1.60% 183 transition G -> S 
8557 L 123 41 3 C -> T 1.10% 183 transition 
 
8639 L 205 69 1 T -> A 35.70% 182 transversion S -> T 
8641 L 207 69 3 C -> T 37.40% 182 transition 
 
8653 L 219 73 3 G -> A 2.20% 183 transition 
 
8668 L 234 78 3 A -> G 1.60% 183 transition 
 
8731 L 297 99 3 G -> A 2.20% 182 transition 
 
8731 L 297 99 3 G -> T 2.70% 182 transversion 
 
8767 L 333 111 3 G -> A 2.80% 181 transition 
 
8791 L 357 119 3 C -> T 1.10% 181 transition 
 
8797 L 363 121 3 T -> C 2.20% 181 transition 
 
8867 L 433 145 1 C -> A 1.10% 183 transversion Q -> K 
8887 L 453 151 3 T -> C 84.10% 182 transition 
 
8890 L 456 152 3 T -> C 5.50% 182 transition 
 
8896 L 462 154 3 T -> C 99.50% 182 transition 
 
8962 L 528 176 3 T -> C 4.40% 182 transition 
 
8974 L 540 180 3 A -> C 2.20% 182 transversion K -> N 
8985 L 551 184 2 C -> T 9.30% 182 transition T -> I 
8989 L 555 185 3 C -> T 1.60% 182 transition 
 
9004 L 570 190 3 G -> A 9.30% 182 transition 
 
9034 L 600 200 3 T -> A 3.30% 183 transversion 
 
9073 L 639 213 3 A -> G 2.70% 183 transition 
 
9088 L 654 218 3 A -> G 1.10% 183 transition 
 
9094 L 660 220 3 G -> A 88.50% 183 transition 
 
9097 L 663 221 3 T -> C 1.10% 183 transition 
 
9133 L 699 233 3 G -> A 1.10% 184 transition 
 
9208 L 774 258 3 C -> T 2.20% 183 transition 
 
9247 L 813 271 3 A -> G 2.70% 182 transition 
 
9274 L 840 280 3 A -> G 6.60% 183 transition 
 
9277 L 843 281 3 T -> C 1.10% 183 transition 
 
9313 L 879 293 3 C -> T 6.50% 184 transition 
 
9364 L 930 310 3 G -> A 1.10% 183 transition 
 
9377 L 943 315 1 C -> A 1.10% 184 transversion L -> I 
9403 L 969 323 3 A -> G 1.10% 184 transition 
 
9409 L 975 325 3 C -> T 1.10% 184 transition 
 
9436 L 1002 334 3 G -> A 2.70% 184 transition 
 
9437 L 1003 335 1 G -> A 1.10% 184 transition V -> I 
9442 L 1008 336 3 G -> A 4.30% 184 transition 
 
9457 L 1023 341 3 T -> C 37.20% 183 transition 
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9517 L 1083 361 3 C -> T 3.80% 183 transition 
 
9535 L 1101 367 3 C -> T 2.20% 183 transition 
 
9538 L 1104 368 3 T -> A 4.40% 183 transversion 
 
9538 L 1104 368 3 T -> C 83.60% 183 transition 
 
9541 L 1107 369 3 T -> C 83.60% 183 transition 
 
9550 L 1116 372 3 G -> A 88.00% 183 transition 
 
9559 L 1125 375 3 G -> T 1.10% 183 transversion 
 
9610 L 1176 392 3 A -> C 2.20% 183 transversion 
 
9644 L 1210 404 1 T -> C 1.10% 184 transition F -> L 
9646 L 1212 404 3 C -> T 3.80% 182 transition 
 
9649 L 1215 405 3 T -> A 88.00% 184 transversion 
 
9689 L 1255 419 1 C -> T 1.10% 184 transition 
 
9715 L 1281 427 3 A -> G 8.20% 184 transition 
 
9751 L 1317 439 3 C -> T 2.20% 184 transition 
 
9766 L 1332 444 3 G -> A 98.40% 184 transition 
 
9796 L 1362 454 3 G -> A 1.10% 184 transition 
 
9859 L 1425 475 3 T -> C 1.60% 183 transition 
 
9898 L 1464 488 3 T -> C 84.20% 183 transition 
 
9933 L 1499 500 2 A -> G 1.10% 183 transition N -> S 
9955 L 1521 507 3 A -> G 4.90% 183 transition 
 
9991 L 1557 519 3 A -> G 4.90% 183 transition 
 
10015 L 1581 527 3 G -> A 2.20% 183 transition 
 
10018 L 1584 528 3 C -> T 99.50% 183 transition 
 
10033 L 1599 533 3 T -> C 24.00% 183 transition 
 
10066 L 1632 544 3 T -> A 1.10% 183 transversion 
 
10111 L 1677 559 3 G -> A 3.30% 183 transition 
 
10150 L 1716 572 3 A -> G 10.40% 182 transition 
 
10177 L 1743 581 3 A -> G 1.10% 182 transition 
 
10207 L 1773 591 3 A -> G 1.10% 182 transition 
 
10216 L 1782 594 3 A -> G 2.20% 182 transition 
 
10226 L 1792 598 1 T -> C 73.80% 183 transition Y -> H 
10226 L 1792 598 1 TAC -> CAT 10.40% 183 Substitution Y -> H 
10229 L 1795 599 1 A -> G 1.60% 183 transition N -> D 
10230 L 1796 599 2 A -> C 3.80% 183 transversion N -> T 
10261 L 1827 609 3 T -> C 99.50% 184 transition 
 
10264 L 1830 610 3 G -> T 1.10% 184 transversion 
 
10280 L 1846 616 1 T -> C 1.10% 184 transition 
 
10337 L 1903 635 1 A -> G 1.10% 184 transition M -> V 
10360 L 1926 642 3 A -> G 1.10% 184 transition 
 
10378 L 1944 648 3 T -> A 88.00% 184 transversion 
 
10384 L 1950 650 3 C -> T 2.20% 184 transition 
 
10522 L 2088 696 3 T -> C 1.10% 184 transition 
 
10585 L 2151 717 3 C -> T 88.50% 182 transition 
 
10591 L 2157 719 3 A -> G 33.00% 182 transition 
 
10627 L 2193 731 3 C -> T 1.60% 183 transition 
 
10639 L 2205 735 3 A -> G 10.40% 183 transition 
 
10645 L 2211 737 3 T -> A 3.90% 181 transversion 
 
10700 L 2266 756 1 C -> T 2.20% 182 transition H -> Y 
10705 L 2271 757 3 T -> C 3.30% 182 transition 
 
10739 L 2305 769 1 T -> C 84.60% 182 transition 
 
10744 L 2310 770 3 T -> C 1.10% 182 transition 
 
10804 L 2370 790 3 C -> A 99.40% 180 transversion 
 
10808 L 2374 792 1 C -> T 1.70% 180 transition 
 
10810 L 2376 792 3 A -> G 3.90% 180 transition 
 
10858 L 2424 808 3 T -> C 1.10% 181 transition 
 
10909 L 2475 825 3 A -> G 1.60% 182 transition 
 
10912 L 2478 826 3 T -> C 1.10% 182 transition 
 
10927 L 2493 831 3 A -> G 1.10% 182 transition 
 
10957 L 2523 841 3 T -> C 89.00% 182 transition 
 
10966 L 2532 844 3 G -> A 1.60% 182 transition 
 
10972 L 2538 846 3 A -> G 1.60% 182 transition 
 
11020 L 2586 862 3 C -> A 88.00% 183 transversion 
 
11038 L 2604 868 3 T -> C 8.70% 183 transition 
 
11050 L 2616 872 3 G -> A 9.80% 183 transition 
 
11062 L 2628 876 3 C -> T 1.10% 183 transition 
 
11068 L 2634 878 3 A -> G 3.80% 183 transition 
 
11107 L 2673 891 3 A -> G 1.10% 183 transition 
 
11143 L 2709 903 3 G -> A 1.10% 181 transition 
 
11176 L 2742 914 3 G -> A 99.40% 181 transition 
 
11248 L 2814 938 3 A -> G 1.10% 178 transition 
 
11261 L 2827 943 1 A -> C 3.40% 178 transversion N -> H 
11296 L 2862 954 3 C -> T 89.30% 178 transition 
 
11317 L 2883 961 3 C -> T 2.20% 178 transition 
 
11323 L 2889 963 3 A -> G 1.10% 178 transition 
 
11375 L 2941 981 1 T -> C 3.90% 181 transition 
 
11509 L 3075 1025 3 A -> G 1.10% 181 transition 
 
11521 L 3087 1029 3 A -> G 1.10% 181 transition 
 
11528 L 3094 1032 1 T -> G 5.00% 181 transversion S -> A 
11560 L 3126 1042 3 C -> T 1.10% 181 transition 
 
11569 L 3135 1045 3 A -> G 97.80% 181 transition 
 
11575 L 3141 1047 3 C -> T 38.10% 181 transition 
 
11581 L 3147 1049 3 C -> T 6.60% 181 transition 
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11596 L 3162 1054 3 C -> T 1.70% 181 transition 
 
11713 L 3279 1093 3 C -> T 89.00% 182 transition 
 
11752 L 3318 1106 3 C -> T 89.00% 181 transition 
 
11798 L 3364 1122 1 C -> T 1.10% 181 transition 
 
11821 L 3387 1129 3 A -> G 1.70% 181 transition 
 
11854 L 3420 1140 3 T -> C 1.10% 180 transition 
 
11929 L 3495 1165 3 T -> C 88.50% 182 transition 
 
11991 L 3557 1186 2 G -> A 1.10% 181 transition R -> K 
12005 L 3571 1191 1 A -> G 1.10% 182 transition I -> V 
12013 L 3579 1193 3 T -> C 1.10% 182 transition 
 
12025 L 3591 1197 3 A -> G 1.10% 182 transition 
 
12076 L 3642 1214 3 C -> T 6.60% 182 transition 
 
12142 L 3708 1236 3 T -> C 1.60% 182 transition 
 
12256 L 3822 1274 3 A -> T 1.60% 182 transversion 
 
12350 L 3916 1306 1 G -> A 3.30% 184 transition D -> N 
12364 L 3930 1310 3 G -> A 1.10% 184 transition 
 
12418 L 3984 1328 3 T -> C 88.00% 184 transition 
 
12454 L 4020 1340 3 T -> A 3.30% 184 transversion 
 
12487 L 4053 1351 3 A -> T 1.10% 184 transversion 
 
12544 L 4110 1370 3 C -> T 1.60% 184 transition 
 
12556 L 4122 1374 3 A -> G 81.50% 184 transition 
 
12625 L 4191 1397 3 A -> T 83.20% 184 transversion 
 
12637 L 4203 1401 3 A -> G 32.60% 184 transition 
 
12648 L 4214 1405 2 T -> C 1.10% 184 transition V -> A 
12667 L 4233 1411 3 A -> T 87.50% 184 transversion 
 
12676 L 4242 1414 3 C -> T 3.80% 184 transition 
 
12679 L 4245 1415 3 G -> A 35.30% 184 transition 
 
12697 L 4263 1421 3 G -> A 1.10% 184 transition 
 
12710 L 4276 1426 1 A -> G 1.10% 184 transition I -> V 
12793 L 4359 1453 3 G -> A 2.70% 184 transition 
 
12799 L 4365 1455 3 A -> G 37.00% 184 transition 
 
12870 L 4436 1479 2 C -> T 1.10% 184 transition A -> V 
12871 L 4437 1479 3 G -> A 2.20% 184 transition 
 
12895 L 4461 1487 3 T -> C 1.10% 184 transition 
 
12898 L 4464 1488 3 T -> C 1.10% 184 transition 
 
12905 L 4471 1491 1 A -> G 1.10% 184 transition I -> V 
12907 L 4473 1491 3 T -> C 1.10% 184 transition 
 
12922 L 4488 1496 3 A -> G 1.10% 184 transition 
 
13033 L 4599 1533 3 T -> C 1.10% 181 transition 
 
13060 L 4626 1542 3 C -> A 1.60% 183 transversion 
 
13066 L 4632 1544 3 T -> C 2.20% 183 transition 
 
13069 L 4635 1545 3 T -> C 8.80% 182 transition 
 
13072 L 4638 1546 3 T -> C 2.20% 183 transition 
 
13082 L 4648 1550 1 G -> A 2.20% 183 transition G -> S 
13117 L 4683 1561 3 A -> T 1.10% 184 transversion 
 
13162 L 4728 1576 3 G -> A 1.10% 182 transition 
 
13180 L 4746 1582 3 T -> C 7.10% 183 transition 
 
13210 L 4776 1592 3 A -> C 8.70% 183 transversion 
 
13210 L 4776 1592 3 A -> T 90.70% 183 transversion 
 
13213 L 4779 1593 3 C -> T 5.50% 183 transition 
 
13223 L 4789 1597 1 A -> T 1.10% 183 transversion S -> C 
13315 L 4881 1627 3 T -> A 1.10% 183 transversion 
 
13344 L 4910 1637 2 A -> G 1.10% 181 transition K -> R 
13348 L 4914 1638 3 A -> T 1.60% 182 transversion 
 
13369 L 4935 1645 3 A -> T 99.40% 180 transversion 
 
13435 L 5001 1667 3 A -> G 88.80% 179 transition 
 
13453 L 5019 1673 3 T -> G 88.80% 179 transversion 
 
13456 L 5022 1674 3 T -> C 1.10% 179 transition 
 
13519 L 5085 1695 3 T -> C 2.20% 179 transition 
 
13522 L 5088 1696 3 T -> C 88.80% 179 transition 
 
13558 L 5124 1708 3 T -> C 88.90% 180 transition 
 
13570 L 5136 1712 3 C -> T 2.20% 180 transition 
 
13579 L 5145 1715 3 C -> T 99.40% 180 transition 
 
13582 L 5148 1716 3 A -> G 2.20% 180 transition I -> M 
13608 L 5174 1725 2 AT -> GA 6.70% 180 Substitution D -> G 
13609 L 5175 1725 3 T -> A 82.20% 180 transversion D -> E 
13609 L 5175 1725 3 T -> C 4.40% 180 transition 
 
13611 L 5177 1726 2 A -> G 39.80% 181 transition K -> R 
13615 L 5181 1727 3 G -> A 1.10% 181 transition 
 
13623 L 5189 1730 2 G -> A 1.10% 180 transition S -> N 
13639 L 5205 1735 3 T -> C 4.90% 182 transition 
 
13646 L 5212 1738 1 G -> A 3.80% 182 transition V -> I 
13648 L 5214 1738 3 T -> A 2.20% 182 transversion 
 
13651 L 5217 1739 3 C -> T 1.10% 182 transition 
 
13664 L 5230 1744 1 C -> T 2.70% 182 transition P -> S 
13674 L 5240 1747 2 C -> T 1.10% 182 transition S -> F 
13681 L 5247 1749 3 G -> A 1.10% 182 transition 
 
13695 L 5261 1754 2 C -> T 1.60% 182 transition S -> L 
13720 L 5286 1762 3 C -> T 2.70% 182 transition 
 
13725 L 5291 1764 2 G -> A 1.10% 181 transition R -> K 
13736 L 5302 1768 1 T -> C 1.10% 182 transition Y -> H 
13753 L 5319 1773 3 A -> G 86.80% 182 transition 
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13792 L 5358 1786 3 A -> T 5.50% 182 transversion 
 
13795 L 5361 1787 3 C -> T 1.10% 182 transition 
 
13837 L 5403 1801 3 C -> A 4.90% 182 transversion 
 
13891 L 5457 1819 3 T -> C 2.20% 182 transition 
 
13906 L 5472 1824 3 A -> G 1.10% 181 transition 
 
13960 L 5526 1842 3 A -> G 35.90% 181 transition 
 
13969 L 5535 1845 3 T -> A 35.90% 181 transversion D -> E 
13981 L 5547 1849 3 A -> G 1.10% 181 transition I -> M 
13993 L 5559 1853 3 T -> C 3.80% 183 transition 
 
14122 L 5688 1896 3 G -> A 88.00% 184 transition 
 
14179 L 5745 1915 3 C -> T 1.60% 183 transition 
 
14251 L 5817 1939 3 G -> A 3.80% 183 transition 
 
14261 L 5827 1943 1 G -> A 2.20% 183 transition V -> I 
14302 L 5868 1956 3 A -> G 1.10% 184 transition 
 
14311 L 5877 1959 3 C -> T 37.50% 184 transition 
 
14374 L 5940 1980 3 C -> T 1.10% 184 transition 
 
14425 L 5991 1997 3 C -> T 2.20% 184 transition 
 
14491 L 6057 2019 3 A -> G 4.30% 184 transition 
 
14506 L 6072 2024 3 A -> G 1.10% 183 transition 
 
14522 L 6088 2030 1 C -> T 1.10% 183 transition 
 
14614 L 6180 2060 3 C -> T 1.10% 183 transition 
 
14629 L 6195 2065 3 A -> G 2.20% 183 transition 
 
14656 L 6222 2074 3 T -> A 99.50% 182 transversion F -> L 
14665 L 6231 2077 3 C -> T 99.50% 182 transition 
 
14669 L 6235 2079 1 A -> G 1.10% 182 transition S -> G 
14675 L 6241 2081 1 G -> A 1.10% 182 transition D -> N 
14686 L 6252 2084 3 G -> A 89.30% 182 transition 
 
14757 L 6323 2108 2 A -> G 1.10% 182 transition K -> R 
14797 L 6363 2121 3 A -> T 3.90% 181 transversion L -> F 
14803 L 6369 2123 3 T -> C 3.90% 181 transition 
 
14806 L 6372 2124 3 T -> C 3.90% 181 transition 
 
14819 L 6385 2129 1 G -> A 1.10% 180 transition V -> I 
14884 L 6450 2150 3 A -> G 1.10% 179 transition 
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7.7 BEAST MCC trees showing divergence between ON1 (cyan) and GA2 
(red) viruses across different RSV ORFs using Kilifi RSV-A dataset 
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S4	Fig:	BEAST	MCC	trees	showing	divergence	between	ON1(cyan)	and	GA2	
(red)	ORFs	
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7.8 Signature SNPs between successful and limited transmission ON1 viruses 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CDS CDS	Nt	Pos. SNP	Codon	Pos. CDS	AA	Pos. Change AA	Change SNP	Type
N 151 1 51 T	->	C Transition
N 558 3 186 T	->	C Transition
N 561 3 187 T	->	C Transition
N 717 3 239 T	->	C Transition
P 567 3 189 T	->	C Transition
M 111 3 37 C	->	T Transition
M 123 3 41 A	->	G Transition
G 69 3 23 G	->	A Transition
G 383 2 128 C	->	T S	->	F Transition
G 821 2 274 C	->	T P	->	L Transition
G 840 3 280 C	->	T Transition
G 893 2 298 C	->	T P	->	L Transition
G 910 1 304 C	->	T H	->	Y Transition
G 929 2 310 C	->	T P	->	L Transition
F 309 3 103 C	->	T Transition
F 364 1 122 G	->	A A	->	T Transition
F 516 3 172 A	->	G Transition
F 1507 1 503 C	->	A L	->	I Transversion
M2-1 549 3 183 T	->	C Transition
M2-2 131 2 44 A	->	G N	->	S Transition
L 219 3 73 G	->	A Transition
L 297 3 99 G	->	T Transversion
L 528 3 176 T	->	C Transition
L 540 3 180 A	->	C K	->	N Transversion
L 774 3 258 C	->	T Transition
L 1002 3 334 G	->	A Transition
L 1101 3 367 C	->	T Transition
L 1599 3 533 T	->	C Transition
L 1782 3 594 A	->	G Transition
L 4122 3 1374 G	->	A Transition
L 4437 3 1479 G	->	A Transition
L 5457 3 1819 T	->	C Transition
L 5991 3 1997 C	->	T Transition
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7.9 Signature SNPs between non-BA and BA viruses 
ORF ORF Nt Pos. ORF AA Pos. Change AA Change SNP Type 
NS1 CDS 133 45 G -> A A -> T Substitution 
NS1 CDS 315 105 G -> A M -> I Substitution 
NS1 CDS 412 138 A -> C N -> H Substitution 
N CDS 1114 372 G -> A A -> T Substitution 
M CDS 266 89 T -> C I -> T Substitution 
SH CDS 170 57 T -> A L -> Q Substitution 
G CDS 10 4 C -> A H -> N Substitution 
G CDS 95 32 G -> A R -> K Substitution 
G CDS 301 101 T -> C S -> P Substitution 
G CDS 325 109 T -> C S -> P Substitution 
G CDS 412 138 ACC -> TCT T -> S Substitution 
G CDS 418 140 T -> C S -> P Substitution 
G CDS 428 143 C -> A T -> N Substitution 
G CDS 472 158 -AAA K ->  Deletion 
G CDS 619 207 A -> C T -> P Substitution 
G CDS 656 219 C -> T P -> L Substitution 
G CDS 686 229 CC -> TT T -> I Substitution 
G CDS 710 237 T -> C L -> P Substitution 
G CDS 739 247 T -> C S -> P Substitution 
G CDS 757 253 60 nt insertion 30 AA insertion Insertion 
G CDS 799 267 C -> T H -> Y Substitution 
G CDS 883 295 AC -> CT T -> L Substitution 
G CDS 892 298 C -> T H -> Y Substitution 
F CDS 135 45 T -> G F -> L Substitution 
F CDS 1585 529 A -> G T -> A Substitution 
M2-1 CDS 425 142 A -> G N -> S Substitution 
M2-1 CDS 545 182 A -> G N -> S Substitution 
M2-2 CDS 103 35 A -> G N -> D Substitution 
L CDS 23 8 A -> G N -> S Substitution 
L CDS 529 177 C -> T H -> Y Substitution 
L CDS 551 184 C -> A T -> N Substitution 
L CDS 1120 374 A -> G N -> D Substitution 
L CDS 2918 973 T -> C M -> T Substitution 
L CDS 3748 1250 A -> G S -> G Substitution 
L CDS 4640 1547 A -> G K -> R Substitution 
L CDS 5148 1716 G -> A M -> I Substitution 
L CDS 5178 1726 T -> A S -> R Substitution 
L CDS 5291 1764 A -> G K -> R Substitution 
L CDS 5360 1787 C -> A A -> E Substitution 
L CDS 6125 2042 C -> T T -> I Substitution 
L CDS 6195 2065 A -> T K -> N Substitution 
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7.10 ML trees showing clustering between ON1 (cyan) and non-ON1 (red) viruses using global RSV-A dataset 
RSV-A F-gene          RSV-A L-gene 
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ON1
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RSV-A N-gene          RSV-A P-gene 
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RSV-A SH-gene          RSV-A M-gene 
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RSV-A M2_1-gene         RSV-A M2_2-gene 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
genotype
GA2_AND_OTHERS
ON1
   
 
 234 
RSV-A NS1-gene         RSV-A NS2-gene 
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7.11 Sites under selective pressure 
KEY:  
* Positive selection; ** Negative Selection; - No site 
GENE SELECTION TEST/ANALYSIS METHOD 
FUBAR SLAC FEL MEME Positive selection 
by all methods 
BUSTED aBSREL 
NS1 22**, 23**, 44**, 48**, 67**, 71**, 76**, 94**, 
139** 
- 22**, 23**, 44**, 71**, 76**, 94** - - Yes None 
NS2 15*, 22**, 70** 22**  19**, 20**, 22**, 54**, 66**, 72**, 96** - - None None 
N 30**, 35**, 49**, 51**, 86**, 100**, 137**, 147**, 
153**, 170**, 172**, 177**, 185**, 186**, 205**, 
243**, 247**, 253**, 259**, 264**, 267**, 268**, 
279**, 316**, 326**, 335**, 350**, 351**, 372** 
51**, 153**, 186**, 
267**, 259** 
30**, 45**, 49**, 51**, 86**, 100**, 137**, 
147**, 153**, 170**, 172**, 177**, 185**, 186**, 
187**, 205**, 243**, 247**, 253**, 259**, 264**, 
267**, 268**, 279**, 326**, 335**, 345**, 350**, 
351**, 360**, 372**, 386** 
- - None None 
P 49**, 68**, 69**, 77**, 98**, 99**, 103**, 129**, 
155**, 157**, 163**, 171**, 182**, 184**, 225** 
98**, 103**, 129**, 
155**, 171**, 225** 
39**, 49**, 68**, 69**, 77**, 98**, 99**, 103**, 
129**, 155**, 157**, 163**, 171**, 182**, 184**, 
194**, 212**, 225**, 240** 
- - None None 
M 6**, 37**, 41**, 51**, 82**, 92**, 122**, 148**, 
157**, 165**, 174**, 188**, 196**, 198**, 208**, 
210**, 218**, 250** 
6**, 196**, 208** 6**, 37**, 41**, 51**, 82**, 92**, 122**, 148**, 
157**, 165**, 188**, 196**, 198**, 208**, 210**, 
218**, 250** 
- - Yes None 
SH 42** 42** 19**, 32**, 42** - - None None 
G 20**, 23**, 80**, 143**, 201*, 202**, 227**, 
228**, 239**, 250*, 251*, 310*, 319** 
80**, 143**, 227**, 
239**, 284*, 310*, 
319** 
14**, 20**, 23**, 80**, 143**, 176**, 186**, 
201*, 202**, 226**, 227**, 228**, 230**, 239**, 
251*, 265**, 273*, 289**, 297*, 310*, 319** 
73*, 201*, 
251*, 273*, 
310* 
310 None None 
F 6**, 12**, 22**, 26**, 60**, 73**, 100**, 110**, 
111**, 112**, 148**, 149**, 154**, 159**, 172**, 
182**, 191**, 196**, 215**, 223**, 226**, 259**, 
293**, 308**, 348**, 360**, 365**, 405**, 411**, 
415**, 422**, 457**, 504**, 528**, 534**, 543**, 
555**, 560**, 568** 
22**, 73**, 159**, 
223**, 405**, 422**, 
457**, 534**, 560**, 
568** 
6**, 22**, 26**, 60**, 73**, 100**, 110**, 112**, 
148**, 149**, 154**, 159**, 172**, 182**, 196**, 
215**, 223**, 226**, 259**, 293**, 308**, 348**, 
360**, 405**, 411**, 415**, 422**, 457**, 504**, 
528**, 534**, 543**, 555**, 560**, 568** 
- - None None 
M2-1 80**, 103**, 120**, 143**, 150**, 186** 103**, 143**, 186** 103**, 125**, 143**, 150**, 164**, 186** - - None None 
M2-2 2** - 2**, 8** - - None None 
L 22**, 28**, 29**, 30**, 34**, 43**, 73**, 78**, 
82**, 99**, 102**, 111**, 114**, 119**, 121**, 
152**, 153**, 154**, 176**, 185**, 200**, 210**, 
29**, 99**, 121**, 
176**, 287**, 392**, 
444**, 475**, 533**, 
22**, 28**, 29**, 30**, 34**, 43**, 78**, 82**, 
99**, 114**, 119**, 121**, 153**, 176**, 200**, 
212**, 213**, 221**, 271**, 281**, 334**, 336**, 
2030*, 2122* - None None 
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212**, 213**, 218**, 220**, 221**, 258**, 271**, 
276**, 280**, 281**, 293**, 296**, 314**, 324**, 
325**, 334**, 336**, 341**, 349**, 361**, 367**, 
368**, 369**, 372**, 375**, 392**, 404**, 405**, 
413**, 427**, 436**, 439**, 444**, 446**, 448**, 
462**, 463**, 475**, 487**, 488**, 507**, 518**, 
526**, 528**, 533**, 540**, 544**, 559**, 563**, 
572**, 581**, 591**, 594**, 609**, 610**, 613**, 
617**, 618**, 639**, 642**, 648**, 650**, 662**, 
689**, 696**, 717**, 719**, 731**, 735**, 737**, 
749**, 757**, 758**, 760**, 769**, 770**, 777**, 
778**, 790**, 792**, 798**, 808**, 825**, 826**, 
831**, 837**, 841**, 846**, 862**, 863**, 868**, 
872**, 876**, 878**, 883**, 891**, 892**, 903**, 
914**, 933**, 938**, 954**, 961**, 963**, 1004**, 
1006**, 1007**, 1016**, 1025**, 1029**, 1033**, 
1034**, 1035**, 1042**, 1045**, 1047**, 1049**, 
1050**, 1054**, 1074**, 1082**, 1093**, 1094**, 
1106**, 1129**, 1135**, 1140**, 1144**, 1145**, 
1178**, 1193**, 1197**, 1199**, 1214**, 1236**, 
1274**, 1282**, 1286**, 1304**, 1305**, 1310**, 
1328**, 1340**, 1345**, 1351**, 1358**, 1362**, 
1370**, 1374**, 1376**, 1381**, 1392**, 1397**, 
1401**, 1402**, 1408**, 1409**, 1411**, 1414**, 
1415**, 1427**, 1435**, 1436**, 1455**, 1483**, 
1487**, 1488**, 1496**, 1510**, 1513**, 1522**, 
1533**, 1534**, 1542**, 1544**, 1545**, 1546**, 
1554**, 1555**, 1561**, 1566**, 1569**, 1576**, 
1582**, 1592**, 1593**, 1606**, 1627**, 1638**, 
1645**, 1647**, 1667**, 1674**, 1679**, 1681**, 
1684**, 1695**, 1696**, 1700**, 1708**, 1712**, 
1715**, 1728**, 1735**, 1739**, 1749**, 1755**, 
1762**, 1771**, 1773**, 1786**, 1787**, 1799**, 
1801**, 1813**, 1819**, 1824**, 1853**, 1868**, 
1894**, 1896**, 1900**, 1909**, 1911**, 1915**, 
1927**, 1931**, 1944**, 1956**, 1959**, 1961**, 
1980**, 2019**, 2024**, 2033**, 2042**, 2060**, 
2061**, 2065**, 2075**, 2077**, 2084**, 2095**, 
2107**, 2123**, 2124**, 2135**, 2150** 
790**, 876**, 954**, 
1054**, 1214**, 
1297**, 1411**, 
1653**, 1773** 
349**, 368**, 392**, 427**, 436**, 439**, 444**, 
446**, 462**, 463**, 475**, 507**, 518**, 528**, 
533**, 544**, 572**, 581**, 591**, 594**, 617**, 
639**, 648**, 662**, 717**, 737**, 749**, 758**, 
760**, 770**, 778**, 790**, 808**, 825**, 826**, 
837**, 846**, 862**, 868**, 872**, 876**, 878**, 
883**, 891**, 914**, 938**, 954**, 963**, 
1006**, 1016**, 1025**, 1033**, 1034**, 1035**, 
1045**, 1050**, 1054**, 1106**, 1140**, 1144**, 
1145**, 1193**, 1199**, 1214**, 1236**, 1274**, 
1286**, 1340**, 1345**, 1351**, 1358**, 1376**, 
1381**, 1397**, 1402**, 1409**, 1411**, 1455**, 
1483**, 1487**, 1488**, 1513**, 1522**, 1533**, 
1544**, 1545**, 1546**, 1561**, 1566**, 1582**, 
1592**, 1627**, 1638**, 1647**, 1674**, 1684**, 
1695**, 1700**, 1715**, 1728**, 1735**, 1771**, 
1773**, 1786**, 1787**, 1813**, 1819**, 1824**, 
1853**, 1868**, 1896**, 1900**, 1909**, 1911**, 
1927**, 1931**, 1956**, 2019**, 2042**, 2061**, 
2065**, 2077**, 2084**, 2123**, 2124**, 2135**, 
2150** 
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7.12 Global sampling of RSV-B full G gene and WGS sequences for 
phylogeographic analysis 
G WGS 
Country No. of samples Entropy Country No. of samples Entropy 
Argentina 34 -0.1302 Argentina 3 -0.0325 
Belgium 3 -0.0202 Belgium 4 -0.0408 
Brazil 3 -0.0202 Brazil 3 -0.0325 
China 91 -0.2414 China 1 -0.0132 
Cuba 38 -0.1405 Germany 3 -0.0325 
Germany 3 -0.0202 Italy 7 -0.0631 
India 39 -0.1430 Jordan 26 -0.1610 
Iran 4 -0.0256 Kenya 16 -0.1158 
Italy 7 -0.0400 Mexico 5 -0.0487 
Japan 1 -0.0080 New_Zealand 41 -0.2139 
Jordan 23 -0.0989 Netherlands 30 -0.1766 
Kenya 15 -0.0721 Peru 24 -0.1528 
Latvia 3 -0.0202 S. Africa 1 -0.0132 
Mexico 5 -0.0306 S. Korea 2 -0.0234 
Netherlands 30 -0.1194 UK 29 -0.1728 
New_Zealand 29 -0.1166 USA 255 -0.3299 
Panama 15 -0.0721 Vietnam 16 -0.1158 
Paraguay 1 -0.0080 Total 466 1.7383 
Peru 19 -0.0860    
Philippines 29 -0.1166    
Qatar 2 -0.0144    
S. Africa 84 -0.2309    
S. Arabia 2 -0.0144    
S. Korea 36 -0.1354    
Spain 53 -0.1749    
Thailand 27 -0.1109    
UK 29 -0.1166    
USA 196 -0.3401    
Uruguay 1 -0.0080    
Vietnam 14 -0.0685    
Total 836 2.7442    
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G WGS 
Continent No. of samples Entropy Continent No. of samples Entropy 
S. America 58 -0.1851 S. America 30 -0.1766 
N. America 254 -0.3619 N. America 260 -0.3256 
Africa 99 -0.2527 Africa 17 -0.1208 
Asia 268 -0.3647 Asia 45 -0.2257 
Europe 128 -0.2873 Europe 73 -0.2904 
Australia and Oceania 29 -0.1166 Australia and Oceania 41 -0.2139 
Total 836 1.568339825 Total 466 1.352903277 
       
Hemisphere No. of samples Entropy Hemisphere No. of samples Entropy 
Southern 63 -0.1948 Southern 44 -0.2228 
Northern 452 -0.3325 Northern 331 -0.2430 
Tropics 321 -0.3675 Tropics 91 -0.3190 
Total 836 0.894855367 Total 466 0.784757005 
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7.13 Global sampling of RSV-A full G gene and WGS sequences for 
phylogeographic analysis 
G WGS 
Country No. of samples Entropy Country No. of samples Entropy 
Australia 1 -0.0052 Australia 1 -0.0091 
Belgium 2 -0.0093 Belgium 2 -0.0162 
Brazil 2 -0.0093 Brazil 2 -0.0162 
Canada 9 -0.0324 China 8 -0.0496 
China 287 -0.3247 Germany 2 -0.0162 
Cuba 46 -0.1121 Hong Kong 4 -0.0286 
Germany 2 -0.0093 India 2 -0.0162 
Hong Kong 3 -0.0132 Italy 2 -0.0162 
India 22 -0.0652 Jordan 38 -0.1541 
Iran 3 -0.0132 Kenya 249 -0.3669 
Italy 2 -0.0093 Lebanon 1 -0.0091 
Japan 5 -0.0201 Mexico 2 -0.0162 
Jordan 38 -0.0978 Netherlands 18 -0.0915 
Kenya 257 -0.3110 New Zealand 50 -0.1839 
Latvia 10 -0.0353 Peru 78 -0.2393 
Lebanon 1 -0.0052 Philippines 12 -0.0677 
Mexico 9 -0.0324 S. Africa 2 -0.0162 
New Zealand 50 -0.1189 S. Korea 1 -0.0091 
Netherlands 19 -0.0583 Taiwan 1 -0.0091 
Panama 2 -0.0093 USA 220 -0.3616 
Paraguay 10 -0.0353 Vietnam 33 -0.1402 
Peru 79 -0.1621 Total 728 1.8331 
Philippines 18 -0.0559    
Qatar 4 -0.0167    
S. Africa 48 -0.1155    
S. Arabia 11 -0.0380    
S. Korea 19 -0.0583    
Spain 149 -0.2382    
Taiwan 1 -0.0052    
Thailand 28 -0.0782    
USA 229 -0.2960    
Uruguay 3 -0.0132    
Vietnam 33 -0.0882    
Total 1402 2.4923    
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G WGS 
Continent No. of samples Entropy Continent No. of samples Entropy 
S. America 94 -0.1812 S. America 80 -0.2427 
N. America 295 -0.3280 N. America 222 -0.3622 
Africa 305 -0.3318 Africa 251 -0.3671 
Asia 473 -0.3666 Asia 100 -0.2727 
Europe 184 -0.2665 Europe 24 -0.1125 
Australia and Oceania 51 -0.1205 Australia and Oceania 51 -0.1862 
Total 1402 1.5946 Total 728 1.5434 
       
Hemisphere No. of samples Entropy Hemisphere No. of samples Entropy 
Southern 51 -0.1205 Southern 51 -0.1862 
Northern 733 -0.3391 Northern 253 -0.3673 
Tropics 618 -0.3611 Tropics 424 -0.3148 
Total 1402 0.8207 Total 728 0.8684 
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7.14 Bayes Factor and Posterior Probability support for RSV transition rates 
between discrete locations in Kenya 
Only the transition rates with BF>3  support are shown. In bold are transitions with 
posterior support of >0.9. 
 
 
RSV-A:  
 
From To Bayes Factor Posterior Probability 
Kilifi Siaya 15370.18 1.00 
Kilifi Kakuma 15370.18 1.00 
Kilifi Dadaab 3839.34 1.00 
Dadaab Kilifi 849.87 1.00 
Siaya Nairobi 491.68 0.99 
Kakuma Siaya 94.28 0.96 
Siaya Kakuma 39.66 0.90 
Kilifi Kisumu 6.25 0.59 
Siaya Kisumu 4.79 0.53 
Kilifi Nairobi 3.11 0.42 
 
 
 
 
RSV-B: 
 
From To Bayes Factor Posterior Probability 
Kilifi Nairobi 5870.76 1.00 
Kilifi Siaya 5870.76 1.00 
Kilifi Dadaab 5870.76 1.00 
Siaya Kakuma 5870.76 1.00 
Dadaab Kakuma 151.32 0.98 
Kilifi Kakuma 61.29 0.95 
Dadaab Siaya 27.33 0.89 
Siaya Kilifi 20.52 0.86 
Kakuma Kilifi 17.42 0.84 
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